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Abstract 
Humans often become co-infected with different malaria strains that differ in virulence, or 
drug resistance. Theoretical models have shown that competition between co-infecting 
strains has important medical implications. Virulent parasites (causing substantial damage to 
their hosts) are assumed to be competitively superior to avirulent parasites, for example, 
driving the evolution of virulence upwards; competition has also been implicated as a major 
determinant in the spread of drug resistance. Even though the precise details differ between 
many theoretical models, they are all based on biological assumptions that remain largely 
untested experimentally. This thesis therefore tests whether competition between co-
infecting malaria strains occurs, and whether more virulent strains have a competitive 
advantage, assumptions underlying most of these evolutionary models. 
I used Plasmodium chabaudi in laboratory mice as a model for human malaria, and 
developed a real-time quantitative PCR assay to track parasite clones in mixed-clone 
infections over time. Several experiments were carried out using this molecular tool, 
showing that intense competition occurs between Plasmodium clones occupying the same 
host. There was a direct relationship between virulence and in-host competitiveness, thus 
supporting a second fundamental theoretical assumption. Host genotype was an important 
determinant as well: competition was more intense in a resistant than a susceptible mouse 
strain. Timing of infection was even more important: the later a parasite clone was 
inoculated after another had established, the more it suffered from competition. 
How in-host competitiveness related to between-host transmission, was assessed by feeding 
infected mice to Anopheles stephensi mosquitoes. This showed a linear relationship between 
in-host competitiveness and mosquito transmission, suggesting that competitive suppression 
in the mouse host translated into reduced transmission to the mosquito vector. Finally, I 
found that drug treatment can disrupt competitive interactions between drug-resistant and - 
sensitive clones, resulting in competitive release of drug resistance, with the potential 
consequence of enhanced spread of resistance. 
This thesis confirms that within-host competition importantly affects the evolution of 
virulence and drug resistance. The results suggest that reducing the number of mixed malaria 
infections could have beneficial effects by reducing the evolutionary selection for increased 
virulence. Also, as resistant hosts were shown to cause more intense competition than 
susceptible hosts, it is suggested that vaccination could enhance selection for increased 
virulence. 
Abbreviations 
AMA!: apical membrane antigen 1 
IFA: immuno-fluorescent antibody assay 
IFN-y: gamma interferon 
1L12: interleukin 12 
i.p.: intraperitoneum (as in i.p. injection) 
i.v.: intravenous (as in i.v. injection) 
MSP1: merozoite surface protein 1 
PCR: Polymerase Chain Reaction 
P1: post-infection 
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TNF-a: Tumour necrosis factor alpha 
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1. General introduction 
1.1. Chocolate cake and the evolution of parasites 
Remember that birthday party when you were small; when you were seven years old? 
Remember that big chocolate cake that your mum had made for you: the one with the icing? 
And remember that there were ten children and that, in principle, everyone could have had a 
piece? So did you? No, of course not, because that awful boy of a Patrick Nasty had two 
pieces! Meaning that, yes, you were left out: on your own birthday! 
This thesis is not about chocolate cakes, and anyone with an interest in those is referred to 
the book by Pamella Asquith (1983). No, this thesis deals with Patrick Nasty, and with a 
special set of Patricks Nasty in particular. Leaving out all those Patricks that roam the world 
and rule our governments, this thesis deals with those that lurk in African mosquitoes to 
strike young children, killing considerate and nice little Patricks in their wake. This thesis is 
about selfishness; about parasites that eat more cake than they deserve; about parasites that 
become so obsessed with having a host to themselves that they start selfishly killing it, 
wiping out their own fellow parasites at the same time. Put in another way: this thesis is 
about understanding why it is that malaria is so deadly, killing over a million children a year. 
'Nothing in biology makes sense except in the light of evolution,' titled Theodosius 
Dobzhansky a beautiful essay, writing that, 'without that light it becomes a pile of sundry 
facts, some of them interesting or curious but making no meaningful picture as a whole' 
(Dobzhansky 1973, p129). Dobzhansky was certainly not the first one to observe this. In 
fact, his words strongly echo what Charles Darwin wrote more than a hundred years earlier, 
in 1859 (Darwin 1859): 'When we no longer look at an organic being as a savage looks at a 
ship, as at something wholly beyond his comprehension; when we regard every production 
of nature as one which has had a history; when we contemplate every complex structure and 
instinct as the summing up of many contrivances, each useful to the possessor, [...] how far 
more interesting [...] will the study of natural history become!' 
Today, however, the absolute majority of people - and scientists for that matter - still look at 
disease as something aberrant and something that should not happen (Nesse & Williams 
1994): after all, we still go to the doctor saying something is wrong with us, rather than 
commenting in awe that we suffer from a highly evolved gut parasite with the most exquisite 
adaptations promoting its own survival in our gut environment, with the - okay - rather 
unpleasant effect of us having diarrhoea. It's not that I think that we should be happy to be 
sick, but objectively, there is just no justification to see disease as something wrong 
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(Williams & Nesse 1991;  Nesse & Williams 1994; Stearns 1999). After all, over fifty 
percent of the species on earth are parasites (Poulin & Morand 2000; Zimmer 2001), which 
means that organisms that do not have the potential to cause disease are hard to find! In 
most, if not all, cases, disease is some highly adapted trait, the result of some exciting history 
that we ourselves have shared with viruses, bacteria, worms or protozoans. 
This thesis tries to contribute to understanding how nasty little Patricks, stealing pieces of 
chocolate cake, have shaped that history. 
1.2. Parasite tragedies 
Until the 1980's it was commonly believed that parasites should evolve to be benign to their 
hosts (Burnet & White 1972; see Anderson & May 1982; Levin 1996), the idea being that if 
parasites depend on their hosts for their own survival and transmission, they should leave 
their hosts alive. Virulent' parasites in this view were those recently introduced to new hosts, 
so that they had not yet evolved benignity. This 'conventional wisdom' has been challenged 
in recent years by researchers who have pointed out that many parasites with a long history 
of co-evolution with their hosts cause high virulence (e.g. Anderson & May 1982; Ewald 
1983; Knolle 1989; Read & Schrag 1991; Lenski & May 1994; Read 1994; Levin 1996). 
Over the last few decades, therefore, several theories have been put forward to explain the 
evolution of virulence (Bull 1994; Read 1994; Levin 1996; Ebert 1999). Some of these 
theories view virulence as a host adaptation to infection (e.g. fever, Ewald 1980); as a direct 
parasite manipulation to increase transmission (e.g. rabies virus increasing the biting rate of 
rabid canids, Ewald 1980); as a coincidental result of parasites being in the wrong 
environment and therefore causing disease (e.g. gut bacteria causing bladder infections, 
Levin 1996); or as the result of short-sighted evolution of pathogens in environments where 
they do not belong (e.g. poliovirus rapidly replicating in central nervous system, causing 
inflammation, Levin 1996). 
No theory has received as much attention, however, as the trade-off model, more satirically 
known as the 'enlightened' view (Levin & Svanborg Eden 1990; Levin 1996). This theory 
describes two main mechanisms by which high virulence can evolve and be maintained (e.g. 
Stearns & Ebert 2001). 
'Following standard usage (e.g. Anderson & May 1982; Frank 1996), virulence is defined here as 
parasite-inflicted reduction of host fitness, and can be expressed in terms of host mortality or 
morbidity. 
Chapter 1 - General introduction 	 2 
First, virulence is an unavoidable consequence of a parasite's efforts to optimise its fitness: 
parasites require extensive host exploitation to obtain transmission to the next host (Figure 
1.1 A), but at the same time such replication damages host tissues, and uses up host resources 
(Figure 1. 1B), thereby increasing the chances of killing the host (e.g. Anderson & May 1982; 
Sasaki & Iwasa 1991; Antia et al. 1994; Frank 1996; Ebert 1999; Read et al. 2002). By this 
logic, parasites that replicate too slowly will be cleared by the host's immune response 
before they can transmit (Antia et al. 1994), whereas parasites that replicate too fast will kill 
their host before they are able to transmit (Anderson & May 1982; Frank 1996). The result is 
selection for parasites with intermediate levels of within-host replication, so that they grow 
fast enough to obtain transmission to the next host, but not so fast that they kill their host 
before realising this; as there is a direct relationship between replication rate and virulence, 
evolution is thus expected to select for parasites with some kind of intermediate level of 
virulence (Figure 1.1C). 
Much higher virulence can evolve, however, due to within-host competition 2 between 
parasite strains 3 (e.g. Levin & Pimentel 1981; Bremermann & Pickering 1983; Ewald 1983; 
Bonhoeffer & Nowak 1994a; 1994b; Nowak & May 1994; Van Baalen & Sabelis 1995; 
Frank 1996; Mosquera & Adler 1998). Thus, prudent parasites suffer great fitness losses in 
hosts simultaneously infected with faster-growing (virulent) parasites: this is because 
virulent parasites kill the host before prudent parasites have realised their fitness potential. 
Even though host death also reduces the fitness of virulent parasites, prudent parasites suffer 
disproportionately and are eliminated by natural selection: a process commonly known as 
'the tragedy of the commons' (Hardin 1968). Thus, even though prudence maximises 
parasite fitness when alone, in mixed infections selfishness will result in persistence of 
highly virulent strains that could not survive without within-host competition (Figure 1. 1D, 
e.g. Nowak & Sigmund 2002). This follows exactly the same logic as the chocolate cake 
mentioned above: one chocolate cake should be enough for 10 children, but due to the 
selfishness of Patrick Nasty, everyone will try to get more than they strictly need, so that 
nice children end up with nothing. 
2  Following ecological definitions (Begon et al. 1996), competition is here defined as the reduction of 
parasite growth, density or transmission, or the increase of parasite death rate, of one parasite strain 
due to the presence of another. 
In this thesis, the words strain, genotype and clone are used interchangeably. 




















Virulence 	 Virulence 
Figure 1.1. Under the trade-off model, both transmission (A) and mortality rate (B) increase with 
increasing parasite replication rate. As a result, parasites obtain an optimal fitness at some 
intermediate level of virulence (C). A parasite in a mixed infection, however, has to compete for 
limited amounts of resources. This will lead to selection for an increased level of virulence, resulting 
in a lower optimal fitness (D). 
1.3. Experimental evidence 
Despite the large amount of theory addressed to the evolution of virulence, experimental 
evidence to substantiate its claims is seriously lacking, so that a real understanding of 
parasite virulence is still not realised. In a way this is surprising, because the theory hinges 
on many assumptions and predictions that are quite easily testable. For example, for 
evolution to occur, there should be heritable variation in parasite growth rates and virulence 
levels, which selection can operate on (Darwin 1859). The theory then assumes that parasites 
with higher growth rates should have both more transmission and cause higher virulence. 
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Also, the theory assumes that there is competition between co-infecting parasite strains, and 
that given such competition, virulent strains will have a competitive advantage in mixed 
infections. Here, I briefly summarise experimental evidence supporting theory, showing that 
there is least support for the assumption that virulent parasites are competitively superior to 
prudent parasites. This is the assumption tested in this thesis. 
1.3.1. Variation in virulence and the trade-off model 
Variation in virulence among parasite strains occurs where it is looked at, for example in 
Plasmodium, Theileria annulata and Babesia bovis (Mackinnon & Read 1999a; Chotivanich 
et al. 2000; Nevils et at. 2000; Taylor et at. 2002; Taylor et at. 2003; Mackinnon & Read 
2004b). That such variation occurs, is even clear from the colloquial language of calling a 
particular flu nasty or mild: indeed, most influenza viruses hardly cause any symptoms, 
whereas some of them have been able to wipe out millions of people (Ewald 1994). 
Although some authors have argued that a relationship between virulence and transmission 
does not always exist (Lipsitch & Moxon 1997; Weiss 2002), many empirical studies have 
now confirmed that it does (Lipsitch & Moxon 1997), for example in pathogenic bacteria in 
Daphnia, Theileria in cows, Plasmodium in humans and Schistosoma mansoni, 
Trypanosoma brucei and Plasmodium chabaudi in mice (Diffley et al. 1987; Ebert 1994; 
Turner et at. 1995; Mackinnon & Read 1999a; Davies et at. 2001; Taylor et al. 2002; 
Mackinnon & Read 2004b). Indirect evidence for the trade-off model comes from 
experiments in which parasites are serially passaged from one host to the next, 
circumventing natural transmission routes. In general these experiments result in increased 
virulence, and it has been suggested that this is a result of artificially diminishing the 
negative effects of high virulence on transmission (Levin & Svanborg Eden 1990; Ebert 
1998; 1999). The most widely cited example supporting the trade-off model is the case of 
myxoma virus that was introduced in Australia in 1950 to control excessive rabbit 
populations. Initially extremely virulent, the virus rapidly evolved to be less virulent, to an 
intermediate level optimising fitness (see Anderson & May 1982). 
1.3.2. Mixed infections and competition between co-infecting strains 
With the use of molecular tools, such as polymerase chain reaction (PCR), it is increasingly 
becoming clear that most, if not all, parasites often share their hosts with other strains of the 
same species (Read & Taylor 2000; 2001). Such mixed infections are probably most 
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thoroughly investigated for human malaria (see below), but they also occur with Crithidia 
bombi in bumblebees, schistosomes in freshwater snails and humans, Theileria annulata in 
cattle, Cryptosporidium parvum in humans and cattle, and Toxoplasma gondii, Streptococcus 
pneumoniae and herpes simplex type un humans (Ben Miled et at. 1994; Obaro et at. 1996; 
Davies et at. 1999; Brouwer et al. 2001; Aspinall et at. 2003; Tanriverdi et at. 2003; Bowden 
et at. 2004; Schmid-Hempel & Funk 2004; Villena et at. 2004; Widmer 2004). 
Mixed infections may result in competition between such strains, by which competition is 
defined as an interaction between the strains, in which the population sizes of one strain are 
depressed by the presence of the other strain (Begon et at. 1996). Competition is well 
described between different parasite species infecting the same host (Richie 1988; Cox 
2001), but it is more likely to occur between different strains of the same species, which 
almost certainly occupy very similar niches (Read & Taylor 2000; Cox 2001; Read & Taylor 
2001). 
Indeed, competition occurs in vivo, between strains of many parasites species, including 
protozoans, bacteria and viruses (Orcutt & Schaedler 1973; Hthgreaves et at. 1975; Seed 
1978; Morrison et at. 1982; Duval-Iflah et at. 1983; Snounou et at. 1992; Taylor et al. 
1997a; Imhoof & Schmid-Hempel 1998b; Lenhoff et at. 1998; Barrow & Page 2000; 
Lipsitch et at. 2000; Taylor et at. 2002; Akiyoshi et at. 2003; De Roode et at. 2003 [Thesis 
Appendix]; Franco et at. 2003). Where competition does not occur, or is very weak, for 
instance between Crithidia bombi strains in Bombus terrestris (Schmid-Hempel et at. 1999), 
this could be due to the different strains occupying different niches within the host (Schmid-
Hempel 2001). 
1.3.3. Virulence and within-host competition 
There is thus no doubt that competition. occurs between co-infecting parasite strains. 
However, whether in such competition virulent parasites are competitively superior to 
avirulent parasites, has to my knowledge never been assessed directly, and the only evidence 
for this is highly indirect. Thus, serial passage of parasites through new host environments 
generally increases virulence (Ebert 1998; Mackinnon & Read 1999b; Mackinnon & Read 
2004a), and attenuated vaccine revertants can arise (Bull 1994; Kew et at. 2002). Both can 
be explained by new mutants arising and increasing in frequency, because they have a 
competitive advantage. However, other explanations are possible: for example, there could 
be an increase of genetic diversity of the parasite population, which in itself could cause 
Chapter 1 - General introduction 	 6 
more virulence than an infection with a single parasite genotype (e.g. Frank 1996; Taylor et 
al. 1998; Read et al. 2002). 
Other indirect evidence comes from a population-structure analysis of fig wasp species 
(Herre 1993; Herre 1995; Frank 1996). These wasps have species-specific parasitic 
nematodes, and where horizontal transmission of the parasites occurred, parasites were more 
virulent (Herre 1993); in retrospect it was concluded that this was due to the increased 
frequency of mixed infections due to horizontal transmission and selection for increased 
virulence (Herre 1995; Frank 1996). A study on Cucumber mosaic virus in eastern Spain 
(Escriu et al. 2000; 2003) also inferred within-host competition to explain the initial increase 
of virulence during epidemic spread. Finally, Ebert and Mangin (1997) used within-host 
competition as a post-hoc explanation for the increased virulence of microsporidia in 
artificial Daphnia magna populations. 
Where competitiveness and virulence have been directly studied, it has been generally shown 
that avirulent parasites competitively suppress virulent parasites, contradicting existing 
theory (Orcutt & Schaedler 1973; Hargreaves et al. 1975; Seed 1978; Duval-Iflah et al. 
1983; Allaker et al. 1988; Lenhoff et al. 1998; Read & Taylor 2000; 2001; Franco et al. 
2003). Importantly, however, most of these studies involved establishing an avirulent strain 
in the host before challenging the host with a virulent strain, so that the avirulent strain grew 
up to considerable numbers before the virulent strain was introduced (Orcutt & Schaedler 
1973; Duval-Iflah et al. 1983; Allaker et al. 1988; Barrow & Page 2000). Thus, the fact that 
the conclusions of these experiments contradict the assumptions of much virulence theory 
could be a result of researchers searching for protective strains of parasites. To take them as 
evidence that a virulence-competitiveness relationship does not exist, is almost as 
meaningless as basing that conclusion on the fact that live attenuated vaccines can be used to 
protect against disease (Handman 2001; Wareing & Tannock 2001; Hoffman et al. 2002b; 
Pugachev et al. 2003). 
1.3.4. A case of common sense? 
One possible reason for the lack of experiments testing the relationship between 
competitiveness and virulence is that many scientists (at least many I have met at 
conferences and within our own building) find this relationship such common sense that 
experiments are not deemed necessary. As pointed out above, many experiments have shown 
that avirulent strains can suppress virulent strains. This could be the result of the exact 
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experimental designs underlying these results, but it could also be that a relationship between 
virulence and competitiveness' does not exist. Certainly such a relationship need not exist. It 
depends on the exact mode of competition through which parasites compete. 
If parasites could compete for limited amounts of resources, nutrients or space (Smith & Holt 
1996), a positive relationship between virulence and competitiveness is expected. This form 
of competition is the one with closest resemblance to competition for chocolate cake, and 
most likely paves the way for the tragedy of the commons and the success of Patricks Nasty: 
this is because parasites will try to use up more resources than their competitors, so that 
faster growing and more virulent parasites are favoured (Brown et al. 2002). 
However, other modes of competition could also occur. First, competition could arise when 
parasites rely on the cooperative production of extracellular growth molecules, such as those 
involved in iron uptake. Here, 'cheating' parasites can arise (Velicer 2003), which rely solely 
on others for the production of such molecules, so that they grow at faster rates in mixed 
infections, but cause lower virulence when alone (Chao et al. 2000; Brown et al. 2002; West 
& Buckling 2003; Griffin et al. 2004). Similarly, where coinfecting pathogens compete by 
producing harmful molecules that affect their competitors (Riley & Gordon 1999), 
competitive ability may not be linked to virulence because competitively superior strains 
may, be directing resources at the production of allelopathic substances rather than 
maximising host exploitation and virulence (Read & Taylor 2000; Gardner et al. 2004; 
Kirkup & Riley 2004; Massey et al. 2004). 
Second, parasite strains may interact through immunity: in mammals, immune effector 
molecules include the lymphocyte product ]FN-y, the macrophage product TNF, and nitric 
oxide and reactive oxygen intermediates. All these molecules act non-specifically, so that 
when induced by one strain, they will affect not only this strain, but also other strains (Cox 
2001). That such competition occurs, is probably best illustrated with vaccines that consist of 
live-attenuated parasites (Mead & Barrow 1990; Handman 2001; Wareing & Tannock 2001; 
Hoffman et al. 2002b; Pugachev et al. 2003). An important possibility is that the immune 
system, when faced with a mixed infection, will focus its attention on a dominant virulent 
parasite, so that the avirulent parasite in fact has a competitive advantage in such infections 
(Taylor et al. 1997a; Read & Taylor 2001; Almogy et al. 2002; Franco et al. 2003; Hughes 
& Boomsma 2004). 
One mathematical model has also shown that when parasites exert sub-lethal effects on their 
hosts, thereby reducing host growth, and when such parasites are at the same time dependent 
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on host size, competition can favour the evolution of reduced virulence (Schjørring & Koella 
2003). 
Thus, there is no a priori reason to assume that virulent parasites are competitively superior 
to prudent parasites; and experiments to test this assumption are badly needed. This thesis 
focuses on within-host competition between malaria parasites, to understand which factors 
determine competitive outcome, and to find out whether virulent parasites are indeed 
competitively superior, as assumed by theory. Only if such a relationship exists, can we 
confirm that within-host competition is a major mechanism by which parasites can evolve 
and maintain high virulence, thereby expanding our understanding of parasite evolution. This 
could not only make us understand why malaria kills over a million people every year, but 
perhaps even predict the consequences of human interventions on the subsequent evolution 
of malaria virulence. 
1.3.5. Other implications of within-host competition 
As discussed, within-host competition is a critical determinant of virulence evolution. 
However, within-host competition is also relevant to the evolution of other traits, such as 
drug resistance and vaccine escape. Thus, the evolutionary success of a drug-resistant 
mutant, whether evolved de novo, or acquired through infection, very much depends on its 
competitiveness relative to the other strains within the same infection (e.g. Hastings & 
D'Alessandro 2000); assuming that competitive suppression of resistant mutants occurs, 
administration of drugs could interfere with such competition and artificially enhance the 
fitness of drug-resistant mutants and thus enhance the spread of resistance (Hastings & 
DAlessandro 2000). Also, where vaccines are used to control disease, it is well known that 
vaccine escape mutants can arise and spread (e.g. Kew et al. 2002); again, how well such 
mutants survive, evolve and spread through the population, depends importantly on how well 
they compete with wild-type mutants in non-vaccinated hosts and attenuated forms of the 
pathogen in vaccinated hosts (e.g. Bull 1994). 
Thus, within-host competition has many important medical implications, but the biological 
factors that determine competition within hosts is at present so poorly understood that 
predictions are practically impossible (Read & Taylor 2000; 2001). 
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1.4. Malaria 	 - 	 .- 
1.4.1. Introduction 
Malaria features in the top ten diseases, with huge medical (Breman 2001) and economic 
(Sachs & Malaney 2002) burdens in this world. Malaria causes coma, respiratory distress 
and severe anaemia (Marsh & Snow 1997), killing perhaps one person every 30 seconds, 
mounting to over at least a million deaths a year (Breman 2001). Most victims are children in 
sub-Saharan Africa, and most cases are caused by the most virulent of the four species of 
human malaria parasites, Plasmodium falciparum. Another 500 million people suffer from 
malaria-related anaemia and immune suppression that leave them vulnerable to other 
diseases, exacerbated by their poverty. 
As malaria parasites have become repeatedly resistant to anti-malarial drugs 
(Wongsrichanalai et al. 2002), and mosquitoes have evolved resistance against widely used 
insecticides (Spielman & DAntonio 2001), more people suffer from malaria today than ever 
before in human history. The parasite has a complex life cycle, and immunity against malaria 
is so poorly understood that a vaccine is also still not available (Richie & Saul 2002; De 
Roode 2003 [Thesis Appendix]; Hoffman & Richie 2003). To find new molecular ways of 
fighting this disease (Hoffman et al. 2002a; Long & Hoffman 2002), the full genomes of 
both malaria parasite (Gardner et al. 2002) and vector have recently been sequenced (Holt et 
al. 2002). Intriguingly, although it is evolutionary processes that render malaria parasites so 
virulent and hard to kill, there are few people working on the evolution of malaria, and most 
of these are concerned with reconstructing the past (e.g. Hume et al. 2003; Su et al. 2003). 
1.4.2. A complex life cycle 
The malaria life cycle (Figure 1.2) starts with the bite of a mosquito that injects haploid 
sporozoites into the human blood stream. These migrate to the liver, where they invade liver 
cells, replicate, and burst out of the cells: one sporozoite can give rise to no less than. 30 
thousand merozoites that travel to the blood where they start causing disease. Merozoites 
invade red blood cells, grow into trophozoites, which mature into schizonts: these may 
contain between 16 and 32 new merozoites for Plasmodium falciparum and around 8 for the 
rodent malaria Plasmodium chabaudi. Merozoites burst out of their red blood cell, ready to 
invade new red blood, cells. This process of asexual replication repeats itself every 48 
(Plasmodiumfalciparum) or 24 (Plasmodium chabaudi) hours, and, in humans, results in the 
fevers so characteristic of malaria. Some parasites make the red b1od cells stick to blood 

















vessels (thereby in some cases killing the patient), while others turn into gametocytes, of 
which male and female forms exist. Gametocytes, when taken up by a new blood-feeding 
mosquito, turn into gametes that fertilise each other to form an ookinete: this parasite crosses 
the mosquito's mid-gut wall, encysting on it to form an oocyst. Meiosis is followed by 
asexual replication, resulting in hundreds to thousands of new sporozoites. These are 
released into the mosquito haemocoel, after which they migrate to the salivary glands; there 
they wait to be injected into the next patient. 
Figure 1.2. The malaria life cycle comprises both a mammalian host, in this case a human (a), and a 
mosquito host (b). Reproduced from Wirth (2002). 
14.3. Virulence in malaria 
Killing at least a million people a year, Plasmodium can be called a virulent parasite, and 
many factors contribute to disease, including host genetics, parasite genetics, and socio-
economics. Several studies have associated parasites with certain alleles of several genes 
with disease (e.g. Engelbrecht et al. 1995; Al-Yaman et al. 1997; Ofosu-Okyere et al. 2001; 
Magesa et al. 2002), although other studies have not (e.g. Contamin et al. 1996; Zwetyenga 
et al. 1998). Moreover, different studies have generally found different allele families to be 
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associated with disease (Engelbrecht et at. 1995; Al-Yaman et at. 1997; Ofosu-Okyere et at. 
2001; Magesa et at. 2002), which could point to geographic variations in hostlparasite 
interactions (Zwetyenga et at. 1998). That host genetics are an important determinant in 
disease becomes apparent from a study in Mali, where the parasite density that triggered 
fever strongly varied from one subject to another (Delley et al. 2000), and from a study in 
Tanzania, where the number of co-infecting malaria clones was host-dependent (Färnert et 
al. 1999). In addition, different people treated for neurosyphilis had different maximum 
malaria parasite densities (Molineaux et al. 2002). A lot of this variation probably arises 
from different people having differences in their immune control of malaria, but also from 
mutations that confer resistance to malaria infection (e.g. Cockburn et al. 2004; 
Mockenhaupt et al. 2004). 
Many factors are involved in virulence of malaria infections, such as rosetting (adherence of 
infected to unindected red blood cells, Rowe et at. 1995), parasite replication rate 
(Chotivanich et al. 2000) and immunopathology (reviewed in Marsh & Snow 1997; 
Artavanis-Tsakonas et at. 2003; Mackinnon & Read 2004b), but it has recently been argued 
that all these factors are very likely related to within-host parasite densities (Mackinnon & 
Read 2004b). Virulence in malaria has been persuasively described in terms of the trade-off 
model (Mackinnon & Read 2004b), in that both virulence and transmission are caused by 
within-host replication of malaria parasites. As such, virulence in malaria can be explained 
as an evolutionary adaptation of parasites to optimise their fitness. 
Whether within-host competition between malaria strains also contributes to the evolution of 
virulence in malaria, is far less clear from existing data. 
1.4.4. Mixed infections in malaria 
Mixed infections in malaria are extremely common, with frequencies of mixed infections 
higher than 80% in some populations, and the number of co-infecting strains exceeding 10 
(Table 1.1). Although there is a strong positive relationship between transmission intensity 
and clone multiplicity (the number of genetically distinct clones per host) (Babiker & 
Walliker 1997; Arnot 1998), people in areas with low transmission, such as The Gambia, 
Sudan and Cameroon, are also commonly infected with several genotypes. Observed within-
host diversity is probably an underestimation, because of the limited discriminatory power of 
genetic tools (Contamin et at. 1995; Arnot 1998; Babiker et al. 1999), and the fact that most 
studies are based on cross-sectional - not longitudinal - surveys, which makes it easy to miss 
strains (Snounou 2004). 
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Table .1.1. Frequency and multiplicity of mixed-genotype infections of the human species P. 
falcipa rum and P. vivax (for different geographic regions and age classes of investigated patients), and 
the rodent malaria P. c. chabaudi. Frequency is the proportion of malaria infections that consist of 
several distinct genotypes; multiplicity is the mean number of genotypes per malaria infection; also 
shown is the range of the number of genotypes observed per infection. 
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1-4 (Conway etal. 1991) 
1-4 (refs in Babiker etal. 1999) 
1-10 (Sutherland etal. 2002) a 
1-4 (Scherf etal. 1991) 
1-6 (Ntoumi etal. 1995) 
1-4 (Ntoumi etal. 1995; refs in 
Babiker etal. 1999) 
1-12 (Konate etal. 1999) 
1-4 (Zwetyenga etal. 1998; 
Konaté etal. 1999) 
(Zwetyenga et al. 1998) 
(Robert etal. 1996) 
1-12 (Becketal.2001)' 
(Otosu.Okyere et al. 2001) 
1-3 (Babiker etal. 1991a; 1998) 
1-4 (Roper etal. 1998) 
1-7 (Basco & Ringwald 2001) 
1-4 (rets in Babikeretal. 1999) 
(Magesa et al. 2002) 
(Felger etal. 1999) 
1-6 (Babiker etal. 1999) 
(Beck et al. 1997) 
Guinea Bissau Antula 	1-78 0.64-0.68 2.0-2.5 	1-8 (Arez etal. 2003) 
Papua New Guinea Madang 0.72 1.7-1.9 	1-3 (Paul etal. 1995) 
Papua New Guinea <18 0.51 (Al-Vaman etal. 1997) 
Colombia Several 	8-51 0.26-0.29 1-3 (Snewin etal. 1991) 
P. vlvax 
Thailand Mae Sod district 0.36 (Cui etal. 2003) 
P. C. chabaudi 
Central African 
Republic 0.23 1.2 	1-2 (Beale etal. 1978) 
EW: entomological infection rate: number of infective mosquito bites/person/year. a  Symptomatic 
patients. b  Asymptomatic carriers. C  Ranges given when, in the cited study, different genetic markers 
or villages were used to assess multiplicity. d  Children vaccinated with SPf66 vaccine. e  Gametocyte 
positive children after drug treatment. f Pregnant women. 
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1.4.5. Competition in human malaria infections 
Competition between different human malaria species has been inferred (Boyd & Kitchen 
1937; Richie 1988; Bruce et al. 2000; Bruce & Day 2002; Mayxay et al. 2004; Snounou & 
White 2004). As such competition is most probably the result of limited resources and cross-
species immune responses, it is even more likely that competition operates between different 
strains of the same species, which rely much more on the same resources (e.g. the type of red 
blood cells they infect), and are probably much more antigenically similar, so that immune 
responses should be more strain-transcending. Despite this, evidence of within-host 
competition between strains of the same species can only be indirectly inferred. 
First, there is a general straight relationship between transmission intensity and clone 
multiplicity, but the slope of this relationship is smaller than 1 (Arnot 1998): this implies that 
not every additional mosquito bite results in a proportionate increase in clone multiplicity, 
which could be due to competition between strains. Second, although in Tanzanian infants of 
1-2 years there was a correlation between parasite density and clone multiplicity, there was 
no such relationship for older children in the same study (Smith et al. 1999a), or for children 
in other studies (e.g. Conway et al. 1991; Färnert et al. 1999; Basco & Ringwald 2001; 
Cattamanchi et al. 2003): thus, in such mixed infections, parasites have to 'share' the 
available number of parasites between them, resulting in at least one of them having lower 
densities than it would have in a single infection. Third, P. falciparum infections in humans 
were genetically more diverse than the corresponding infections in mosquitoes (Arez et al. 
2003), which could be a result of competition for transmission. 
Indirect evidence for competition also comes from a large number of studies that have tried 
to relate malaria morbidity to clone multiplicity. In high-transmission areas, where people 
are infected many times with different malaria strains, multiplicity increases early in 
childhood, reaches peak levels at 3-7 years and decreases thereafter (Ntoumi et al. 1995; 
Mercereau-Puijalon 1996; Konaté et al. 1999; Smith et al. 1999a); at young age clone 
multiplicity in these areas is associated with clinical disease, whereas at older age it is not 
(Engelbrecht et al. 1995; Contamin et al. 1996; Robert et al. 1996; Al-Yaman et al. 1997; 
Beck et al. 1997; Färnert et al. 1999; Magesa et al. 2002). In low-transmission areas, on the 
other hand, there are no age-effects (Conway et al. 1991; Zwetyenga et al. 1998; Konaté et 
al. 1999; Basco & Ringwald 2001), and clone multiplicity is associated with disease 
(Mercereau-Puijalon 1996; Roper et al. 1998; Zwetyenga et al. 1998; Ofosu-Okyere et al. 
2001). 
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These contrasting relationships are most likely caused by different immune mechanisms 
(Smith et al. 1999b). Thus, with age, subsequent infections with different strains result in a 
gradual acquisition of strain-specific immune responses: having a broad range of such 
responses then results in cross-reactive immunity that may prevent superinfection with novel 
strains and subsequent disease (Smith et al. 1999b; Tanner et al. 1999). However, 
individuals without such strong immunity - such as infants, primigravid women (Beck et al. 
2001) and travellers - become readily infected with new strains against which they have no 
protective immunity; these strains then grow up and cause disease (Lines & Armstrong 1992; 
Contamin et al. 1996; Mercereau-Puijalon 1996; Arnot 1998; Babiker 1998; Roper et al. 
1998; Felger et al. 1999; Missinou et al. 2001; Ofosu-Okyere et al. 2001; Kun et al. 2002; 
Cattamanchi et al. 2003). Taken together, these studies thus strongly suggest that there is 
competition between malaria strains in the same host. In immune individuals, in which 
infection protects against further superinfection and high parasite densities of novel strains, 
that competition is strong; in non-immune individuals, on the other hand, novel strains can 
easily infect and grow up to high enough numbers to cause disease, showing they suffer less 
from competition. However, it is possible that the patterns observed in non-immune 
individuals are in fact the result of PCR artefacts: thus the correlation between parasite 
densities and the number of clones could arise if the detected clones have high parasite 
densities, obscuring PCR detection of minority clones (Contamin et al. 1995; Arnot 1998; 
Roper et al. 1998; Smith et al. 1999b). 
1.4.6. Plasmodium chabaudi as a model system 
The only way to demonstrate competition unequivocally is by using experimental malaria 
infections. For ethical and logistic reasons, however, experimental malaria infections of 
humans are not possible, so that I use the rodent malaria Plasmodiurn chabaudi in laboratory 
mice as a model instead. Even though the natural host of Plasmodium chabaudi is the thicket 
rat (Thamnomys rutilans), P. chabaudi in mice has been widely used as a model system for 
the human malaria parasite Plasmodium falciparum, because it shares many infection 
characteristics with P. falciparum (Cox 1988; Carlton et al. 2001; Mackinnon & Read 
2004b). 
Both species usually infect normocytes (older red blood cells), rather than reticulocytes, 
undergo sequestration to endothelial cells in the microvasculature (Cox et al. 1987; Gilks et 
al. 1990), and undergo rosetting: the adherence of infected to uninfected cells (Rowe et al. 
1995; Rowe et al. 1997; Mackinnon et al. 2002a). In resistant mouse strains, P. chabaudi 
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shows recrudescent parasitaemic peaks after recovery from the acute phase (Cox .1988; 
Taylor-Robinson 1995; Phillips et al. 1997), as does P. falciparum in humans. Both species 
also undergo clonal antigenic variation (Biggs et al. 1991; Roberts et al. 1992; Phillips et al. 
1997), and provoke strain-specific immunity (Jarra & Brown 1985; Mackinnon & Read 
2004b). Mixed-strain infections of P. chabaudi also occur in natural populations (Table 1.1, 
Beale et al. 1978). The main difference between the two species is that P. chabaudi in mice 
reaches levels of parasitaemia of 30-60%, whereas P. falciparum only exceptionally reaches 
parasitaemia levels higher than 10% (Taylor-Robinson 1995). 
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Figure 1.3. Parasite density (A) and red blood cell density (B) of one C57B1/6J mouse infected with 
an avirulent and one mouse infected with a virulent clone of P. chabaudi. Parasite densities are 
characterised by an exponential increase during the first seven days, after which they collapse. New 
parasite waves are detected about 12 and 15 days into the infection, after which one or more parasite 
peaks can occur, consisting of antigenic variants of the parasite (Phillips et al. 1997). The period until 
the second parasite wave is referred to as the acute phase of the infection; the part of the infection 
starting with that second wave is the chronic phase of infection. When parasite numbers increase 
exponentially, red blood cell densities in the mouse decrease rapidly: this is a consequence of both 
parasite lysis of red blood cells and immune mechanisms clearing infected and uninfected red blood 
cells. The collapse of parasite densities after the initial peak (also called crisis) is a combination of red 
blood cell densities becoming low and immunity aimed directly at parasites. Virulent parasites reach 
higher peak densities and cause more anaemia (lower red blood cell densities) in the mice they infect 
than do avirulent parasites. Data obtained from Chapter 4. 
Chapter 1 - General introduction 	 16 
P. chabaudi makes a good model for studying the evolution of virulence. Many different 
parasite isolates were derived from the wild (Beale et al. 1978), and clonal isolates of these 
differ in their intrinsic virulence (Mackinnon & Read 1999a; Ferguson et al. 2003b). Parasite 
densities can be easily recorded using microscopy (Figure 1.3A), and virulence can be easily 
measured, for example by counting red blood cell densities of infected mice (Figure 1.3B) or 
recording mouse live weights (e.g. Mackinnon & Read 1999a; Ferguson et al. 2003b). 
Furthermore, P. chabaudi can be readily transmitted to mosquitoes in the lab (e.g. 
Mackinnon & Read 1999a; Ferguson et al. 2003b), so that the whole life cycle can be 
studied. Finally, P. chabaudi infects a range of different mouse strains, so that the effects of 
host genotype effects on virulence ecology and evolution can also be assessed (Stevenson et 
al. 1982; Mackinnon et al. 2002b). 
1.4.7. Competition in Plasmodium chabaudi 
Evidence for competition in human malaria may be indirect, but in P. chabaudi several 
experiments have now unequivocally demonstrated competition between different strains 
(Snounou et al. 1992; Taylor et al. 1997a; Read & Taylor 2000; De Roode et al. 2003 
[Thesis Appendix]); this competition is most likely due to both resource competition and 
strain-transcending immunity. 
Asexual P. chabaudi parasites need blood glucose (e.g. Li et al. 2001) and red blood cells, 
and the huge decrease of red blood cell numbers during an infection (Figure 1.3B) results in 
an enormous decrease in available resources. Anaemia in malaria is caused by a combination 
of parasite rupture (Cox 1988; Menendez et al. 2000; McQueen & McKenzie 2004) and 
immune mechanisms, such as phagocytosis of parasitised and unparasitised red blood cells 
(Cox 1988; Jakeman et al. 1999; Menendez et al. 2000), and decreased red blood cell 
production (Cox 1988; Menendez et al. 2000). That parasite growth is limited by available 
red blood cells has been shown experimentally: blood transfusion during and after peak 
parasitaemia prolonged the patency of infection for up to five days after peak parasitaemia 
(Yap & Stevenson 1994). One theoretical study has also shown that the initial growth of 
parasites is very much dependent on the availability of red blood cells, that there is a critical 
threshold red blood cell density for parasite establishment, and that parasite numbers can 
collapse due to a decrease in red blood cell densities regardless of immunity (Hetzel & 
Anderson 1996). 
Competition for resources such as red blood cells is certainly not the only mode of 
competition (Heliriegel 1992; Gravenor et al. 1995; Haydon et al. 2003). Apparent 
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competition, through a shared immune response, is also likely to occur in P. chabaudi 
infections in mice. Clearance of parasites during the acute phase is predominantly regulated 
by non-specific Thi cellular responses. These involve activation of CD4+ cells, upon parasite 
antigen presentation by mainly dendritic cells; CD4+ Thi cells activate macrophages, with 
the subsequent induction of interleukins such as Tumour Necrosis Factor alpha (TNF-(x) and 
Interferon gamma (IFN-y), stimulation of Natural Killer Cells, and the production of nitric 
oxide and reactive oxygen species (Taylor-Robinson 1995; Phillips et al. 1997; Li et al. 
2001). As these molecules act non-specifically, they will affect not just one but all the clones 
present in the blood at that time. This has been confirmed by heterologous-challenge 
experiments that showed cross-immunity between different P. chabaudi strains and even 
different rodent malaria species (Jarra & Brown 1989; Snounou et al. 1989). Parasite clone-
specific immunity is also involved in clearance and control of initial P. chabaudi 
parasitaemia, however (Jarra & Brown 1989; Snounou et al. 1989), with antibodies targeting 
parasitised red blood cells for phagocytosis through clone-specific processes (Mota et al. 
1998). Acquired immunity is also strain-specific (Jarra & Brown 1985), and during the 
chronic phase of infection Th2 antibody-mediated, and directed at specific strains and 
antigenic variants (Taylor-Robinson 1995; Phillips et al. 1997; Li et al. 2001). 
The implication is that clones that differ substantially in their immunogenic properties 
should affect each other less than those that are very similar; also, immune-mediated 
competition during the chronic phase should be weaker than during the acute phase (De 
Roode et al. 2003 [Thesis Appendix]), not just because of very specific immune responses, 
but also because of red blood cell densities recovering during the chronic phase (Hetzel & 
Anderson 1996). 
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1.5. Thesis aims 
Even though competition in P. chabaudi has been shown to occur, nothing is know about 
how virulence relates to within-host competitiveness. This thesis deals with experimentally 
elucidating whether virulence is directly related to competitive ability and which biological 
factors affect the outcome of competition between virulent and avirulent parasites. 
Besides this, I studied how antimalarial drugs interfere with within-host competition, and 
how within-host competition affects between-host transmission: this latter question is not 
only important for virulence studies, but also for studies on drug resistance, vaccine-escape 
mutants, and any other medically important traits affected by within-host competition. As the 
quantitative assessment of individual clones in an infection is a crucial prerequisite for all 
these studies, I first developed a molecular quantitative technique to do this (Chapter 2). 
Subsequent chapters then deal with the following related questions. 
• Is there a relationship between virulence and within-host competitive ability, as 
predicted by theory? (Chapter 3) 
• What role does host genotype play in the outcome of within-host competition between 
virulent and avirulent parasites? (Chapter 4) 
• What role does the timing of infection play in the outcome of competition; are resident 
parasite genotypes competitively superior to super-infecting genotypes? As such, can 
avirulent parasites become competitively superior to virulent parasites? (Chapter 5) 
• How does within-host competitive ability relate to between-host fitness? Does 
competitive superiority within the mammalian host translate into competitive superiority 
within the vector population? (Chapter 6) 
• Can the use of anti-malarial drugs change patterns of competition between virulent and 
avirulent parasites, and how could this affect the subsequent spread of drug resistance? 
(Chapter 7) 
In the final chapter (Chapter 8), I consider the implications of the findings in chapters 2-7 for 
the evolution of virulence ('what role does Patrick Nasty play?'), the spread of drug-
resistance, and for malaria. I also ask whether these findings could be used to predict the 
evolutionary consequences of human interventions aimed at reducing the malaria burden in 
the field. 
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2. Real-time PCR for analysis of genetically mixed infections of malaria 
parasites: technique development and validations 
Part of this chapter has been published as: Cheesman, S. J., de Roode, J. C., Read, A. F. & Carter, R. 
2003 Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: 
technique validation and applications. Mel. Biochem. Parasite!. 131, 83-91. (See Thesis Appendix) 
2.1. Abstract 
Here I report the development and validation of real-time quantitative PCR to analyse 
mixed-clone Plasmodium chabaudi infections. Using allele-specific primers I quantified the 
relative proportions of two genetically distinct P. chabaudi clones over a 100-fold range, 
from small blood samples that are easily obtained from experimental animals. I demonstrate 
that the time of day when samples are taken affects the accuracy of the PCR results, showing 
that best results are obtained between 9:00 and 13:00 hours. As the described PCR assays are 
based on between-clone sequence differences in the highly polymorphic rnspl gene, the 
technique could in principle be expanded to combinations of any two clones that have 
sequence differences in that or any other gene. 
2.2. Introduction 
2.2.1. Why we need PCR 
Eight genetically distinct Plasmodium chabaudi clones have been well characterised for their 
life-history characteristics such as asexual growth, virulence and infectivity to mosquitoes 
(Mackinnon & Read 1999a). Ideally, one could compete any of these clones against any 
other to study within-host competition, thus finding out whether virulent clones indeed out-
compete avirulent clones (see Chapter 1). In the past, the choice of clones and experiments 
has been dictated by available diagnostic tools, rather than those clones' biological 
properties, such as virulence. Taylor et al. (1997a; 1998), used two clones distinguishable by 
monoclonal antibodies; even though such antibodies can be raised against any clone of 
choice, antibody assays are extremely tedious and time-consuming in practice. De Roode et 
al. (2003 [Thesis Appendix]) chose three clones for the simple reason that they could be 
distinguished by size polymorphisms in their mspl (merozoite surface protein 1) genes as 
visualised on agarose gels following PCR amplification. With the advent of more 
sophisticated and high-throughput PCR techniques, however, clone choice can now be based 
on biological properties rather than on the availability of antibodies or old-fashioned PCR 
protocols. 
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This chapter describes the use of real-time quantitative PCR for the analysis of genetically 
diverse infections. Real-time quantitative PCR is a recent and highly versatile technique that 
can in principle be used for quantification of any organism of choice. The method is based 
on quantifying DNA template concentrations in PCR reactions (Higuchi et at. 1993), and as 
such concentrations are often directly proportional to the number of parasites in a tested 
sample, real-time quantitative PCR has wide applications in parasitology (Bell & Ranford-
Cartwright 2002). To date, for example, the method has been used to quantify Toxoplasma 
gondii DNA from clinical samples (Lin et al. 2000), Borrelia burgdorferi spirochaetes from 
tick vectors, and the rickettsial organisms Ehrtichia phagocytophila and E. risticii from their 
hosts (reviewed in Bell & Ranford-Cartwright 2002). For malaria specifically, real-time PCR 
has been used to quantify the erythrocytic (Hermsen et at. 2001; de Monbrison et at. 2003), 
pre-erythrocytic (Bruña-Romero et at. 2001; Witney et al. 2001) and sporozoite stages (Bell 
& Ranford-Cartwright 2004) of Plasmodium falciparum; it is also used as a diagnostic tool 
to detect absence and presence of parasites (de Monbrison et at. 2003; Fabre et al. 2004). 
P. chabaudi has several genes, such as the mspl and amal (apical membrane antigen 1) 
genes, that are extremely polymorphic between different clones (Cheesman S.J., pers. 
comm., Deleersnijder et at. 1991; McKean et at. 1993). As any two clones almost certainly 
have some sequence polymorphisms in one of these genes, clone-specific real-time PCR 
assays could be designed to distinguish and quantify these clones in mixed infections. 
This thesis deals with only one such combination: mixed-clone infections of AS and AJ 
parasites. Ironic as this may seem after an argument about the versatility of real-time 
quantitative PCR, there are good reasons for this. First, this combination can be used to 
identify those factors that need optimising in terms of the PCR assays and sampling itself. 
Second, this clone combination is a combination of a virulent (AJ) and an avirulent (AS) 
clone, and can be used to reveal those biological factors that are most likely to affect within-
host competition. These include virulence per se (Chapter 3), host genotype (Chapter 4), the 
timing of infection (co- or super-infection; Chapter 5), transmission to the mosquito vector 
(Chapter 6), and the absence or presence of anti-malaria drugs (Chapter 7). Only when it has 
been demonstrated that real-time PCR is suitable to study all of these factors, will it make 
sense to expand the method to a larger number of clone combinations. 
2.2.2. Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) is a revolutionising technique to produce a selective 
enrichment of a specific DNA sequence by a factor exceeding 106,  facilitating analyses that 
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require large amounts of DNA (Saiki et al. 1988). PCR amplification involves two 
oligonucleotide primers that flank the DNA sequence to be amplified, and repeated cycles of 
heat denaturation of the DNA, annealing of the primers to their complementary sequences 
and extension of the annealed primers with DNA polymerase. As the extension products are 
also complementary to and capable of binding primers, each successive cycle essentially 
doubles the amount of DNA synthesised in the previous cycle (Saiki et al. 1988), thus giving 
rise to an exponential increase in DNA product. This exponential phase lasts for many 
cycles, but eventually the reaction becomes less efficient, and DNA amounts reach a plateau. 
This may occur because primer concentrations drop, enzymes and nucleotides become 
limiting, or because re-association between amplified products occurs before primers can 
anneal (Williams et al. 1998). If the reaction indeed reaches plateau because the 
concentration of product drives product re-association, samples containing different starting 
amounts of DNA will reach plateau at the same DNA concentration; at that time they will 
contain identical amounts of product, masking initial sample differences (Williams et al. 
1998; Bell & Ranford-Cartwright 2002). Thus, end products of PCR can be used 
qualitatively (absence or presence of a certain DNA sequence), but cannot be used to 
quantify initial DNA template concentrations. 
2.2.3. Real-time quantitative PCR 
Recent developments have made quantification of initial DNA template concentrations 
possible, however, and of these, real-time quantitative PCR assays are the most widely used 
(Higuchi et al. 1993; Heid et al. 1996; Williams et al. 1998; Bell & Ranford-Cartwright 
2002). The power of real-time quantitative PCR is that it does not rely on end product 
analysis, but that it quantifies DNA on the basis of the exponential phase of the PCR 
reaction. PCW amplification is monitored in real time, using fluorescence that is emitted 
either by DNA intercalating dyes, such as ethidium bromide (Higuchi et al. 1993), or by 
fluorogenic probes that specifically bind to the amplified product (Heid et al. 1996). The 
amount of fluorescence increases when the PCR reaction proceeds, as the amount of 
amplified DNA increases. Cycle-by-cycle monitoring (Figures 2. 1A, E) makes it possible to 
very precisely identify the cycles in which the PCR is in the exponential phase, with the PCR 
product doubling every cycle. After the PCR run, a baseline is set that identifies the cycle in 
which the exponential signal can be distinguished from the background for each sample. The 
number of cycles it takes for the fluorescence of a sample to be distinguished from the 
background is called the C- value, and is inversely related to initial template concentration. 
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A standard curve is generated, plotting the log concentrations of known standards against the 
CT values (Figures 2. 1B, F), and concentrations of target template of unknown samples can 
be extrapolated from this. An alternative approach to quantification is based on the S-shape 
of the amplification curves. Calculating the second derivative of each amplification curve 
yields a maximum in the early logarithmic phase of the PCR. This second derivative 
maximum is then used as a crossing point (Cr) in the further calculations to determine initial 
target concentrations. This approach is used for most of the experiments in this thesis. 
One advantage of the fluorogenic probe approach over the intercalating dye approach is that 
it is more specific (Heid et al. 1996). The reason is that intercalating dyes, such as ethidium 
bromide, bind to any double-stranded DNA, including primer dimers and non-specific 
amplification products, and can therefore artificially increase the estimate of the initial 
template concentration (Higuchi et al. 1993). Despite this disadvantage, I used the 
intercalating dye approach for the work described in this thesis. The reason is that, at least 
when I started my PhD, the intercalating dye system was cheaper, had a shorter developing 
time (in terms of developing primers), was universally applicable to all potential markers, 
and was most widely used (Bell & Ranford-Cartwright 2002). More recently, however, I 
started to use the fluorogenic probe assay (Chapter 6). 
Figure 2.1. (A) Logplot of fluorescence against cycle number for four AS DNA standards of known 
concentration (7.2, 0.72, 0.072 and 0.0072 ng4tl: circles, squares, crosses and diamonds respectively). 
(B) A standard curve based on the logplot in (A): the cycle number at which the reaction enters the 
log-linear phase is inversely related to the initial template concentration. (C) Melting curve of the four 
known standards in (A), an AJ DNA sample (dashed line, plusses) and a negative control (dashed 
line). (D) First negative derivatives of melting curves in (C). The four AS DNA standards show peaks 
around 88°C; the specific AS PCR product thus has a melting temperature of 88°C. AS 0.0072 ng/pi 
shows a tiny primer dimer peak at around 76°C. The negative control shows no specific product as 
expected, but a big primer dimer peak at around 77°C. AJ DNA also shows no specific product; there 
is thus no cross-reaction between AJ DNA and AS primers. (E) Logplot of fluorescence against cycle 
number for four AJ DNA standards of known concentration (4.3, 0.43, 0.043, 0.0043 ng4tl: circles, 
squares, crosses and diamonds respectively). (F) A standard curve based on the logplot in (E). (G) 
Melting curve of the four known standards in (E), an AS DNA sample (dashed line, plusses) and a 
negative control (dashed line). (H) First negative derivatives of melting curves in (G). The four AJ 
DNA standards show peaks around 88°C; the specific AJ PCR product thus has a melting temperature 
of 88°C. The negative control shows no specific product as expected, but a primer dimer peak at 
around 82°C. AS DNA also shows no specific product, but a non-specific peak at around 86°C; there 
is thus no cross-reaction between AS DNA and AJ primers. 
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2.2.4. The Roche Lightcycler 
Even though the first real-time PCR experiments were done with a very basic setup of a 
traditional thermal cycler and a video camera (Higuchi et al. 1993), commercial systems for 
real-time quantitative PCR are now widely available (Williams et al. 1998; Bell & Ranford-
Cartwright 2002). All these instruments record fluorescence in real time as the samples pass 
photodetection diodes within the instrument, following fluorophore excitation using an 
integral light source. 
This study makes use of the Roche Molecular Biochemicals Lightcycler system, with a 
SYBR Green I detection assay (Roche). In this system, blue light from a LED is focused on 
the tip of a glass capillary (in which the reaction occurs), and excites the SYBR Green I dye. 
The emitted fluorescent light is then conducted back into the optical unit of the Lightcycler, 
where a set of filters and mirrors separates the light into different wavelengths that can be 
detected in one of three detection levels. SYBR Green I fluoresces strongly when bound to 
the minor groove of double-stranded DNA (dsDNA), but minimally when free in solution. 
The fluorescence intensity of bound SYBR Green I is relative to the amount of PCR product. 
Fluorescence is measured every cycle after the elongation phase, when there is only dsDNA, 
and can thus be used to monitor the increase in PCR product formation. 
As mentioned above (§ 2.2.3), the downside of this intercalator system is that it non-
specifically binds to any dsDNA, including non-specific PCR products and primer dimers. In 
the development of SYBR Green I based assays, it is therefore important to optimise primers 
and reaction conditions, and it is essential to be able to obtain a product melting curve, 
revealing the presence of specific PCR products, non-target products and primer dimers. The 
Lightcycler system is capable of providing this: at the end of the PCR run, the temperature of 
the samples is slowly raised, and the fluorescence monitored at frequent intervals (Figures 
2.1C, G). As soon as the dsDNA starts to denature, the SYBR Green I dye is released, and 
fluorescence decreases. 
The melting temperature (T m) of a DNA fragment is defined as the temperature at which half 
of the DNA becomes single-stranded, and half remains double-stranded. This temperature 
can be easily visualised by taking the first negative derivative (-dF/dT) of the melting curve. 
It is then visible as a peak when plotting -dF/dT against temperature (Figures 2. 1D, H). This 
permits easy identification of the fragment-specific T m. As each DNA fragment has a unique 
Tm, the melting curve shows whether the targeted fragment has been produced, and whether 
non-specific products and primer dimers have been produced. 
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2.3. Parasites and hosts 
The parasites I used were three Plasmodium chabaudi chabaudi clones denoted AS, 
AS(pyrlA) and AJ. AS and AJ were originally clonally isolated from different thicket rats in 
the Central African Republic, and are genetically distinct (Beale et al. 1978). AS(pyrlA) was 
derived through pyrimethamine selection from clone AS (Walliker et al. 1975); AS and 
AS(pyrlA) are thus genetically very similar, and can be quantified using the same PCR 
primers. 
As hosts I used two inbred mouse strains denoted C57BL'6J and CBA/Ca (Ann Walker, 
University of Edinburgh). Mice were fed on 4 lB maintenance diet (Harlan UK) and drinking 
water supplemented with 0.05% para-amino benzoic acid (Jacobs 1964); they were kept in a 
12 L : 12 D cycle. I will refer to these mouse strains as C57 and CBA from hereon. Mice 
were always at least six weeks old, and were either males or females, depending on 
availability. Parasite inoculations consisted of 106  parasites, were prepared from donor mice 
by diluting blood in 0.1 ml calf-serum solution (50% heat-inactivated calf-serum, 50% 
Ringer's solution [27mM KC1, 27mM CaC1 2, 0.15 M NaCl], 20 units heparinlml mouse 
blood), and injected via the intraperitoneum. Alternatively, mice were infected with frozen 
parasite-infected blood stored in liquid nitrogen, and defrosted in citrate saline (0.9% NaCl, 
1.5% tri sodium citrate dihydrate, pH 7.2) prior to inoculation. 
2.4. PCR assays 
2.4.1. DNA standards for AS and AJ 
Seven female C57 mice were infected with AS, and seven were infected with AJ. On day 8 
post-infection (P1) these mice were killed and as much blood collected from them as 
possible. DNA was extracted as described previously (Grech et al. 2002). Briefly, mouse 
white blood cells were removed by column purification using CF1 1 (Sigma) and 
Plasmodipur filters (Euro-Diagnostica). Parasites were isolated from host erythrocytes by 
- saponin lysis and genomic DNA prepared by phenol-chlorophorm extraction. DNA 
concentrations were measured using a spectrophotometer. AS DNA and AJ DNA were 
diluted down to 400 ng/p.l and 500 ng/pJ respectively and stored as aliquots for future use in 
real-time PCR. Later on I measured these standards against standards produced by S.J. 
Cheesman, using real-time quantitative PCR, and found them to be and 72.0 ng/p.l for AS 
and 40.3 ng/pJ for AJ. Apparently, as I had not treated my samples with RNAse, the RNA 
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that was present highly skewed my quantifications based on spectrophotometry. Values of 
72.0 ng/jtl for AS and 40.3 ng/fl for AJ were used in subsequent experiments. 
When these standards were running low, I prepared new standards. I infected ten female C57 
mice with AS and another ten with AJ. Mice were bled again and DNA extracted as 
described above. DNA samples were treated with RNAse before re-extracting with phenol-
chiorophorm. DNA samples were then quantified using the old set of standards and set to 
57.5 ng/tl for AS and 49.9 ng/Jtl for AJ. 
For each PCR run, DNA standards were freshly prepared from these stocks by serial dilution 
in H20, and ranged from 0.0072 - 7.2 or 0.00575 - 5.75 ng/pi for AS, and 0.00403 - 4.03 or 
0.00499 - 4.99 ng/j.tl for AJ. 
2.4.2. PCR assays for AS and AJ 
Primers were designed against variable block III of the mspl gene (Cheesman et al. 2003 
[Thesis Appendix]). For AS they were ACAGTAACACAAGAAGAAC (forward; f86837) and 
GATACTTGTGTTGATGCTGG (reverse; f86838); for AJ they were ACCAGCACAAGAAGCA-
ACAA (forward; f86835) and TTGCGGGTTCTGTTGAGGCT (reverse; f86836). Reaction 
conditions were almost similar for AS and AJ, both with 0.4 tM of forward and reverse 
primers. The only difference was that in the AS reaction the final M902  concentration was 
4.5 mlvi, whereas with AJ it was 3.5 mM. Both PCR assays started with a denaturation step 
at 95°C for 600 s. Amplification consisted of 40 cycles, with 95°C denaturation, 6 s of 
annealing at 59°C for AS and 61°C for AJ, and 7 s of elongation at 72°C. Amplification was 
followed by a melting curve analysis, with 0.2°C/s increment from 65°C to 95°C. Reaction 
volumes were lOpi, with ljfl of DNA per reaction for standards and 2 tl of DNA per 
reaction for unknown samples. It was concluded that these reaction conditions are optimal, 
as they showed straight standard curves, and no primer dimer formation (Figure 2.1, 
Cheesman et al. 2003 [Thesis Appendix]). 
2.4.3. Cross-reactivity 
To check for cross-reactivity, I tried to amplify AJ DNA using AS primers and reaction 
conditions, and to amplify AS DNA using AJ primers and reaction conditions. In both my 
experiments (Figures 2.113, H), and others (Cheesman et al. 2003 [Thesis Appendix]) there 
was no such cross-reactivity. 
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2.5. Quantification of AS and AJ parasites in artificially prepared mixtures 
2.5.1. The need for artificial mixtures 
Before using real-time PCR as a quantification method in real experiments, I wanted to make 
sure that obtained proportions of AS and AJ parasites reflected the true proportions of the 
parasites present. Therefore several series of AS and AJ mixtures were prepared and real-
time PCR was used to analyse these. 
2.5.2. Artificial mixtures 
The first series of artificial mixtures described here was prepared by R. Carter (see also 
Cheesman et al. 2003 [Thesis Appendix]). These mixtures were made from three female 
CBA mice: one infected with AS, one infected with AJ, and one uninfected. Red blood cell 
densities were assessed by flow cytometry using a coulter counter (Beckman Coulter), and 
blood smears were taken to calculate parasitaemia (as the percentage of red blood cells 
infected with parasites). Mice were killed and blood was collected in 5 ml of citrate saline. 
This resulted in a new volume, which was measured. The red blood cell densities of these 
solutions were calculated, and solutions were diluted with citrate saline to a concentration of 
109 red blood cells/mi. The AS solution was then diluted with the control solution to make its 
parasitaemia identical to that of the AJ solution (7.4%). 
The AS and AJ solutions with the same numbers of red blood cells and parasites were mixed 
to give artificial mixtures with different ratios between the two clones (AS:AJ, 100:0, 99:1, 
80:20, 67.5:32.5, 50:50, 32.5:67.5, 20:80, 6:94, 1:99, 0:100). Each mixture had a volume of 
200 pi, corresponding to 2.0 x 108  red blood cells. The original mice had around 1.0 x 1010 
red blood cells per ml blood, so that 2.0 x 108  roughly corresponded to 20 jt1 of blood, which 
is significantly more than blood samples usually taken for DNA extraction (5 tl). 
DNA was extracted from these blood mixtures by S.J. Cheesman, using the Roche High Pure 
Template Preparation Kit (Roche). Of each extracted DNA sample, 2 j.il was used per PCR 
reaction. Quantifications were done twice for each sample, with two AS quantifications in 
one run, and two AJ quantifications in another run. The means of the two replicates were 
averaged and the average proportions of AS per sample were compared to the expected 
proportions (Figure 2.2). This showed that real-time quantitative PCR works well for 
quantifying AS and AJ parasites in these mixtures, as the data points fell almost exactly on 
the theoretically perfect straight line of observed vs. expected values (Figure 2.2). 
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Figure 2.2. Observed versus expected proportions of AS in artificial mixtures of AS and AJ parasites. 
Artificial mixtures were made from blood from three female CBA mice: one uninfected, one infected 
with AS and one infected with AJ. Diamonds represent data points, while the dashed line represents 
the theoretically perfect 1:1 observed:expected relationship. 
2.5.3. Artificial mixtures serially diluted 
The artificial mixtures described above were effectively based on 20 jtl of mouse blood per 
sample. In standard experiments, it would be more ideal to use 5 .tl samples, as these are 
more easily obtained from the tails of the mice sampled. The mixtures were also based on 
one level of parasitaemia only; for real-time PCR to be useful in experiments, however, it 
would have to work well over several orders of magnitude of parasitaemia. I therefore 
prepared a new series of artificial mixtures, using effectively 5 tl of mouse blood per 
sample, and diluting extracted DNA from these mixtures 10- and 100-fold. 
One female C57 mouse was infected with AS, one with AJ and one was left uninfected. Red 
blood cell densities, were assessed and blood smears taken to calculate parasitaemia. When 
the AS mouse reached a parasitaemia of 42%, mice were killed and blood was collected in 2 
ml of citrate saline. This resulted in a new volume, which was measured. Red blood cell 
densities of these solutions were calculated, and solutions were diluted with citrate saline to 
the same number of red blood cells/mi. The AJ solution was diluted with the control solution 
to make its parasitaemia identical to that of the AS solution (42%). The AS and AJ solutions 
with the same numbers of red blood cells and parasites were then mixed to give artificial 
mixtures with different ratios between the two clones. Volumes were chosen such that the 
final mixtures represented 5 tl of mouse blood. 





























From these mixtures I extracted DNA using Instagene Matrix (BioRad). Subsequently I 
diluted these DNA samples 10- and 100-fold in sterile H 20. AS and AJ were quantified and 
the proportion of AS calculated. Observed AS proportions were compared to the expected 
proportions (Figure 2.3), showing that quantifications of the AS proportions were very close 
to what they should have been for undiluted (Figure 2.3A), 10-fold diluted (Figure 2.313) and 
100-fold diluted (Figure 2.3C) samples. Thus, real-time quantitative PCR can be used to 
accurately quantify AS and AJ proportions in small blood samples, and over two orders of 
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Figure 2.3. Observed versus expected proportions of AS in artificial mixtures of AS and AJ parasites 
(A), and in those same mixtures diluted 10 times (B) and 100 times (C). Diluted mixtures were 
obtained by diluting extracted DNA in sterile water. Artificial mixtures were made from blood from 
three female C57 mice: one uninfected, one infected with AS and one infected with AJ. Open circles 
represent data points, while the dashed lines represent the theoretically perfect 1:1 observed:expected 
relationships. 
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Figure 2.4. Observed versus expected proportions of AS in artificial mixtures of AS and AJ parasites 
at parasitaemia levels of 30% (A), 3.0% (B) and 0.3% (C). Artificial mixtures were made from blood 
from three male CBA mice: one uninfected, one infected with AS and one infected with AJ. Solutions 
of AS- and AJ- infected blood were created and diluted 1, 10 or 100 x with uninfected blood to create 
mixtures. Triangles represent data points, while the dashed lines represent the theoretically perfect 1:1 
observed:expected relationships. 
2.5.4. Artificial mixtures at different levels of parasitaemia 
The 10- and 100-fold diluted artificial mixtures described in § 2.5.3 were obtained through 
diluting DNA samples in H20. Here, I will describe mixtures that were based on diluting 
artificial mixtures using uninfected blood. This is important, as it is theoretically possible 
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that when parasite numbers are low relative to the blood volume they are in, quantifications 
could be affected by the presence of relatively many PCR inhibitors, or because PCR 
template concentration is low compared to non-template DNA (from white blood cells). 
One male CBA mouse was infected with AS(pyrlA), one was infected with AJ and one 
mouse was left uninfected. When the AS mouse reached 31% parasitaemia, and the AJ 
mouse 33.9% parasitaemia, volumes of respectively 30 and 27 j.tl of tail blood were diluted 
into an end volume of 1500 jfl of citrate saline/blood. AS and AJ stock solutions were then 
used to prepare artificial mixtures (AS:AJ, 50:50, 10:90, 1:99, 99:1, 9:1), making sure that 
the end volume represented a volume of 5 tl of mouse blood. The AS and AJ stock solutions 
were also diluted 10- and 100-fold using blood from the control mouse. These dilutions were 
used to prepare mixtures of the same ratios, at levels of 3.0 % and 0.3 % parasitaemia 
respectively. Quantifications were done twice for each sample, and the observed mean 
proportions of AS were compared to the expected proportions (Figure 2.4). 
As observed AS proportions were again very close to those expected, it is clear that real-time 
quantitative PCR can be used to accurately estimate AS and AJ proportions in small blood 
samples, and over a range of 30 down to 0.3 % parasitaemia. 
2.5.5. Artificial mixtures prepared from real-life samples 
Despite the results described in §§ 2.5.2 - 2.5.4, I became concerned at one point that AS 
was relatively under-quantified in artificial mixtures, especially at low concentrations (see § 
2.6.3.3). At that time I had already analysed one experiment fully (Chapter 4), and was 
concerned that the results obtained might have been biased towards AJ. To find out if this 
was indeed the case, I decided to create another set of artificial mixtures. These were based 
on 5 .tl blood samples that I had collected from single AS(pyrlA) or AJ infections in CBA 
mice as part of the experiment described in chapter 4. These blood samples had been frozen 
at —70 °C since the experiment, and not been used before. 
I prepared 50 mixtures, each consisting of a 5 j.tl blood sample from an AS(pyrlA) infected 
mouse and a 5 tl blood sample from an AJ infected mouse. DNA was extracted from these 
blood mixtures using Instagene Matrix (BioRad) and real-time PCR was performed. Three 
ranges of parasitaemias were distinguished (>10%, 1.0 - 10% and 0.1 - 1.0%) to find out if 
the level of parasitaemia itself influenced a bias (if such a bias already existed). 
There turned out to be no bias, however, for any of the three parasitaemia ranges (Figure 
2.5). In all cases the observed proportions of AS in these mixtures were scattered around the 
































perfect observed vs. expected relationship. There was considerable scatter around these lines, 
but this is not surprising given the fact that obtaining exactly 5 p.1 of blood from each mouse 
is not possible, because not all blood is released from the 5 p.1 glass capillaries that are used. 
The fact that the data points are around the line, however, and not mostly below it, shows 
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Figure 2.5. Observed versus expected proportions of AS in artificial mixtures of AS and AJ parasites 
at parasitaemia levels of >10% (A), 1.0-10% (B) and 0.1-1.0% (C). Artificial mixtures were made by 
mixing together blood obtained from female CBA mice infected with either AS or AJ. These blood 
samples had been frozen for more than 12 months. Triangles represent data points, while the dashed 
lines represent the theoretically perfect 1:1 observed:expected relationships. 


























2.5.6. Mixtures analysed straight after DNA extraction or nine months later 
One possible explanation for finding an under-representation of AS in the artificial mixtures 
described in § 2.6.3.3, is that DNA samples were stored too long at —20 °C before PCRs were 
done, and that hydrolysis of DNA had to some extent degraded the DNA (S.J. Cheesman and 
A.S. Bell, pers; comm.). Some evidence for this comes from quantifying artificial mixtures 
straight after DNA extraction and again later, when they had been frozen for nine months. 
Leaving the samples frozen for such a long time indeed resulted in an under-representation 
of AS in some of the artificial mixtures (Figure 2.6). It was therefore decided that to obtain 
the most reliable results, PCRs would have to be done as soon as possible after DNA 
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Figure 2.6. Observed versus expected proportions of AS in artificial mixtures of AS and AJ parasites 
at a level of 0.3% parasitaemia. PCR reactions were done on these samples shortly after DNA 
extraction (A) and again when DNA samples had been frozen for nine months (B). Artificial mixtures 
were made as described in Figure 4; note that results in (A) are identical to those shown in Figure 
2.4C. Triangles represent data points, while the dashed lines represent the theoretically perfect 1:1 
observed:expected relationships. 
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2.6. Time of day effects in quantification by real-time PCR 
2.6.1. Introduction 
The time at which blood samples for PCR analysis are taken, could affect the reliability of 
the analysis. This is because using a DNA-based method for parasite quantification assumes 
a direct relationship between DNA-concentration and parasite number; such a relationship 
only exists when every parasite has only one genome (and thus only one PCR template). 
A 1:1 relationship between parasites and genome copies certainly does not exist for malaria 
parasites throughout the entirety of their erythrocytic schizogonic cycle. Plasmodium species 
in laboratory mice undergo a 24-hour asexual replication cycle within the blood, during 
which several asexual parasitic stages can be distinguished (Cox 1988; Chimanuka et al. 
1999). The cycle begins with haploid merozoites invading red blood cells; for P. chabaudi in 
a 12 L 12 D cycle, this is thought to happen early in the morning, when it is dark (Cox 
1988; Chimanuka et al. 1999). Merozoites grow into haploid ring-stage parasites, resembling 
diamond rings (Figure 2.7A). Ring-stage parasites turn into trophozoites, distinguished by 
densely stained cytoplasm that is no longer in the shape of a ring, and lacks a yacuole. 
Trophozoites mature from early trophozoites (still resembling rings; Figures 2.713, C) into 
late mature trophozoites (Figure 2.713). The parasites now undergo nuclear division, and 
when two or more nuclei are visible, the parasite is called a schizont. Schizonts (Figure 2.7E) 
may contain between 4 and 8 new merozoites (Cox 1988), which upon red blood cell lysis 
invade uninfected red blood cells (Figure 2.717). 
As a merozoite contains 1 genome copy, whereas a schizont may contain around 8, it is 
obvious that at some stage of the erythrocytic cycle DNA is replicated 2 up to 8 times. 
Several authors have grown malaria parasites in culture in the presence of [ 3H]adenosine or 
other isotopes that are incorporated into DNA during DNA synthesis. Quantifying amounts 
of DNA using scintillation assays, they have shown that DNA synthesis occurs primarily in 
maturing trophozoites and schizonts, in both P. falciparum (Gritzmacher & Reese 1984; 
Inselburg & Banyal 1984) and P. chabaudi (Newbold et al. 1982). Indeed, DNA synthesis 
inhibitors did block the maturation of trophozoites, but not the differentiation of rings into 
trophozoites (Inselburg & Banyal 1984). Based on such results, it would be best to sample 
infections at times when rings are the most abundant life-stages, to ensure as much as 
possible that concentrations of DNA correspond linearly to numbers of parasites. It would 
therefore be important that parasites underwent their erythrocytic cycles in synchrony, which 
means that at any time point there would be predominantly one parasite stage only 
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(Chimanuka et al. 1999). Different parasite clones are known to undergo schizogony at 
different times during the day (at least in reversed L:D cycles: McLean 1986), and it is thus 
important to study the erythrocytic cycles of both AS and AJ, so that time points at which 
both parasites occur in predominantly the ring-stage can be identified. 
Here, I analysed the erythrocytic schizogonic life cycles of AS(pyrlA) and AJ parasites over 
two 24-hour periods during experimental infection. Doing this, I wanted to find out whether 
AS(pyrl A) and AJ parasites were synchronous, and having such information, to identify the 
most optimal time during the day at which to take samples. The fact that the artificial 
mixtures described in §§ 2.5.2 - 2.5.5 gave accurate results, and the fact that they were all 
prepared from parasites between 08:00 and 12:00 hours, suggested that morning might be the 
optimal time for doing this. 
(A) 	 (B) 	 (C) 
(D) 	 (E) 	 (F) 
5pm 
Figure 2.7. Microscopic images of red blood cells infected with ring-stage parasites (A), early 
trophozoites (B, C), late trophozoites (D), a schizont with 8 merozoites (E) and newly invaded ring-
stage parasites (F). Images were obtained using 1000x light microscopic magnification of Giemsa-
stained blood smears. 
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2.6.2. Material and methods 
In this experiment I used AS(pyrlA) and AJ. For simplicity AS(pyrlA) will be referred to as 
AS from hereon. Hosts were eight weeks old C57 and CBA female mice (Ann Walker, 
University of Edinburgh), which were kept in a 12 L: 12 D cycle. 
The experiment consisted of three treatments for both C57 and CBA mice: infections with 
AS alone, infections with AJ alone, and mixed AS+AJ infections. Each treatment group had 
5 mice, resulting in 30 mice in total. Mice infected with just AS or AJ received 106  parasite-
infected red blood cells, whereas mice infected with both clones received 2 x 106  parasites, 
made up of 106  AS and 106  AJ parasites. Inoculations were prepared from donor mice by 
diluting blood in 0.1 ml calf-serum solution (50% heat-inactivated calf-serum, 50% Ringer's 
solution [27mM KC1, 27mM CaCl 2 , 0.15 M NaCl], 20 units heparin/mi mouse blood), and 
injections were done via the intraperitoneum. 
To monitor production of asexual parasites, I took thin blood smears from tail blood. These 
were fixed with methanol and stained with Giemsa to determine levels of asexual 
parasitaemia using 1 000x microscopy. When asexual parasitaemia was high, I counted 500 
red blood cells in at least 4 microscopic fields. With lower parasitaemias I counted at least 20 
microscopic fields (corresponding to at least 10,000 red blood cells), and calculated the 
average number of cells per field. Red blood cells infected with asexual parasites were 
classified into the following categories: red blood cells infected with rings (ring-stage 
parasite), early trophs (early trophozoites), late trophs (late trophozoites) and schizonts. 
Absolute densities of these were calculated as the product of parasitaemias and red blood cell 
densities (measured using a Coulter Counter) taken on the same day. 
Measurements were taken at 4-hourly intervals starting at 09:00 hours on day 5 and ending at 
09:00 hours on day 6 P1, and again at 4-hourly intervals starting at 09:00 hours on day 12 
and ending at 09:00 hours on day 13 PT. At all these time points I also collected 5 l blood 
samples from each mouse. For mixed AS+AJ infections, these samples were DNA extracted 
as such. For single infections, however, I always pooled the blood sample of an AS infected 
mouse with that of an AJ infected mouse. Thus, for example, the blood samples from mouse 
1 from the AS infected C57 mice were always pooled with those of mouse 1 from the AJ 
infected group of C57 mice. DNA was extracted using Instagene Matrix (BioRad) and AS 
and AJ DNA concentrations were measured using real-time quantitative PCR. 
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Figure 2.8. Parasite densities at 4-hourly intervals from 9:00 hours on day 5 P1(9:00) to 9:00 hours 
on day 6 P1(09:00). Shown are densities for single AS (A, B), single Al (C, D) and mixed AS+AJ (E, 
F) infections in C57 and CBA mice respectively. Left panels for each mouse strain show densities of 
ring-stage parasites (rings), early trophozoites (early trophs) and total parasite (total) densities, while 
right panels show late trophozoite (late trophs) densities; the latterwere shown in separate panels as 
they were much lower than the densities of rings, early trophs and totals. All data points are the means 
(± 1 s.e.m.) of 5 mice, except for AS infections in C57 mice, which are based on 4. 
2.6.3. Results and discussion 
2.6.3.1. Parasite dynamics over time 
Between 09:00 on day 5 and 09:00 on day 6 PT, all infection types (AS, AJ and AS+AJ) 
increased their parasite densities (grey dashed lines in left panels of Figures 2.8A-F). During 
most of the 24-hour period, ring-stage parasites were the predominant parasites in all 
infections (solid lines in left panels of Figures 2.8 A-F), thus showing that P. chabaudi 
infections in this experiment are relatively asynchronous. This in contrast with human 
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malaria parasites in culture (Inselburg & Bnyal 1984), and in vitro synchronised P. 
chabaudi parasites (Chimanuka et al. 1999), which showed very distinct and sequential 
peaks of rings, trophs and schizonts, indicating synchronous development. 
Infections of AS in both C57 and CBA mice showed peaks of late trophozoites around 17:00 
(Figures 2.8A, B), and in CBA mice, this followed a slight increase of early trophozoites 
between 9:00 and 13:00 (Figure 2.813). Total parasitaemias increased mostly between 17:00 
and 01:00 (Figures 2.8A, B). Both these observations indicate that AS parasites underwent 
schizogony sometime between 17:00 and 01:00. In AJ and AS+AJ infections, there was an 
increase in the numbers of early trophozoites between 9:00 and 17:00 (Figures 2.8C-F). This 
increase in early trophozoites was followed by large peaks of late trophozoites in AJ and 
AS+AJ infections at around 21:00, and increases in total parasitaemias around 01:00, 
indicating that schizogony in AJ and AS+AJ infections happened between 21:00 and 01:00. 
Thus, AS and AJ parasites seemed to undergo schizogony about 4 hours apart; the fact that 
AS+AJ infections resembled AJ single infections more than AS single infections is probably 
a result of AJ being the dominant clone in those infections. It must be noted, however, that 
AS infections had much lower parasite densities than AJ and AS+AJ infections, and that 
especially late trophozoite counts were sometimes based on a single trophozoite only. Some 
caution must therefore be taken in interpreting these results. 
For all infections, hardly any schizonts were detected (results not shown), probably because 
most schizonts sequestered in mouse organs such as the liver (Gilks et al. 1990; Chimanuka 
et al. 1999) and spleen (Gilks et al. 1990). The fact that I did not observe a dip in total 
parasitaemias prior to schizogony (Gilks et al. 1990; Chimanuka et al. 1999), and that there 
was not a marked and quick increase in parasitaemia (Chimanuka et al. 1999), again 
confirms that the infections studied here were desynchronised. 
On days 12 and 13, parasite densities were much lower than on days 5 and 6 P1, and it was 
therefore harder to obtain reliable parasite counts, and to interpret patterns of parasite 
dynamics. Nonetheless, it appeared that, in general, early trophozoites increased in density 
between 09:00 and 17:00 (dashed black lines in left panels of Figures 2.913-F), after which 
late trophozoites peaked at around 21:00, even for AS infections in CBA mice (right panels 
of Figures 2.9B-F). Thus, even though early trophozoite production seemed to have shifted 
to an earlier time of day since days 5-6 P1, parasite replication still happened at the same 
time (following the late trophozoite peaks at around 21:00). Densities for AS infections in 
C57 were so low (most counts based on 1 or a few parasites; late trophozoites not observed), 
that interpretations for them are not possible. 
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Figure 2.9. Parasite densities at 4-hourly intervals from 9:00 hours on day 12 P1(9:00) to 9:00 hours 
on day 13 P1(09:00). Annotations are as in Figure 2.8. All data points are the means (± 1 s.e.m.) of 5 
mice, except for AS infections in C57 mice, which are based on 4. 
2.6.3.2. DNA synthesis over time 
To find out when DNA replication occurs in these P. chabaudi infections, I analysed blood 
samples taken at 4-hourly intervals using real-time PCR. The AS and AJ DNA 
concentrations obtained in that way were then divided by the total density of parasite-
infected red blood cells to obtain an estimate of the DNA content per infected cell. 
For the samples collected on days 5 and 6 PT, the DNA content per infected cell increased 
throughout the day (Figure 2.10). For AS infections in C57 mice, this generally happened 
between 09:00 and 17:00 (Figure 2.10A), whereas for AJ and AS+AJ infections this 
happened mostly between 13:00 and 21:00 (Figures 2.10C-F). AS infections in CBA mice 
did not show much variation through time, although a slight increase was observed between 
21:00 and 01:00 (Figure 2.10B). In general, however, it can be concluded that DNA content 





















per parasite increased when numbers of early and late trophozoites increased (see § 2.6.3.1; 
Figure 2.8). This has also been observed in highly synchronous P. chabaudi infections 
(Newbold et al. 1982). 
C57 mice 	 CBA mice 
AS 	 AS 
AJ 
(C) 
9:00 13:00 17:00 21:00 01:00 0500 09:00 
AS+AJ  


























9:00 13:00 17:00 21:00 01:00 05:00 09:00 	 9:00 13:00 17:0021:00 01:00 05:00 09:00 
Figure 2.10. DNA content per infected red blood cell at 4-hourly intervals from 9:00 hours on day 5 
P1(9:00) to 9:00 hours on day 6 P1(09:00). Shown are means for single AS (A, B), single AJ (C, D) 
and mixed AS+AJ (E, F) infections in C57 and CBA mice. All data points are the means (± 1 s.e.m.) 
of 5 mice, except for AS infections in C57 mice, which are based on 4. RBC: red blood cell. 
PCR analysis was not done on samples from C57 mice collected on days 12 and 13 P1, as 
parasitaemias were too low for accurate quantification. They were done for CBA mice, 
however, revealing different patterns than those seen on days 5 and 6 P1 (Figure 2.11). 
Highest DNA contents per parasite were now observed at 09:00 on day 12 for AS and AJ, 
with peaks again at 01:00 on day 13 P1 (Figures 2.11A, B). For AS+AJ infections, a peak 
was seen at 17:00 on day 12 PT. Whether these results are truly indicative of what happened 




























in these infections, is questionable, as overall parasite densities were far lower than those on 
days 5 and 6 P1 (see also § 2.6.3.1). If they are, then the most likely explanation for the 
differences between days 5-6 and days 12-13 P1 is that infections became less synchronised. 
This would mean that at any one time point more maturing trophozoites were present, thus 
obscuring the patterns as seen on days 5 -6. This in itself would not be surprising; the 
infections studied here all peaked around day 7/8 PT, and parasites may be less synchronous 
after than before their peak parasitaemias (M.J. Mackinnon, pers.comm.). 
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Figure 2.11. DNA content per infected red blood cell at 4-hourly intervals from 9:00 hours on day 12 
P1(9:00) to 9:00 hours on day 13 P1(09:00). Shown are means for single AS (A), single AJ (B) and 
mixed AS+AJ (C) infections in CBA mice only; C57 mice had too low parasitaemias to perform real-
time quantitative PCR. All data points are the means (± 1 s.e.m.) of 5 mice, except for AS infections 
in C57 mice, which are based on 4. 
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Figure 2.12. Observed versus expected proportions of AS in artificial mixtures made from blood 
samples obtained from C57 and CBA mice infected with either AS or AJ. Mixtures were made at 
09:00 (A), 13:00 (B), 17:00 (C) and 2 1:00 (D) on day 5 PT and at 01:00 (E), 05:00 (F) and 09:00 (A) 
on day 6 P1. Circles and triangles represent data points, while the dashed lines represent the 
theoretically perfect 1:1 observed:expected relationships. 
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2.6.3.3. Observed and expected AS proportions at 4-hourly intervals 
From the above paragraphs, it would seem best to analyse mixed infections early in the 
morning, when not many mature trophozoites are present and DNA content per parasite is 
low. Here I analyse the observed proportions of AS in the artificial mixtures made by 
pooling AS and AJ samples together, and compare them to those as expected on the basis of 
the total numbers of parasite-infected red blood cells that should have been present in these 
mixtures. It is important to note here that PCRs were not done straight after DNA extraction, 
and that hydrolysis of DNA might therefore have occurred (§ 2.5.6). Indeed, it was found 
that AS proportions were slightly lower than expected. I therefore corrected these 
proportions for the 09:00 time-points to use these as a reference point to analyse all the other 
time points. 
Doing this, I found that the observed proportions of AS at 09:00 (Figure 2. 12A) were much 
closer to the expected proportions, and showed less scatter around the observed:expected line 
than did the observed proportions of AS at 13:00, 17:00, 2 1:00 and 01:00 (Figures 2. 12B-E). 
Proportions at 05:00 also were very close to their expected values, except for two outlying 
values (Figure 2. 12F). On days 12 - 13 P1, AS observed proportions were closest to expected 
proportions at 13:00 (Figure 2. 13B), while the rest of the time points showed considerable 
deviation from and scatter around the 1:1 observed:expected line (Figures 2.1 3A, C-F). 
2.6.3.4. AS proportions over time 
The observed AS proportions in the real AS+AJ mixed infections were analysed over time. 
Despite the fact that time of day affected the relationship between observed and expected 
proportions of AS in artificial mixtures Q. 2.6.3.3), there was hardly any evidence that the 
observed AS proportions in the real AS+AJ mixed infections changed between 09:00 and 
17:00 on dayS P1 (Figures 2.14A, B for C57 mice and 2.14C, D for CBA mice respectively), 
although they did decrease afterwards (Figures 2.14A-D). On days 12-13 P1, AS proportions 
were considerably less constant over time (Figures 2. 14E, F; CBA mice only), although they 
were still constant between 09:00 and 13:00. 
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Figure 2.13. Observed versus expected proportions of AS in artificial mixtures made from blood 
samples obtained from CBA mice infected with either AS or AJ. Mixtures were made at 09:00 (A), 
13:00 (B), 17:00 (C) and 21:00 (D) on day 12 P1 and at 01:00 (E), 05:00 (F) and 09:00 (A) on day 13 
Pt. Circles and triangles represent data points, while the dashed lines represent the theoretically 
perfect 1:1 observed:expected relationships. 
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Figure 2.14. Proportions of AS in mixed AS+AJ infections over a 24-hour period. Shown are AS 
proportions at 4-hourly intervals from 09:00 hours on day 5 P1(9:00) to 09:00 hours on day 6 P1 
(09:00) for C57 (A, B) and CBA mice (C, D) respectively, and AS proportions at 4-hourly intervals 
from 09:00 hours on day 12 P1(9:00) to 09:00 hours on day 13 P1(09:00) for CBA mice only (E, F). 
Panels A, C and E show data for individual mice, while panels B, D and F show means (± 1 s.e.m.) for 
the same mice. 
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2.6.4. Conclusions: time of day effects in quantification by real-time PCR 
This experiment showed that, in general, parasites mature between 09:00 in the morning and 
21:00 at night. During this time DNA synthesis takes place, increasing the DNA content per 
parasite. This was especially true before peak parasitaemia, but to a lesser extent after peak 
parasitaemia, when infections seemed to be less synchronised. 
It was shown that time of day affected the results of real-time PCR analysis, showing that, at 
least on days 5 and 6 PT, most accurate results were obtained at 9:00 in the morning. This, 
together with the fact that observed AS proportions in real mixed AS+AJ infections were 
rather stable between 09:00 and 17:00 on days 5-6 PT and between 09:00 and 13:00 on days 
12-13 P1, shows that the best sampling time would be between 09:00 and 13:00 in the 
morning. The other artificial mixtures described in this chapter were made in exactly that 
time interval, and were accurately quantified for AS and AJ parasites, supporting this 
assertion. 
The reason that less accurate results were obtained at certain time points, is probably due to 
the different parasite clones undergoing different erythrocytic cycles. AS started producing 
trophozoites before AJ, and the DNA content per parasite also increased earlier for AS than 
for AJ. That could explain why an overquantification of AS was observed in artificial 
mixtures prepared at 13:00 and 17:00 on day 5 (Figures 2.1213, Q. An overquantification of 
AJ in artificial mixtures was observed at 21:00 and 01:00 (Figures 2.12D, B), when AJ had 
started to produce trophozoites, thus increasing its DNA content per parasite. 
The infections in this experiment were not synchronous. There was no rapid increase of 
parasitaemia over a short time, lifting parasitaemia from one plateau to the next (Chimanuka 
et al. 1999), there was no clear succession of parasite stages (Newbold et al. 1982; Gilks et 
al. 1990; Chimanuka et al. 1999), and there was no dip in parasitaemia prior to schizogony 
(Cox et al. 1987; Gilks et al. 1990). This is possibly the result of a build-up of asynchrony of 
parasite populations that have been serially passaged through mice, as happened with the 
parasites used here. It would be interesting to test this possibility by comparing the 
synchrony of these parasites with infections of the same parasites initiated with mosquito 
inoculations or initiated with in vitro synchronised parasites (Chimanuka et al. 1999). 
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2.7. Overall conclusions 
All the experiments described in this chapter were designed to find out whether real-time 
quantitative PCR can be used to accurately quantify AS and AJ parasites in mixed AS+AJ 
infections. On the basis of the presented results, the following conclusions can be drawn. 
• AS- and AJ-specific real-time PCR assays were designed and found to be highly 
accurate. Furthermore, the AS assay did not amplify AJ DNA and the AJ assay did not 
amplify AS DNA. 
• The real-time PCR assays for AS and AJ can be used to accurately quantify AS and AJ 
proportions in artificially prepared parasite mixtures from very low (-0.1 %) to very 
high (>30 %) parasitaemias. 
• AS and AJ proportions can be accurately quantified with real-time PCR, using small 
volumes of blood (5 p.1), which are easily obtained from the tails of mice. 
• The best time for sampling blood from mice for subsequent .PCR analysis is between 
09:00 and 13:00. 
As the DNA sequences for the mspl gene and other genes for more P. chabaudi clones are 
available, these real-time PCR assays could be expanded for analysing mixed-clone 
infections consisting of different clones from the ones described here (Cheesman et al. 2003 
[Thesis Appendix]). 
Chapter 2 - Real-time PCR 	 49 
3. Virulent parasites are competitively superior in genetically diverse 
malaria infections 
A shorter version of this chapter is submitted as: De Roode, J. C., Pansini, R., Cheesman, S. J., 
Walliker, D. & Read, A. F. Virulent parasites are competitively superior in genetically diverse malaria 
infections. 
3.1. Abstract 
Humans and animals often become co-infected with microparasite strains that differ in 
virulence. The outcome of the ensuing interaction can determine how sick the host becomes, 
and the direction of selection on virulence genes. Serial passage experiments and the 
reversion to virulence of attenuated live vaccines imply that virulent variants are 
competitively superior. However, direct evidence that this is the case is seriously lacking. I 
show here that in a rodent malaria model virulence is positively associated with competitive 
ability. Thus, measures to reduce malaria transmission should, by also reducing multiplicity 
of infection, impose evolutionary pressure on malaria for reduced virulence. 
3.2. Introduction 
Genetically diverse infections are common (Read & Taylor 2000; 2001) and in malaria are 
the rule rather than the exception (e.g. Beale et al. 1978; Snewin et al. 1991; Paul et al. 1995; 
Daubersies et al. 1996; Babiker et al. 1999; Felger et al. 1999; Bruce et al. 2000). Mixed 
genotype infections are of medical significance, because a large body of evolutionary theory 
asserts that competition between co-infecting pathogen genotypes can select for increased 
virulence, and thus more severe disease (Levin & Pimentel 1981; Bremermann & Pickering 
1983; Van Baalen & Sabelis 1995; Frank 1996; Gandon 1998; Mosquera & Adler 1998; 
Ebert 1999). This theory assumes that parasites that prudently exploit their hosts, and are 
thus avirulent, will be out-competed by more aggressive parasites, which rapidly exploit 
their hosts. Even if this means that host life expectancy is reduced so that all parasites do 
worse, prudent parasites will do disproportionately worse, and be eliminated by natural 
selection: a process commonly referred to as 'the tragedy of the commons' (Hardin 1968). 
However, evidence that parasites with higher virulence are indeed competitively superior is 
currently circumstantial and anecdotal. Serial passage of pathogens through new host 
environments typically increases virulence (Ebert 1998), and live attenuated vaccines, such 
as polio, can revert to wild type virulence (Bull 1994; Kew et al. 2002). Both phenomena 
could be due to virulent variants rising in frequency because they have a competitive 
Chapter 3 - Virulence and coFnpetitiveness 	 51 
advantage (Bull 1994, Ebert 1998). Some in vitro evidence supports this argument (Ebert 
1998), but some direct in vivo competition experiments between avirulent and virulent 
parasites in a range of different disease models contradict this view: avirulent genotypes 
have been shown to overgrow virulent strains in some cases (Orcutt & Schaedler 1973; 
Hargreaves et al. 1975; Duval-Iflah et al. 1983; Allaker et al. 1988; Lenhoff et al. 1998; 
Franco et al. 2003, reviewed in Taylor and Read 2000). This could be because experimental 
effort is directed at the search for protective lines of parasites, rather than at directly 
determining the competitive ability of virulent strains: some of these experiments indeed first 
established an avirulent strain to protect against infection with a virulent one. Regardless, 
these current in vivo data contradict standard models of virulence evolution, and the 
explanations of why virulence increases following serial passage and reversion of live 
attenuated vaccines. 
Malaria parasites vary in virulence (summarised in Mackinnon & Read 2004b; Read et al. 
2004). Determining whether there is a relationship between intrinsic virulence and 
competitive ability in malaria parasites is important for predicting the consequences for 
disease severity of interventions that reduce clone multiplicity in malaria infections, such as 
bed-nets and strain-specific vaccines. Here, I test whether virulence and competitive ability 
are linked in the rodent malaria Plasmodium chabaudi, a parasite often used as a model for 
human malaria (Cox 1988). 
3.3. Material and methods 
3.3.1. Parasites and hosts 
Four P. chabaudi clones were used: 3 lines derived clonally from the same ancestral parasite, 
denoted AS(pyrlA), AS and AS(pyrlB), and an unrelated clone AJ (see Thesis Appendix). 
AS and AJ were originally isolated from thicket rats of the species Thamnomys rutilans 
(Beale et al. 1978); AS(pyrlA) was then obtained from AS through drug selection with 
pyrimethamine (Walliker et al. 1975), and AS(pyrlB) was derived from AS(pyrlA) by 
passage through 11 generations of mice, 6 generations of thicket rats and 4 generations of 
mosquitoes (not in this order). I will refer to these clones as AS aviruie nt, ASmojerate , and ASviniient  
for AS(pyrlA), AS and AS(pyrlB) respectively. 
Hosts were six weeks old C57B116J inbred female mice (Harlan, England), which were fed 
on 41B maintenance diet (Harlan, England) and drinking water supplemented with 0.05% 
para-amino benzoic acid (Jacobs 1964), and kept in a 12 L: 12 D cycle. 
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3.3.2. Experimental design 
The experiment consisted of 7 treatments with 5 mice each: single infections of AS aviruient , 
AS mocierate , AS viruient and AJ, and mixed infections of AJ with either of the 3 AS clones. Thus, I 
used AJ as a reference strain against which to compete the different AS clones. Infections 
were initiated with 106  parasites for single and 2 x 106  parasites  (106  AS and 106  AJ) for 
mixed infections. I used a double dose of parasites to initiate mixed infections, because I 
wanted to compare the performance of an individual clone in a mixed infection to its 
performance in a single infection, requiring equal numbers of parasites at inoculum; a 
twofold difference in parasite numbers has a negligible effect on parasite dynamics and 
virulence (Timms et al. 2001). I prepared inoculations from donor mice by diluting blood in 
0.1 ml calf-serum solution (50% heat-inactivated calf-serum, 50610 Ringer's solution [27mM 
KC1, 27mM CaC12, 0.15 M NaCl], 20 units heparin/mi mouse blood), and injected them via 
the intraperitoneum. 
3.3.3. Virulence and parasite dynamics 
To monitor virulence, red blood cell densities were recorded (using flow cytometry; 
Beckman Coulter): red blood cell densities decrease dramatically during infection, and these 
decreases correlate with host mortality and thus virulence (Mackinnon et al. 2002b). 
To monitor production of asexual parasites and gametocytes (the sexual transmission stages) 
thin blood smears were prepared from tail blood. These were fixed with methanol and 
stained with Giemsa to determine levels of asexual parasitaemia and gametocytaemia as the 
percentage of infected red blood cells using 1000x microscopy. When asexual parasitaemia 
was high, 500 red blood cells in at least 4 microscopic fields were counted; with lower 
parasitaemias and gametocytaemias at least 20 microscopic fields were counted 
(corresponding to at least 10,000 red blood cells). Parasite densities and gametocyte densities 
were calculated as the product of parasitaemias or gametocytaemias and red blood cell 
densities taken on the same day. 
Tail blood samples of 5 j.il were taken from mice harbouring mixed infections in citrate 
saline. After 1 minute's centrifugation at 13,000 rpm, the supernatant was removed and 
pelleted blood cells stored at -70°C for subsequent DNA extraction using Instagene Matrix 
(BioRad). I used real-time quantitative PCR to measure the DNA concentrations of both AS 
and AJ in these samples (Chapter 2, Cheesman et at. 2003 [Thesis Appendix]), and 
calculated the proportion of AS and AJ of the total parasite population. Absolute numbers of 
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AS and AJ were then calculated by multiplying these proportions by the overall parasite 
density on the same day. 
PCRs were performed when parasitaemias were higher than 0.1%, which is the lowest level 
at which AS and AJ proportions can be accurately estimated (Chapter 2). The real-time 
quantitative PCR protocols cannot distinguish between asexual parasites and gametocytes, 
and so they estimate the densities of all parasites. In the data analyses, I treated these as 
estimates of asexual densities. Gametocyte densities were 2-3 orders of magnitude lower 
than asexual parasite densities, and are thus a negligible component of overall parasite 
numbers. 
Measurements were taken every day from day 0 to day 22 post-infection (P1), then every 2 
days from day 24 to day 28 PT, when the experiment was terminated. Measurements were 
taken between 9.00 and 10.30 a.m., when peripheral blood almost exclusively harboured 
haploid ring stages of the parasites (Chapter 2). 
3.3.4. Trait definition and statistical analysis 
To measure virulence I determined red blood cell loss as the difference between a mouse's 
initial red blood cell density and the minimum it reached during the infection. 
Mice generally experienced several waves of parasites, with the first being substantially 
larger and longer. For each mouse, I calculated the period until the end of the first wave, and 
defined this as the acute phase of the infection. The subsequent period, the chronic phase, 
was defined as starting the day parasite numbers began to recover after the collapse of the 
first wave. To calculate the number of parasites present during the whole infection, and 
during the acute and chronic phases, I calculated the area under the relevant parasite density 
by day P1 curves. As the limit of detecting parasites was around 100/pi, I treated 
observations of zero parasites as being 100 parasites/pi. I could accurately .quantify AS and 
AJ proportions of 0.01 at levels of 0.1% parasitaemia or higher (Chapter 2); below that I set 
the clone densities at the limit of detection (100/tl). Parasite densities in single infections 
were set to the same level when parasitaemias were lower than 0.001%. Persistence was 
defined as the number of days until AS or AT disappeared below detectible levels. 
For gametocytes, I calculated the total densities over the whole infection. I was able to 
analyse overall numbers of gametocytes only, as the real-time quantitative PCR protocol 
does not distinguish between AS and AT gametocytes. 
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Analysis was carried out using ANOVAs and ANCOVAs in Minitab (Version 13.30, 
Minitab Inc.). For all the models I first fitted the maximal model including covariate (when 
relevant) and interactions between explanatory variables. I then minimised the models by 
removing non-significant terms (p>0.05), beginning with interactions. Where necessary, data 
were log transformed to meet the necessary normality and homogeneity of variance 
assumptions. 
3.4. Results 
In each of the treatments AS avjjent+AJ and ASrnodcrate+AJ, one mouse had delayed and low 
parasite densities, suggesting that these mice had accidentally received a lower dose of 
parasites than all the other mice (Timms et al. 2001). They were removed from the analysis. 
AJ was the most virulent of the 4 parasite clones (causing most anaemia), and AS avient the 
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Figure 3.1. Virulence (anaemia) of the three related AS clones and the unrelated clone AJ in single 
clone infections. Red blood cell (RBC) loss is the difference between red blood cell densities of mice 
at the start of the infections and the minimum they subsequently reached at around day 10 P1. For 
clarity ASayimient is labelled as AS(a), AS moderale as AS(m) and ASyi ruient as AS(v). Bars are the means of 
5 replicate mice (+ 1 s.e.m.). All four clones differ in virulence (F 315=16, Pez0.001), as do the three 
AS clones (F2 , 12=13, Pez0.001). 
Clone AJ competitively suppressed all three AS clones, prematurely truncating infections 
and reducing parasite densities (Figure 3.2). However, the extent of the competitive 
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suppression was related to intrinsic virulence. Alone, all AS clones persisted for at least 30 
days, but in competition with AJ, AS avijent disappeared below PCR-detection after just 10 (± 
0) days (mean ± 1 s.e.m.), AS moierate after 11.8 (± 0.8) days, and AS yiruieni after 20 (± 2.5) days 
(F212=9.7, p=0.005). In all three cases, persistence was less than in the corresponding single-
clone infections (F 1 , 24=42, p<O.00l). Persistence differed between the three AS clones in 
mixed infections (F 2,=7.09, p=0.004),  and the persistence of clone AJ was unaffected by 
the presence of any of the AS clones (Figures 3.2G-I; F 3 , 14=0.85, p=0.49). 
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Figure 3.2. Parasite densities over time (mean ± 1 s.e.m.), comparing AS and AJ clones in mixed 
infections (A-C), AS clones in mixed and single infections (D-F) and AJ clones in mixed and single 
infections (G-I). All data points are based on 5 replicate mice, except for mixed AS(a)+AJ and 
AS(m)+AJ infections (4 mice). The limit of detection was 100 parasites per iii blood, so that y-axes 
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During both the acute and chronic phases of infections, the total numbers of parasites 
produced by all the AS clones were reduced in the presence of clone AJ (Figures 3.3A, B; 
F 1 =39, p<O.00l and F 1 , 22 30, p<O.00i respectively), but the densities that clones reached 
varied across the AS clones (F224=26, p<O.00l; F222=21, p<O.00I respectively). Parasites 
with higher intrinsic virulence achieved higher densities in competition with AJ, so that there 





















Figure 3.3. Total numbers of AS (A, B) and AJ (C, D) parasites produced during the acute (left 
panels) and chronic (right panels) phases of infections (mean + 1 s.e.m.). P. chabaudi parasites have a 
24 hour replication cycle, so that the sum of the daily parasite densities gives the total number of 
parasites present in an infection. Data points are based on 5 replicate mice, except for mixed 
AS(a)+AJ and AS(rn)+AJ infections (4 mice). * Value denotes a density of 0, as AS(a) disappeared 
below detection levels in mixed AS(a)4-AJ infections during the acute phase. 
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The tester clone AJ produced similar numbers of parasites during the acute phase when in 
mixtures with AS avient and AS erate , but it was competitively suppressed in the presence of 
AS 111 (Figure 3.3C; F314=7.9. p=0.002). It produced more parasites during the chronic 
phase when mixed with ASviient than when alone or in mixture with the other AS clones 
(showing facilitation rather than competition; Figure 3.3D; F 116=6.9, p=0.019). Summarised 
over the whole infection, AJ produced as many parasites in single and mixed infections 
(17314=2.0. p=O. 16). 
Thus, not only did the most virulent AS clone grow best in competition with AJ, it also 
competitively suppressed AJ during the acute phase. It seems likely that this arose because 
the total number of parasites of both clones that could be present in an infection was 
constrained. Overall parasite numbers (AS+AJ) in mixed infections were the same as those 
produced by AJ alone (F 116=0.01, p=0.94; F 1 , 16=1.17, p=0.30 for acute and chronic phases 
respectively), and the implication is that where a clone achieves substantial densities, the 
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Figure 3.4. Virulence and competitiveness of the three AS clones. Plotted points are the numbers of 
acute phase parasites produced by the three AS clones in mixed infections (i.e. competitiveness; mean 
± 1 s.e.m.) as a function of the red blood cell loss they caused in single infections (i.e. intrinsic 
virulence; mean ± 1 s.e.m.). Red blood cell means are based on 5 mice each, whereas competitiveness 
means are based on 4 mice for AS(a) and AS(m), and 5 mice for AS(v). 
Gametocyte densities over time in AS a,.jk t+AJ and AS mocicrate +AJ infections mostly 
resembled patterns of gametocyte densities seen in AJ infections, while those in AS V I U Ient+AJ 
infections were intermediate between and AJ (Figure 3.5); gametocyte numbers 
summarised over the whole infection in mixed infections were not different from those in AJ 
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single infections (F 1 , 16=3.10, p=O.lO). On the basis of this, it seems likely that AJ was the 
dominant clone in terms of transmission in AS avji... t+AJ and AS ra +AJ infections, 
whereas both and AJ had transmission potential from AS viruient+AJ infections. This 
would not be surprising as AS avjient and ASmoderate disappeared from mixed infections much 
more quickly than did AS jnt . However, to really confirm this assertion, AS and AJ 
transmission to mosquitoes would have to be studied (see Chapter 6). 
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Figure 3.5. Gametocyte densities over time (mean ± 1 s.e.m.). (A) Gametocyte densities for AS(a), AJ 
and AS(a)+AJ infections. (B) Gametocyte densities for AS(m), AJ and AS(m)+AJ infections. (C) 
Gametocyte densities for AS(v), AJ and AS(v)+AJ infections. For mixed infections, overall (AS+AJ) 
numbers of gametocytes are shown only, as the real-time quantitative PCR does not distinguish 
between AS and AJ gametocytes. All data points are based on 5 replicate mice, except for mixed 
AS(a)+AJ and AS(m)+AJ infections (4 mice). As the limit of detection was 100 gametocytes per jil 
blood, y-axes start at 2. X-axes terminate at day 20, as gametocyte production after that day was 
negligible. 
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3.5. Discussion 
These results show that in P. chabaudi, in-host competitiveness increases with virulence, 
thus supporting a large body of theory that predicts selection for increased virulence due to 
competition in mixed infections (Levin & Pimentel 1981; Bremermann & Pickering 1983; 
Van Baalen & Sabelis 1995; Frank 1996; Gandon 1998; Mosquera & Adler 1998). To my 
knowledge this is the first in vivo evidence for such a relationship in a medically relevant 
model of disease. These results are consistent with standard explanations of why serial 
passage of P. chabaudi (Mackinnon & Read 1999b; Mackinnon & Read 2004a) and many 
other organisms (Ebert 1998) increases virulence, and why vaccine revertants arise (Bull 
1994): newly arisen virulent parasites can have a competitive advantage. 
The fact that experiments involving several different organisms have found the reverse 
(avirulent parasites outgrowing virulent ones: Read & Taylor 2001) could be because 
experimentalists actively search for strains that protect the host from infection by virulent 
strains, or because a relationship between virulence and competitiveness does not always 
exist. The latter is possible if faster growing parasites attract more attention from the immune 
system (Bruce ci' al. 2000; Franco er al. 2003; Hughes & Boomsma 2004), or when parasites 
rely on the cooperative production of extracellular growth molecules. Here, 'cheating' 
parasites can arise, which rely solely on others for the production of such molecules, so that 
they grow at faster rates in mixed infections, but cause lower virulence when alone (Chao et 
al. 2000; Brown et al. 2002; West & Buckling 2003). Similarly. where coinfecting pathogens 
compete by interference competition, competitive ability might not be linked to virulence 
because competitively superior strains may be directing resources at the production of 
allelopathic substances rather than maximising host exploitation (virulence) (Read & Taylor 
2000; Kirkup & Riley 2004; Massey et al. 2004). These types of considerations imply that 
the biological details governing interactions between pathogens will determine the 
qualitative nature of relationships between virulence and competitive ability in any particular 
disease situation. 
In malaria, competition most likely results from competition for limited resources (such as 
red blood cells or blood sugar), and competition through strain-transcending immunity 
(Snounou et al. 1989; Hellriegel 1992; Snounou et al. 1992; Taylor et al. 1997a; Taylor & 
Read 1998; Read & Taylor 2001; De Roode et al. 2003 [Thesis Appendix]). Immunity is 
certainly important, as there is some evidence that resistant hosts cause stronger competition 
than susceptible hosts (Chapter 4. De Roode et al. 2004b [Thesis Appendix]). Indeed, 
immune mechanisms may also be responsible for the facilitation observed here in the chronic 
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phase (Figure 3.3D). During this phase, immunity is largely specifically directed against 
strains and antigenic variants produced by those strains (Jarra & Brown 1985; Phillips et al. 
1997; Buckling & Read 2001), and the presence of several clones rather than one during that 
phase could make it harder for the immune system to clear the infection effectively (Chapter 
4, De Roode et al. 2003; De Roode et al. 2004b [Thesis Appendix]). 
An important implication of this study is that actively reducing clone multiplicity in malaria 
infections in human populations could have public health benefits. Besides the immediate 
protective benefits of interventions such as drugs, bed-nets and in due course (hopefully) 
vaccines, reducing clone-multiplicity could have beneficial evolutionary effects: by reducing 
the number of competing clones per human, the evolutionary selection for increased 
virulence could be reduced, thus selecting for less virulent parasites. As such, reducing 
clone-multiplicity may be an elegant example of evolutionary medicine, where human 
actions can be used to direct pathogen evolution in for us favourable directions (Zimmer 
2003). 
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4. Host genotype affects the outcome of within-host competition 
between malaria parasites 
Published as: De Roode, J. C., Culleton, R., Cheesman, S. J., Carter, R. & Read, A. F. 2004 Host 
heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria 
infections. Proc. R. Soc. Lond. B. Biol. Sci. 271, 1073-1080. (See Thesis Appendix) 
4.1. Abstract 
During an infection, malaria parasites compete for limited amounts of food and enemy-free 
space. Competition affects parasite growth rate, transmission, and virulence, and is thus 
important for parasite evolution. Much evolutionary theory assumes that virulent clones 
outgrow avirulent ones, favouring the evolution of higher virulence. I infected laboratory 
mice with a mixture of two Plasmodium chabaudi clones: one virulent, the other avirulent. 
Using real-time quantitative PCR to track the two parasite clones over the course of the 
infection, I found that the virulent clone overgrew the avirulent clone. However, host 
genotype had a major effect on the outcome of competition. In a relatively resistant mouse 
genotype (C5713116J), the avirulent clone was suppressed below detectible levels after ten 
days, and apparently lost from the infection. In contrast, in more susceptible mice (CBA/Ca), 
the avirulent clone was initially suppressed, but it persisted, and during the chronic phase of 
infection, it did better than it did in single infections. Thus, the qualitative outcome of 
competition depended on host genotype. I suggest that these differences may be explained by 
different immune responses in the two mouse strains. Host genotype and resistance could 
therefore play a key role in the outcome of within-host competition between parasite clones, 
and the evolution of parasite virulence. 
4.2. Introduction 
According to a large body of theory, competition within hosts generates selection for 
pathogens that do more damage to their host (virulence: Levin & Pimentel 1981; 
Bremermann & Pickering 1983; Frank 1992, 1996; Van Baalen & Sabelis 1995; Gandon 
1998; Mosquera & Adler 1998; Ebert 1999; Read et al. 2002). Parasite fitness in singly 
infected hosts is assumed to be maximised when the benefits of host exploitation (increased 
transmission rate) balance the costs (increased host mortality) (Levin & Pimentel 1981; 
Anderson & May 1982; Bremermann & Pickering 1983; May & Anderson 1983; Sasaki & 
Iwasa 1991; Frank 1992, 1996; Antia et al. 1994; Van Baalen & Sabelis 1995; Antia & 
Lipsitch 1997). But in genetically diverse infections, parasites that slowly exploit hosts will 
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be out-competed by those that exploit hosts more rapidly. Even if host life expectancy is 
reduced so that all parasites do worse, prudent parasites do disproportionately worse and are 
thus eliminated by natural selection. 
The majority of mixed-infection models of virulence assume that more virulent strains have 
a competitive advantage. Logical as this may seem, there is hardly any experimental 
evidence to suggest that this is indeed the case, and some evidence that the opposite is true 
(Read & Taylor 2001). Within-host competition is certainly widespread, and is mediated by 
limited resources, strain-transcending immune responses (apparent competition) or direct 
interference between competing genotypes (Read & Taylor 2001). In rodent malaria, for 
example, both resource and apparent competition probably play a role (Snounou et at. 1989; 
Hellriegel 1992; Snounou et al. 1992; Taylor et at. 1997a; Taylor & Read 1998; Read & 
Taylor 2001; De Roode et at. 2003 [Thesis Appendix]). But while strains with a higher 
growth rate probably will do better in resource competition, they could also become a 
prefened target for strain-specific immune responses, giving less abundant genotypes an 
advantage (Bruce et at. 2000; Read & Taylor 2000). 
If there is a lack of experimental evidence to suggest that virulent clones are competitively 
superior to avirulent clones, there is even less evidence that any superiority is consistent in 
genetically different hosts. Numerous studies have shown that disease virulence varies with 
host genotype, with some host types being more susceptible to severe disease than others 
(e.g. Stevenson et at. 1982; Ebert & Hamilton 1996; Ebert et at. 1998; Imhoof & Schmid-
Hempel 1998a; 1998b; Carius et al. 2001; Mackinnon et at. 2002b). This variation in 
resistance is likely to be reflected in variation in the strengths of resource- or immune-
mediated competition between parasites within hosts. Indeed, one study has now shown that 
this is the case: an experiment on the endophyte Epichloe bromicota parasitic on the grass 
Bromus erectus showed that parasite strains that competitively excluded some strains on one 
host genotype, were excluded themselves on another (Wille et at. 2002). 
Here, I ask whether host genotype is also an important determinant of competitive outcome 
in a model of human disease. I studied mixed infections of a virulent and an avirulent clone 
of the rodent malaria parasite Ptasmodium chabaudi in two different strains of laboratory 
mice. Based on the theory outlined above, I predicted that the virulent parasite clone would 
rapidly outgrow the avirulent clone in both mouse strains. This did occur in one mouse 
strain, but in the other, competitive suppression was transient, with the avirulent clone 
persisting to do better in the chronic phase of infection than it would have done on its own. 
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4.3. Material and methods 
4.3.1. Parasites and hosts 
I used two genetically distinct Plasmodium chabaudi chabaudi clones, denoted AS(pyrlA) 
and AJ. AS(pyrlA) was derived through pyrimethamine selection from clone AS (Walliker 
et al. 1975). Both AS and AJ were originally isolated from thicket rats (Beale et al. 1978). 
For simplicity AS(pyrlA) will be referred to as AS from hereon. I chose AS and AJ clones 
because they differ in their growth rates and virulence (Mackinnon & Read 1999a), with AS 
producing fewer parasites and causing less virulence than AJ. 
Hosts were eight weeks old C57B1I6J and CBAICa inbred female mice (Ann Walker, 
University of Edinburgh). They were fed on 41B maintenance diet (Harlan, England) and 
drinking water supplemented with 0.05% para-amino benzoic acid to enhance parasite 
growth (Jacobs 1964). They were kept in a 12:12 hour light-dark cycle. I will refer to these 
mouse strains as C57 and CBA from hereon. 
4.3.2. Experimental design and inoculation of mice with parasites 
The experiment consisted of three treatments for both C57 and CBA mice: infections with 
AS alone, infections with AJ alone, and mixed AS+AJ infections. Each treatment group had 
5 mice, resulting in 30 mice in total. Mice infected with just AS or AJ received 106  parasite-
infected red blood cells, whereas mice infected with both clones received 2 x 106  parasites, 
made up of 106  AS and 106  AJ parasites. The latter was done because in the analysis I 
wanted to compare the performance of a clone on its own to its performance in a mixed 
infection, requiring equal numbers of each parasite clone at inoculation. Although mice that 
were infected with both clones received a double dose of parasites, previous work has shown 
that a two-fold difference in parasite numbers has a negligible effect on parasite dynamics 
and virulence (Timms et al. 2001). 
I prepared inoculations from donor mice by diluting blood in 0.1 ml calf-serum solution 
(50% heat-inactivated calf-serum, 50% Ringer's solution [27mM KC1, 27mM CaC12, 0.15 M 
NaCl], 20 units heparin/mi mouse blood), and injected them via the intraperitoneum. 
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4.3.3. Monitoring of virulence and infections 
To monitor virulence, I recorded mouse live weights and red blood cell densities (using flow 
cytometry; Beckman Coulter). Both body mass and red blood cell densities decrease 
dramatically during infection, and these decreases correlate with host mortality and thus 
virulence (Mackinnon et al. 2002b). 
To monitor production of asexual parasites and gametocytes (the sexual transmission stages) 
I took thin blood smears from tail blood. These were fixed with methanol and stained with 
Giemsa to determine levels of asexual parasitaemia and gametocytaemia using 1000x 
microscopy. When asexual parasitaemia was high, I counted 500 red blood cells in at least 4 
microscopic fields. With lower parasitaemias and gametocytaemias I counted at least 20 
microscopic fields (corresponding to at least 10,000 red blood cells), and calculated the 
average number of cells per field. Gametocyte numbers were counted using polarised light. I 
calculated parasite densities and gametocyte densities as the product of parasitaemias or 
gametocytaemias and red blood cell densities taken on the same day. 
I took measurements every day from day 0 to day 23 post-infection (PT), three times a week 
from day 23 to day 48 Fl, once a week from day 48 to day 69 and on day 83 P1, when the 
experiment was terminated. Measurements weretaken between 9.00 and 10.30 a.m., when 
peripheral blood almost exclusively harboured haploid ring stage parasites (see Chapter 2). 
4.3.4. Monitoring of individual clones in mixed infections 
I collected 5 iil samples of tail blood from mice harbouring mixed infections in citrate saline. 
After 1 minute's centrifugation at 13,000 rpm, I removed the supernatant and stored the 
pelleted blood at -70°C for subsequent DNA extraction using Instagene Matrix (BioRad). I 
used real-time quantitative PCR to measure the DNA concentrations of both AS and AJ in 
these samples (Chapter 2, Cheesman et al. 2003 [Thesis Appendix]), and calculated the 
proportion of AS and AJ of the total parasite population. Absolute numbers of AS and AT 
were then calculated by multiplying these proportions by the overall parasite density on the 
same day. 
I took blood samples on the same days that we took our other measurements, but performed 
PCRs only when parasitaemias were higher than 0.1%, which is the lowest level at which we 
can accurately estimate AS and AJ proportions (Chapter 2). The real-time quantitative PCR 
protocols cannot distinguish between asexual parasites and gametocytes, and so they 
estimate the densities of all parasites. In the data analyses, I treated these as estimates of 
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asexual densities. Gametocyte densities were 2-3 orders of magnitude lower than asexual 
parasite densities, and are thus a negligible component of overall parasite numbers. 
4.3.5. Trait definition 
Prior to statistical analysis I defined and constructed the following traits that described part 
of or whole of the infection. For measures of virulence I determined the 'minimum weight' 
and 'minimum red blood cell density' that mice reached. Mice that died were included in the 
analysis of minimum weights and red blood cell densities, using weight or red blood cell 
density on the day of death as the minima they reached. For all other traits, these mice were 
excluded from the analyses. 
Mice generally experienced several waves of parasites, with the first being substantially 
larger and longer. For each mouse, I calculated the period until the end of the first wave, and 
defined this as the acute phase of the infection. The subsequent period, the chronic phase, 
was defined as starting the day parasite numbers began to recover after the collapse of the 
first wave (day 15.6 ± 0.55 P1; mean ± 1 s.e.m.). To calculate the number of parasites present 
during the whole infection, and during the acute and chronic phases, I calculated the area 
under the relevant parasite density by day P1 curves. As the limit of detecting parasites was 
around 100/tl, I treated observations of zero parasites as being 100 parasites/tl. I could 
accurately quantify AS and AJ proportions of 0.01 at levels of 0.1% parasitaemia or higher 
(Chapter 2); below that I set the clone densities at the limit of detection (100/tl). Parasite 
densities in single infections were set to the same level when parasitaemias were lower than 
0.001%. 
For gametocytes, I chose slightly different ways of calculating densities, as they showed 
different dynamics to asexual parasites, having a first wave before day 9 and one or several 
thereafter. I calculated total gametocyte densities over days 0-9 and days 10-83 PT, and total 
densities over the whole infection. I could analyse overall numbers of gametocytes only, as 
the real-time quantitative PCR protocol does not distinguish AS and AJ gametocytes. 
4.3.6. Statistical analysis 
I analysed all traits mentioned above using ANOVAs and ANCOVAs in Minitab (Version 
13.30, Minitab Inc.). The explanatory variables used were mouse 'Strain' and infection 
'Treatment'. Strain had two factor levels (C57 and CBA); Treatment had up to three factor 
levels (AS, AJ and AS+AJ), depending on the analysis. For all models I first fitted the 
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maximal model including covariate (when relevant), Treatment, Strain and an interaction 
between Treatment and Strain. I then minimised the models by removing non-significant 
terms (p>0.05), beginning with the interaction. I log transformed initial and minimum red 
blood cell densities as well as all parasite and gametocyte densities prior to analysis, to meet 
the necessary normality and homogeneity of variance assumptions. 
4.3.7. Follow-up experiment 
To confirm the most important findings of this study, I compared the results obtained here 
with those obtained in the experiment described in Chapter 2 (§ 2.6.2). This experiment was 
exactly as the one described here, except that mice were sampled on days 6 and 13 P1 only. 
4.4. Results 
One C57 mouse infected with AJ died on day 12, one infected with AS+AJ on day 7 and two 
CBA mice infected with AS+AJ died on day 10 and 11 P1. AJ infections induced greater 
weight loss and lower minimum red cell densities than AS infections (Treatment: F 1 , 17=25.4, 
p<O.00l; Treatment: F 1 ,.18=25.3, p<0.001 respectively), regardless of mouse genotype (Strain 
and Treatment x Strain n.s.). Thus, as expected, AS was the less virulent clone. 
4.4.1. AS and AJ parasite densities 
In mixed infections in both C57 and CBA mice, there were substantially more AJ than AS 
parasites during the first 10-14 days (Figures 4.1A, B). After day 10, AS disappeared below 
detectible levels in C57 mice, and never reappeared. It persisted, however, in the three CBA 
mice that survived the first two weeks. One of these experienced separate AS and AJ parasite 
waves around day 35 and 55 p.i. (Figure 4.2A). In the other two mice, AS started to 
overgrow AJ around days 22 and 18 respectively (Figures 4.213, Q. Later in the infection AJ 
overgrew AS again in one of these (Figure 4.2C). 
Formal analysis confirmed this picture. During the acute phase in both mouse strains, AS 
was competitively suppressed by AJ, producing far fewer parasites in mixed infections than 
it did alone (Figures 4.1C, D and 4.3A; Treatment: F1 , 13=155, p<0.001). This suppression 
was greater in CBA than in C57 mice (Treatment x Strain: F 1 , 13=9.1, p0.01). In C57 mice, 
AS completely disappeared below detectible levels before the end of the acute phase, 
showing competitive exclusion. 
Chapter 4 - Host genolype and within-host competition 	 68 
In CBA mice, AS was also competitively suppressed during the acute phase, but it was not 
excluded. During the chronic phase, it produced more parasites than it would have done 
alone (Figures 4.113, 4.3B; Treatment: F 113=6.8, p=0.022; Treatment x Strain: F 1 , 13=34, 
p<0.001), showing that AS actually benefited from the presence of AJ (i.e. facilitation, not 
competition). During both acute and chronic phases, AS produced more parasites in CBA 
than in C57 mice, whether alone or in mixture (Fig. 4.3A, B; Strain: F 113=125, p<0.001; 
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Figure 4.1. Log parasite densities over time (mean ± 1 s.e.m.) for C57 mice (left) and CBA mice 
(right). The top row (A and B) shows AS and AT parasite densities in mixed AS+AJ infections, the 
middle row (C and D) compares AS parasite densities in single AS infections and mixed AS+AJ 
infections, and the bottom row (E and F) compares AJ parasite densities in single AJ and mixed 
AS+AJ infections. All data points are based on 5 replicate mice, except for single AJ infections in C57 
mice (4 mice after day 12), mixed AS+AJ infections in C57 mice (4 mice after day 7) and mixed 
AS+AJ infections in CBA mice (4 mice on day 11 and 3 mice from day 12 onwards). As the limit of 
detection was 100 parasites per i1 blood, y-axes start at 2. 
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Figure 4.2. Log AS and AJ parasite densities over time in mixed AS+AJ infections for the three CBA 
mice (A, B and C) that survived the acute phase. As the limit of detection was 100 parasites per R 1 
blood, y-axes start at 2. 
During the acute phase, AJ produced roughly the same numbers of parasites in mixed and 
single infections, in both C57 and CBA mice (Figures 1E, F and 3C; Treatment: F 112 = 1.42, 
p=0.25), thus showing that, unlike AS, AJ did not suffer from competition. Like AS, it 
produced more parasites in CBA than in C57 mice (Strain: F 1 , 14=27, p<0.001). During the 
chronic phase, AJ produced slightly fewer parasites in C57, but more in CBA mice than it 
did on its own (Figure 4.313; Treatment x Strain: F 1 , 12=8.1, p=0.015). When analysing these 
numbers for CBA mice only, however, there was no difference between single and mixed 
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infections (Treatment: F 1 ,6=2.7, p=O. 15), thus showing that, unlike AS, AJ did not experience 
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Figure 4.3. Total numbers of parasites produced during the acute phase (left) and chronic phase of the 
infection (right) for C57 and CBA mice (mean ± 1 se.m.). Plotted points are AS parasite densities in 
single AS and mixed AS+AJ infections (A and B), AJ parasite densities in single AJ and mixed 
AS+AJ infections (C and D), and overall parasite numbers in single AS, single AJ, and mixed AS+AJ 
infections (E and F). All data points are based on 5 replicate mice, except for single AJ infections in 
C57 mice (4 mice), mixed AS+AJ infections in C57 mice (4 mice) and mixed AS+AJ infections in 
CBA mice (3 mice). * Value denotes a parasite density below detection. 
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4.4.2. Follow-up experiment 
In the follow-up experiment, I infected another five of both C57 and CBA mice with AS+AJ, 
and sampled these on day 6 and day 13 Fl. In both mouse strains AS was present on day 6. 
By day 13, however, AS had disappeared below detectible levels in the peripheral blood of 
C57 mice (Figure 4.4A), but was still present in CBA mice (Figure 4.413), actually 
overgrowing AJ at that time. These results thus confirmed the qualitatively different 
dynamics of mixed infections in C57 and CBA mice as observed in the main experiment. 
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Figure 4.4. Proportions of AS and AJ (mean + 1 s.e.m.) in mixed AS+AJ infections in C57 (A) or 
CBA mice (B) on days 6 and 13 post-infection. Data are based on five replicate mice in a follow-up 
experiment. * Value denotes a proportion of 0. 
4.4.3. Overall parasite densities 
During the acute phase, infections in C57 mice consisted of fewer parasites than those in 
CBA mice (Figure 3E; Strain: 17 120=1 10, p<O.00I). In both mouse strains, AJ and AS+AJ 
infections produced more parasites during the acute phase than did AS infections 
(Treatment: F, 20=74, p<0.00I). 
During the chronic phase. AJ and AS+AJ infections produced more parasites than AS 
(Figure 4.317; Treatment: F 2 , 20=28, p<0.001).  Al and AS+AJ infections also differed from 
each other, but differently in the two mouse genotypes: in C57 mice AS+AJ infections 
produced slightly fewer parasites than Al infections, whereas in CBA mice they produced 
more (Figure 4.3F; Treatment x Strain: F 2 , 20=1 1, p=O.00l). Due to these higher numbers in 
CBA mice during the chronic phase, AS+AJ infections produced more parasites in CBA 
mice over the whole of the infection than did Al infections (Treatment x Strain: F 2,=26, 
p<0.0o1). 










4.4.4. Gametocyte densities 
In C57 mice, most gametocytes were produced during the first 9 days of the infection, with 
AS having lower densities than AJ and AS+AJ (Figure 4.5A; Treatment: F 227=11.71, 
p<0.001), whereas in CBA mice most gametocytes were produced after day 9 Fl, when AJ 
produced fewer gametocytes than AS and AS+AJ (Figure 4.513; Treatment: F 220=5.0, 
p=0.017; Strain: F 120=6.04, p=0.023; Treatment x Strain: F22 0=6.1, p=0.009). In C57 mice, 
gametocyte peaks in mixed infections mostly resembled those of AJ infections, the 
numerically dominant clone during that period (Figures 4.5A, 4.IA). In CBA mice, mixed 
infections produced gametocyte dynamics that did not resemble gametocyte production in 
either AS or AJ single infections, but which peaked during a period when both clones were 
present in high numbers (Figures 4.513, 4.113). Summarised over the whole infection, AJ 
produced most gametocytes in C57 mice, but fewest in CBA mice, in which AS produced 
most (Strain: F 1 p=0.008; Treatment x Strain: F2 20 = 8.3, p=0.002). 
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Figure 4.5. Log gametocyte densities over time (mean ± 1 s.e.m.) for C57 (A) and CBA mice (B) 
infected with single AS, single Al, or mixed AS+AJ infections. Shown are overall (AS+AJ) numbers 
of gametocytes only, as the real-time quantitative PCR cannot be used to distinguish AS and AJ 
gametocytes. All data points are based on 5 replicate mice, except for single Al infections in C57 
mice (4 mice after day 12), mixed AS+AJ infections in C57 mice (4 mice after day 7) and mixed 
AS+AJ infections in CBA mice (4 mice on day 11 and 3 mice from day 12 onwards). As the limit of 
detection was 100 gametocytes per p1 blood, y-axes start at 2. 
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4.5. Discussion 
The results presented here show that host heterogeneity affects the outcome of in-host 
competition between pathogen strains. In C57 mice, the avirulent clone disappeared below 
detectible levels from the peripheral blood after ten days of the infection and produced far 
fewer parasites than it would have done on its own. This competitive suppression almost 
certainly reduced the clone's transmission potential: the period of greatest gametocyte 
production in single infections occurred after day 10 p.i. (Figure 4.5A). As the avirulent 
clone never reappeared over the course of the study, it seems that it was competitively 
excluded, something that has not been observed before in this species (Taylor et al. 1997b; 
Taylor & Read 1998; Read et al. 2002). In contrast, the virulent clone did not suffer at all 
from competition in mixed infections. 
In CBA mice, the avirulent clone was also competitively suppressed during the acute phase, 
but it persisted and went on to produce more parasites during the chronic phase than it would 
have done on its own. Thus, in CBA mice, competitive suppression gave way to facilitation. 
This may have resulted in enhanced transmission: the density of the avirulent clone peaked 
around day 20 p.i. and coincided with a large gametocyte peak (Figures ID and SB). 
Whether the presence of the more virulent clone actually enhanced the overall fitness of the 
avirulent clone would depend on the host mortality rate induced by the virulent clone, and on 
how many of the gametocytes produced around this time were of the virulent clone. 
This experiment, with just two parasite clones and two mouse strains, generated the whole 
spectrum of outcomes currently captured in a range of different mixed-strain models of 
virulence evolution. In extreme co-infection models. clone dynamics are unaffected by the 
presence of other clones (e.g. May & Nowak 1995; Leung & Forbes 1998); in these 
experiments, this was so for clone AJ in both mouse strains. Coexistence with competitive 
suppression of at least one clone, as envisaged in other models (e.g. Sasaki & Iwasa 1991; 
Frank 1992, 1996; Herre 1995; Van Baalen & Sabelis 1995) occurred within CBA mice. 
Finally, the competitive exclusion of AS from C57 mice before much transmission stage 
production occurred, bears substantial resemblance to superinfection models (which are 
perhaps better called superseding infection models: Van Baalen & Sabelis 1995). These 
models allow no coexistence and postulate that competitive suppression instantly reduces 
transmission to zero (e.g. Levin & Pimentel 1981; Bremermann & Pickering 1983; 
Bremermann & Thieme 1989; KnoIle 1989; Nowak & May 1994; Leung & Forbes 1998; 
Gandon et al. 2002). Thus, it may prove difficult to capture the real world complexities of a 
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disease like malaria (and others: Hood 2003) in models that assume that the outcome of 
competition is independent of environmental conditions, such as host genotype. 
A general conclusion of the above models is that mixed-clone infections will generate 
selection for increased virulence. However, the precise details of competition will affect the 
transient evolutionary dynamics, and magnitude of standing virulence in a population, which 
is what is relevant to animal and human health. Competitive exclusion of avirulent clones, 
for instance, will affect potential evolutionary trajectories, rates of evolution and average 
levels of virulence in a population. 
Several recent studies have shown that parasite virulence depends on host genotype (e.g. 
Ebert & Hamilton 1996; Ebert et al. 1998; Imhoof & Schmid-Hempel 1998a; 1998b; Carius 
et al. 2001; Mackinnon et al. 2002b), and theory has shown that such host-genotype 
dependence of virulence can explain why polymorphisms in growth rate and virulence are 
maintained (Regoes et al. 2000). If the outcome of competition is as dependent on host 
genotype as the expression of virulence itself, this could contribute to the maintenance of 
growth rate and virulence polymorphisms in the parasite population as well. Wille et al. 
(2002) also suggested this when they found that some strains of the endophyte Epichloe 
bromicola competitively excluded other strains on one genotype of its host Bromus erectus, 
but not on another. 
Clone AS was competitively suppressed by AJ, except during the chronic phase of infections 
in CBA mice, where AS did better than it did on its own. This could be due to a combination-
of strain-specific immunity and antigenic variation. In two of the surviving CBA mice AS 
overgrew AJ after it had been suppressed earlier (Figures 313, Q. This might suggest that the 
immune system had been focusing on the clone that had produced the highest number of 
parasites up till then (AJ), giving AS some advantage. Strain-specific immunity is certainly 
well known in P. chabaudi (e.g. Jarra & Brown 1985; Buckling & Read 2001, R. Carter 
unpublished results), and facilitation of one pathogen due to the immune response focusing 
on another has also been suggested for fungal species infecting leaf-cutter ants (Hughes & 
Boomsma 2004). P. chabaudi is also known to produce antigenic variants at high rates 
(McLean et al. 1982; McLean et at. 1990; Brannan et al. 1994; Phillips et al. 1997). Novel 
antigenic variants escape variant-specific host responses, and when there are more clones in 
an infection, each generating variants, it seems likely that the immune response may be less 
efficient at controlling the infection. A combination of strain-specific immunity and 
antigenic variation has also been suggested to play a role in mixed-species and mixed-strain 
infections of human Plasmodia (Bruce et at. 2000). 
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Why did C57 and CBA mice show such-different dynamics and outcomes of competition? 
One important possibility is a strain difference in the efficacy of immune control. Mouse 
strains differ considerably in their resistance to P. chabaudi infections (Stevenson et al. 
1982). Resistance is associated with reduced parasite densities, and appears to be a complex 
genetic trait, involving many genes affecting immunity and red blood cell production and 
characteristics (Stevenson et al. 1982; Yap et al. 1994; Fortin et al. 2002). Parasite densities 
were higher in CBA mice (Figure 4.3E), and such higher densities could reduce the chance 
of stochastic loss and increase the chance of producing antigenic escape variants. 
If differences in overall immune control do explain the strain differences in the outcome of 
competition, one would expect to find coexistence of the two parasite clones in C57 mice 
that were made more su,sceptible, for example by administration of anti-IL 12 monoclonal 
antibodies (Yap et al. 1994). Conversely, clone AS would be expected to disappear in CBA 
mice that were more resistant, for example by artificially increasing their 1L12 levels (Yap et 
al. 1994). 
If overall resistance does affect the outcome of within-host competition, then differences are 
not only expected between host genotypes, but also between individuals that differ in their 
sex, nutritional or health status, vaccination status, or any other factors that influence 
resistance. Semi-immune mice are much more resistant to P. chabaudi infection than naive 
mice (Buckling & Read 2001; Mackinnon & Read 2003). Extrapolating from the results 
presented here, it would be expected that only the virulent clone would survive in such 
vaccinated hosts. It is important to test this, because this implies that vaccination could 
increase the frequency of virulent clones in a population, thus leading to unforeseen 
consequences of vaccination (Gandon etal. 2001; Gandon etal. 2003; Read et al. 2004). 
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5. Timing of infection affects strength of competition and competitive 
dominance in genetically diverse malaria infections 
To be submitted as: De Roode, J. C., Helinski, M., Anwar, M. A. & Read, A. F. Timing of infection 
affects strength of competition and competitive dominance in genetically diverse malaria infections. 
5.1. Abstract 
Parasite infections often consist of different strains of the same species. Within-host 
competition between such strains shapes the evolution of drug resistance and disease 
severity. Although such evolution has been thoroughly investigated using mathematical 
models, biological factors that cause competition and determine competitive dominance of 
competing clones are still poorly understood. This study investigates how relative timing of 
infection of parasite strains affects competition between them. Experiments were carried out 
using two pairs of genetically distinct clones of the rodent malaria Plasmodium chabaudi in 
laboratory mice: these clones were either infected simultaneously or 3 or 11 days apart. 
When clones infected mice first, they generally did not suffer from competition, whereas 
they did when infecting mice at the same time as, or days after, their competitor. When 
infecting mice 11 days after their competitor, competitive suppression was even greater than 
when infecting them after 3 days. These results show that timing of infection is a major 
determinant of the outcome of within-host competition: relative timing does not only change 
the strength of competition, but also relative competitive dominance, so that competitively 
inferior clones can be competitively superior when infecting hosts first. The results are 
discussed in the light of strain-specific immunity, with implications for virulence evolution 
theory. 
5.2. Introduction 
Humans and animals often become infected with different strains of the same parasitic 
species (Read & Taylor 2001), so that parasite strains have to compete for limited amounts 
of rdsources and interact through strain-transcending immunity. Such competition can be 
intense (Read & Taylor 2001), and has many important medical consequences. Within-host 
competition is a major determinant in the evolution and epidemiology of drug resistance, for 
example (Hastings & D'Alessandro 2000; De Roode et al. 2004a [Chapter 7, Thesis 
Appendix]), because the evolutionary success of drug-resistant mutants crucially depends on 
whether it is able to out-compete drug-sensitive wild-type strains. The same is true for 
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vaccine-escape mutants (e.g. Kew et al. 2002): their evolution and spread through the 
population will depend on their competitiveness with attenuated pathogen forms in 
vaccinated hosts and wild-type strains in others (Bull 1994). Finally, it is asserted that 
competition between parasite strains selects for increased virulence and thus more severe 
disease: this is because virulent genotypes are assumed to out-compete prudent genotypes, 
resulting in a selective advantage of high virulence (e.g. Levin & Pimentel 1981; 
Bremermann & Pickering 1983; Van Baalen & Sabelis 1995; Frank 1996). 
The epidemiological and evolutionary consequences of within-host competition have been 
thoroughly investigated theoretically, but which biological factors exactly cause competition 
and determine the success of competing clones, is mostly unknown. Thus, in many models it 
is assumed that parasites with higher growth rates, and inflicting more damage to the host, 
are competitively superior to less harmful parasites, yet experimental evidence to support 
this claim is practically absent (but see Chapter 3). Experiments on mixed infections 
generally show that competitive success of competing clones cannot be easily predicted from 
their growth rates in single infections (Nakamura et at. 1992; Hodgson et at. 2004), and that 
host genotype (Wille et at. 2002; De Roode et al. 2004b) and timing of infection (Orcutt & 
Schaedler 1973; Morrison et at. 1982; Duval-Iflah et at. 1983; Allaker et al. 1988; Barrow & 
Page 2000) also play an important role. Colonisation of a host before a competitor (of the 
same or a different species) can prevent (Hood 2003) or drastically reduce the growth of the 
competitor, even if that competitor would be competitively superior in simultaneous 
infections (e.g. Ishii et at. 2002; Thomas et at. 2003). 
In human malaria, mixed infections are extremely common, with prevalence reaching over 
80% in high-transmission areas (e.g. Babiker et al. 1999; Konaté et al. 1999; Magesa et at. 
2002). These mixed infections occur because hosts become infected with different strains 
simultaneously (i.e. co-infection) or sequentially (i.e. super-infection). Co-infection occurs 
because meiotic recombination and random mating occur frequently in malaria populations 
(Babiker et al. 1994; Babiker et at. 1995; Paul et al. 1995; Conway et at. 1999), so that one 
mosquito bite can contain a range of genetically distinct genotypes (Conway et at. 1991; 
Druilhe et al. 1998). Super-infection is also common, and occurs because people are bitten 
by numerous mosquitoes injecting different malaria strains (Ntoumi et at. 1995; Daubersies 
et al. 1996; Arnot 1998; Basco & Ringwald 2001; Arez et at. 2003). 
Whether malaria strains infect their host simultaneously or sequentially, will very likely 
affect the extent to which they suffer from competitive suppression. This is because malaria 
parasites replicate exponentially during an infection, causing severe anaemia (Cox 1988; 
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Jakeman et al. 1999; Menendez et al. 2000), and inducing strong anti-parasitic immune 
responses (Taylor-Robinson 1995; Li et al. 2001; Artavanis-Tsakonas et at. 2003); therefore 
strains infecting a host already infected with another strain will have fewer resources and 
encounter a stronger immune response than strains infecting naive hosts (e.g. Heliriegel 
1992). 
To study whether sequential infection indeed causes strong competitive suppression, two 
experiments were carried out using the rodent malaria Plasmodium chabaudi. In the first 
experiment, two clones denoted AS and CB were used, and mice were infected with them 
simultaneously or 3 days apart. It was also studied how the initial ratio affected competition: 
thus, another group of mice were infected with an inoculum consisting of 100CB:1AS. The 
second experiment used clones AS(pyrlA) and AJ: mice were infected with these clones 
simultaneously or 3 or 11 days apart. Thus, this experiment was designed to test whether 
super-infection causes stronger competition than co-infection, and also whether competitive 
suppression becomes greater the later the second clone infects the host after the first clone. 
5.3. Material and methods 
5.3.1. Parasites and hosts 
Two main experiments were conducted, each making use of a different pair of Plasmodium 
chabaudi clones. Experiment 1 used clones AS and CB, while experiment 2 used AS(pyrlA) 
and AJ. AJ, AS and CB were originally cloned from wild parasite isolates from thicket rats 
in the Central African Republic (Beale et al. 1978); AS(pyrlA) was then derived from AS by 
selection for resistance against the drug pyrimethamine (Walliker et at. 1975). 
Hosts were nine weeks old C57B116J female inbred mice (Harlan, England), kept in a 
reversed (experiment 1) or normal (experiment 2)12 L : 12 D cycle; they were kept and fed 
as described (De Roode et al. 2004b [Thesis Appendix]). 
5.3.2. Experiment 1: AS and CB 
The first experiment, studying competition between clones AS and CB, consisted of three 
sub-experiments. The first sub-experiment ('co-infection') tested whether parasite clones 
suffer from competition when infecting the same host simultaneously: 6 mice were infected 
i.v. with 104 AS parasites, 6 mice with 10 4 CB parasites, and 24 mice with 10 4 AS + 104 CB. 
The second sub-experiment ('super-infection') then asked whether competition is stronger 
Chapter 5— Super- and co-infection 	 1 	 79 
for clones that infect mice already infected with another clone: 2 groups of 7 mice were 
infected with either 10 4 AS or CB parasites alone; 11 mice were infected with 10 4 AS on day 
0 and then with 104 CB on day 3, and another 10 mice were infected with 10 4 CB on day 0 
and 104 AS on day 3. The third sub-experiment ('100CB:1AS') asked whether the initial 
ratio of co-infecting clones affects the strength of competition, with mixed infections 
consisting of 10 4 CB and 102  AS parasites: thus, 3 mice were infected with 102  AS parasites, 
3 with 10 4 CB and 3 with 10 4 CB and 102  AS parasites. 
Mouse red blood cell densities were determined by counting the number of cells in a volume 
of 5 tl tail-blood using flow cytometry (Beckman Coulter). Thin blood smears were taken to 
determine parasitaemias (here defined as the percentage of red blood cells infected with 
parasites) using 1000x microscopy; parasite densities were then calculated as the product of 
red blood cell densities and parasitaemias taken on the same day. For mixed infections, 
numbers of AS and CB parasites were determined using immuno-fluorescent antibody assays 
(IFAs). The monoclonal antibodies used were H3, reacting specifically to CB, and B4 and 
B 15, reacting specifically to AS (Boyle et at. 1982; McLean et at. 1991); WA protocols were 
as described elsewhere (Taylor et at. 1997a). These assays give ratios of the two infecting 
clones, which - multiplied by the overall parasite density - give the clonal parasite densities 
on a given day. As IFAs can give biased estimates of ratios (Taylor et at. 1997a), it was 
necessary to carry out controlled experiments to compare obseryed AS:CB ratios with those 
expected in artificial mixtures, and to correct the estimated ratios before using them to 
calculate AS and CB densities (see Thesis Appendix). Measurements were taken three times 
a week until day 35 ('co-infection'), 57 ('super-infection') or 41 ('100CB:1AS') post-
infection. 
5.3.3. Experiment 2: AS(pyrlA) and AJ 
Using a different pair of P. chabaudi clones, the second experiment asked whether clones 
suffered more from competition the later they infected a host already infected with another 
clone. On days 0, 3 and 11, groups of 5 mice were infected i.p. with either 106  AS(pyrlA) or 
106  AT parasites alone, while another group of mice were infected with both 106  AS(pyrlA) 
and 106  AT parasites simultaneously. Mice in two further treatment groups were infected 
with 106  AS(pyrlA) parasites on day 0 and then with 106  AJ parasites on days 3 or 11, while 
the final two groups of mice were infected with 106  AT parasites on day 0 and then with 10 6 
AS(pyrlA) parasites on days 3 or 11. 
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Mouse red blood cell densities were determined using flow cytometry (Beckman Coulter) of 
2 jil of tail blood. Thin blood smears were taken and parasitaemias calculated using 
microscopy (Chapter 4, De Roode et al. 2004b [Thesis Appendix]): parasite densities were 
then calculated as the product of red blood cell densities and parasitaemias taken on the same 
day. In mixed infections, AS(pyrlA) and AJ were distinguished and quantified using strain-
specific real-time quantitative PCR (Chapters 2, 4, Cheesman et al. 2003; De Roode et al. 
2004b [Thesis Appendix]). Measures were taken daily up till 12 days, after which they were 
taken every 2 days until day 35 post-infection (for mice infected with one clone or with a 
mixture simultaneously), or until 35 days after infection with the second clone (for the other 
mixed infections). 
5.3.4. Statistical analysis 
All analyses were carried out using ANOVA's in Minitab (v. 13.30, Minitab Inc.), log 
transforming the data when necessary to meet normality and homogeneity of variance 
assumptions. Total numbers of parasites of specific clones produced over the whole infection 
were calculated: P. chabaudi parasites have a 24 hour replication cycle, so that the sum of 
the daily parasite numbers gives the number produced over the entire infection. When mice 
were monitored for different numbers of days, and it was necessary to compare these mice, I 
calculated parasite densities over the shortest number of days: for example, even though 
mice in the super-infection experiment (Experiment 1) were monitored for 57 days, I only 
used data over the first 35 days when comparing them to mice in the co-infection experiment 
(monitored for 35 days only). 
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5.4. Results 
Several mice died, while others had delayed and substantially reduced parasite densities, 
suggesting that they received lower parasite densities than anticipated (Timms et al. 2001). 
All these mice were excluded from the analysis; numbers of mice on which the analysis was 
based, are shown in Tabfe 5.1. 
Table 5.1. Numbers of mice that were analysed from each treatment group. 
Experiment 1 	 Experiment 2 
co-infection exp. 
AS alone 5 AS(pyrlA) alone day 0 4 
CB alone 3 AS(pyrlA) alone day 3 5 
AS(pyrlA)+CB 19 AS(pyrlA) alone dayll 5 
super-infection exp. AJ alone day 0 3 
AS(pyrl A) alone 6 AJ alone day 3 4 
CB alone 3 AJ alone day 11 5 
AS(pyrlA) day 0, CB day 3 7 AS(pyrlA)+AJ day 0 4 
GB day 0, GB day 3 5 AS(pyrlA) day 0, AJ day 3 4 
100GB: IAS(pyrlA) exp. AS(pyrl A) day 0, AJ day 11 3 
AS(pyrlA) alone 2 AJ day 0, AS(pyrlA) day 3 5 
GB alone 2 AJ day 0, AS(pyrl A) day 11 4 
AS(pyrlA)+GB 3 
5.4.1. Experiment 1: AS and CB 
5.4.1.1. AS and CB dynamiGs through time 
In mice simultaneously infected with AS and CB, both parasite clones produced about half 
of the total parasite population: AS had a slightly higher peak than CB around day 10, while 
CB had a higher peak than AS around day 16 (Figure 5.1A). Compared to single infections, 
both AS and CB suffered from competition, producing about 3 million fewer parasites in 
mixtures than they did alone (Figures 5. 113, Q. 
Compared to infections initiated with AS and CB simultaneously, parasite dynamics were 
markedly different in mice infected sequentially. Thus, in mice infected with AS on day 0 
and CB 3 days later, AS dominated until day 16 (Figure 5.1D), and competitively suppressed 
CB (Figure 5.11) during this time. AS parasite numbers then plummeted and were 
suppressed (Figure 5.1E), while CB densities rose sharply, so that CB started to dominate the 
infection: it remained the dominant clone for the rest of the infection (Figure 5.113). 
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Figure 5.1. Log AS and CB parasite densities over time (mean ± 1 s.e.m.) in experiment 1. The left 
column shows AS and CB densities in mixed infections, the middle column compares AS densities in 
single and mixed infections, and the right column compares CB densities in single and mixed 
infections. (A-C): mice were infected with AS and CB simultaneously; (D-F): mice were infected 
with CB 3 days after AS; (G-I): mice were infected with AS 3 days after CB; (J-L): mice were 
infected with AS and CB simultaneously, with an inoculum of 100CB:IAS. The threshold density at 
which parasites could be detected was around 100/Ill mouse blood, so that y-axes start at 2. Curves in 
panels J-L are interrupted, because no samples were taken between days 22 and 35. See table 5.1 for 
the numbers of mice on which data-points are based. 
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In mice infected with CB first (Figure 51G), AS was competitively suppressed for almost 
the entirety of the infection (Figure 5.IH), whereas CB was not (Figure 5.11). In contrast 
with CB, which managed to overgrow AS in infections where AS was inoculated first, AS 
never managed to overgrow CB in infections where CB was inoculated first. In fact, AS 
parasite numbers followed the same up- and downward dynamics as CB in these infections, 
so that whenever CB numbers decreased, AS numbers decreased with them (Figure 5. 1G). 
Mixed infections initiated with a IOOCB: lAS inoculum showed very similar dynamics as 
those initiated with CB 3 days before AS. CB was the dominant clone in these infections 
(Figure 5.1J), and whenever CB densities decreased, AS densities decreased with them. The 
result was that AS suffered greatly from competition in these infections (Figure 5.11K), 











Figure 5.2. Total numbers of AS (A) and CB (B) produced over the whole infection in single and 
mixed (AS and CB simultaneously or 3 days apart) infections in experiment 1 (mean + i s.e.m.). 
Numbers of mice on which data-points are based are given in Table 5.1. 
5.4.1.2. AS and CB parasite densities 
The extent to which AS and CB suffered from competition in mixed infections depended on 
when they infected their host: when infecting mice first, neither AS nor CB suffered a 
reduction in parasite numbers, but when infecting the same host simultaneously or 3 days 
after their competitor, they did (Figure 5.2). AS suffered a 37 (±24) % (mean and 95% 
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confidence interval) reduction in parasite numbers in mice simultaneously infected with CB 
(F122 =10, p=0.004), and an even greater reduction (95±35%) when infecting mice 3 days 
after CB (Figure 5.2A; single/mixed x day interaction: 17 131 =68, p<0.001). CB suffered a 40 
(±30) % reduction in parasite numbers in mice simultaneously infected with AS (17 120=7.9, 
p=O.011), but did not suffer significantly more when infecting mice 3 days after AS 
(58±28% reduction; Figure 5.213; single/mixed x day interaction: F 1 , 28=1.3, p=0.26). 
In mixed infections initiated with a ratio of 100CB:1AS, AS suffered greatly from 
competition (a 97±88% reduction of parasite numbers), whereas CB did not (Figure 5.3; 
single/mixed x clone interaction: F 17= 13.2, p=0.008). The competitive suppression of AS in 










Figure 5.3. Total numbers of AS and CB produced over the whole infection in single and mixed 
infections (100CB:1AS) in experiment 1 (mean + 1 s.e.m.). See table 5.1 for the numbers of mice on 
which data-points are based. 
5.4.1.3. 	Overall parasite densities 
Mice infected with AS and CB simultaneously experienced as many parasites as infections 
consisting of AS or CB alone (Figure 5.4A; F 2,=1.1, p=0.36), implying that competition 
was a direct effect of these clones having to share the 'available number of parasites' 
between them. Mice infected with CB alone also had as many parasites as those infected 
with AS and CB 3 days apart (Figure 5.4C; Tukey: p>0.05); but mice infected with AS alone 
had fewer parasites than those infected with AS first and then CB. Thus, because CB was 
able to overgrow AS, these mice experienced heavier parasite burdens than mice infected 
with AS only (Figure 5.4C; Tukey: p=0.02). Finally, infections initiated with 100CB: lAS 
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produced as many parasites as AS single infections (Tukey: p>0.05), explaining that AS 
suffered from competition in these mixed infections in which the available number of 
parasites had to be shared with CB. 
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Figure 5.4. Overall parasite numbers over the whole infection (mean + 1 s.e.m.) for infections in 
experiments 1 and 2. In experiment 1, mice infected with AS and CB simultaneously had as many 
parasites as those infected with AS or CB alone (A; p>0.05); mice infected with CB 3 days after AS 
had higher parasite densities than those with AS alone (C; p<0.05), but as many as those with CB 
alone (C; p>0.05). In experiment 2, mice infected with AS(pyrlA) and AJ simultaneously had higher 
parasite densities than mice infected with AS(pyrlA) alone (B: p<0.05)  but as many as those with AJ 
alone (B: p>0.05); mice infected with AJ 3 or 11 days after AS(pyrlA) had lower parasite densities 
than mice infected with AJ alone (D; p<0.05) and as many as those infected with AS(pyrlA) alone 
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5.4.2. Experiment 2: AS(pyrlA) and AJ 
Among the single-clone infections, mice infected with AJ lost more red blood cells than 
those infected with AS(pyrlA) (Clone: F 1 =21, p<O.00l), confirming that AJ was more 
virulent than AS(pyrlA) (Chapters 3, 4, De Roode et al. 2004b [Thesis Appendix]). 
5.4.2.1. AS(pyrl A) and AJ dynamics through time 
With a different set of clones, and different techniques for distinguishing them, the second 
experiment showed that the longer the time between infection and super-infection, the more 
the super-infecting clone suffered from competition. As found previously (Chapters 3 and 4, 
De Roode et al. 2004b [Thesis Appendix]), in mice infected simultaneously with AS(pyrlA) 
and AJ. AJ was the dominant clone for the entirety of the infection, with AS(pyrlA) 
disappearing below detectible levels within 11 days (Figure 5.5A). Compared to single 
infections, AS(pyrlA) produced far fewer parasites in these mixed infections than in single 
infections (Figure 5.5B), whereas AJ did not (Figure 5.5C). 
AJ did suffer from competition only when it infected mice 3 or 11 days after AS(pyrlA) 
(Figures 5.517, I). However, even when inoculated after AS(pyrlA), it always became the 
dominant clone later on in the infections, overgrowing AS(pyrlA) around day 10 in mice 
which it infected 3 days after AS(pyrlA) (Figure 5.513), and around day 25 in mice which it 
infected 11 days after AS(pyrlA) (Figure 5.5G). Because AJ was always able to overgrow 
AS(pyrlA) in these infections, AS(pyrlA) was competitively suppressed by AJ, even when 
it was inoculated 3 days before AJ (Figure 5.5E). 
In contrast with AJ, AS(pyrlA) never became the dominant clone in mice infected with AJ 3 
or 11 days before AS (Figures 5.5J, M), and it suffered greatly from competitive suppression 
(Figures 5.5K, N). Competitive suppression was so strong that AS(pyrlA) was only detected 
in 3 Out of the 5 mice which it infected 11 days after AJ. AJ did not suffer at all from 
competition when it was the first clone to infect mice (Figures 5.5L, 0). 
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Figure 5.5. Log parasite densities over time for infections in experiment 2 (mean ± 1 s.e.m.). The left 
column shows AS(pyrlA) and Al densities in mixed infections, while the middle column compares 
AS(pyrlA) densities in single and mixed infections and the right column compares AJ densities in 
single and mixed infections. (A-C): mice were infected with AS(pyrlA) and AJ simultaneously; (D-
F): mice were infected with AJ 3 days after AS(pyrlA); (G-I): mice were infected with AJ 11 days 
after AS(pyrlA); (J-L): mice were infected with AS(pyrlA) 3 days after AJ; (M-O): mice were 
infected with AS(pyrlA) 11 days after AJ. The threshold density at which parasites could be detected 
was around 100/pi mouse blood, so that y-axes start at 2. See table 5.1 for the numbers of mice on 
which data-points are based. 
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5.4.2.2. AS(pyrlA) and AJ parasite densities 
AS(pyrlA) produced as many parasites in mixed infections when inoculated 11 days before 
AJ as it did alone, but it produced fewer parasites when it infected mice 3 days before AJ 
(38±34% reduction), on the same day as AJ (79±37% reduction) or 3 or 11 days after AJ 
(99±44% and 99±45% reduction respectively; Figure 5.6A). Thus, the later AS(pyrlA) 
infected mice with respect to AJ, the more it suffered from competition (single/mixed x day 
interaction: F437=4.8, p=0.004). 
In contrast with AS(pyrlA), AJ produced as many parasites in mice that it infected 11 or 3 
days before AS(pyrlA) or on the same day (Figure 5.6B); it did suffer from competition, 
however, when infecting mice after AS(pyrlA), and more so when infecting 11 days 
(97±12% reduction) than 3 days (88±34% reduction) later (single/mixed x day interaction: 
F4 =11.5, p<0.001). Thus, both clones suffered more from competition the later they 
infected mice already infected with the other clone, but over the whole range of infections, 
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Figure 5.6. Total numbers of AS(pyrlA) (A) and AJ (B) produced over the whole infection in single 
and mixed infections in experiment 2 (mean + 1 s.e.m.). See table 5.1 for the numbers of mice on 
which data-points are based. 
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5.4.2.3. 	Overall parasite densities 
Among the infections initiated on day 0, there were considerable differences in the overall 
parasite numbers produced per infection (Treatment: F 6 , 20=1 1.7, p<O.00l), with single 
infections of AS(pyrlA) producing fewer parasites than single infections of AJ (Figure 5.413; 
Tukey: p=0.02). Mice infected with AS(pyrlA) and AJ simultaneously and those with AJ 
first and then AS(pyrlA) had as many parasites as those infected with AJ alone (Figures 
5.413, D; Tukey: p>0.05 for all), while those infected with AS(pyrlA) first and then with AJ 
had as many as mice infected with AS(pyrlA) alone (Figure 5.41); Tukey: p>0.05 for both); 
these latter mice thus experienced fewer parasites during an infection than those infected 
with AJ alone (Tukey: p<O.00I for day 3 and p=0.02 for day 11), showing that prior 
infection with AS(pyrlA) reduced the number of parasites in these mice (Figure 5.413). 
5.5. Discussion 
These results show that timing of infection is a major determinant of the outcome of within-
host competition. Clones did generally not suffer from competition when they infected mice 
first, but did when they infected mice simultaneously with, or after, their competitor. The 
later a clone was inoculated after another, the more it suffered from competition. Relative 
timing of infection could as such turn around competitive hierarchies, so that clones that 
were competitive inferior in simultaneous co-infections, became competitively dominant 
when inoculated first. The degree to which clones suffered from competition, however, was 
also dependent on genetic background: thus, in experiment 2, AJ was always able to 
overgrow AS(pyrlA) in mice which it infected later, whereas AS(pyrlA) never became 
dominant in mice already infected with AJ. Finally, it was shown that an initial ratio of 
100CB: lAS resulted in similar clone dynamics and competition as seen in infections where 
AS infected mice 3 days after CB. 
Why did clones generally suffer more from competitive suppression by an already resident 
clone than by one inoculated simultaneously or later? Within-host competition between 
malaria clones is likely the result of a combination of resource competition and strain-
transcending immunity (e.g. Richie 1988; Heliriegel 1992; Snounou er al. 1992; Read & 
Taylor 2000; 2001; De Roode etal. 2003 [Thesis Appendix]; Haydon etal. 2003). During an 
infection, malaria parasites replicate exponentially, reaching parasite densities exceeding 
millions of parasites per p.1 blood between 8 and 10 days into the infection (Figures 5.1, 5.5). 
This exponential growth is followed by an exponential collapse of parasite numbers, which 
is the result of both parasite destruction of red blood cells and immune clearance of infected 
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and uninfected red blood cells (e.g. Cox 1988; Heliriegel 1992; Yap & Stevenson 1994; 
Taylor-Robinson 1995; Jakeman et al. 1999; Menendez et al. 2000; Li et al. 2001). Thus, 
parasite clones infecting mice simultaneously must divide the available red blood cells and 
many other resources, such as blood glucose, between them and will be affected by cross-
reactive immune responses induced against them. Parasites inoculated 3 days after their 
competitor should then have less time to grow up to high numbers before conditions become 
unfavourable; this was also confirmed by mixed infections initiated with 100CB: lAS, in 
which AS did not have enough time to replicate extensively before resources ran out and 
immunity came into place. Clones inoculated 11 days after their competitor should suffer 
even more competitive suppression, as they infect a host severely depleted of red blood cells 
and other resources and with strong immune responses in place (Hellriegel 1992). 
The degree to which clones suffer from competition will also depend on how specific 
immune responses are. Clearance of parasites during the acute phase of infection (i.e. the 
period until parasites have collapsed after their initial exponential rise) probably ihvolves 
interferon-gamma (IFN-y), nitric oxide and reactive oxygen species (Taylor-Robinson 1995; 
Li et al. 2001). All these molecules act non-specifically, so that when induced by one clone 
they will also affect another. Strain-specific clearance mechanisms (Jarra & Brown 1989; 
Snounou et al. 1989), dependent on specific antibodies (Mota et al. 1998), are also involved, 
however, so that clones that are controlled by very similar immune responses should affect 
each other more than clones that are controlled by very different responses. 
The current experiments suggest that this is indeed the case. Several studies have shown that 
clones AS and CB are relatively antigenically distinct: some of these (Jarra & Brown 1989; 
Snounou et al. 1989) transfused AS-infected mice with CB-infected red blood cells, showing 
that CB parasites maintained patent levels when AS parasites were cleared (and vice versa); 
others immunised mice with AS or CB and then challenged these mice with AS or CB as the 
hetero- or homologous clone (Jarra et al. 1986), showing that protection was stronger against 
homologous rather than heterologous challenge. A general conclusion from these 
experiments is that immunity elicited against AS is much better at clearing AS than CB, and 
vice versa. In the infections described in the current study, CB densities rose while AS 
densities went down (Figure 5. 1D), probably because the immune response was directed 
against AS, the first clone experienced by these mice; the fact that CB densities levelled off 
before increasing (between days 10 and 15: Figure 5.113) was probably a result of a strong 
decrease of red blood cells and other resources induced by the presence of AS; with 
resources rising again, and immunity focusing on AS, CB could then grow up until it itself 
became the focus of strain-specific immunity. Because these mice, first infected with AS, 
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produced immune responses that were not protective against CB, they experienced more 
parasites overall than mice infected with AS alone (Figure 5.4C). Interestingly, similar 
effects were not seen in infections in which AS followed CB (Figure 5.1G): in these 
infections AS dynamics almost exactly followed CB dynamics, suggesting that immune 
responses focusing on CB also affected AS. This is in accordance with studies that have 
shown that immunity elicited by CB has a stronger effect on AS than immunity elicited by 
AS has on CB (Jarra et al. 1986). The result was that AS in these infections suffered a lot 
more from competition than it did in simultaneous co-infections with CB. 
Unlike AS and CB, AS(pyrlA) and AJ are thought to be rather antigenically similar, so that 
immune responses directed against AS(pyrlA) or AJ are to a large degree cross-reactive; this 
was found in experiments in which mice were immunised with AS(pyrlA) and then 
challenged with AJ, or vice versa (S.J. Cheesman, pers. comm.). In the infections in the 
current study, where AJ came 3 days after AS(pyrlA), AJ managed to overgrow AS(pyrlA), 
but not to the same degree as CB did in mice already infected with AS (cf. Figures 5. 1D and 
5.5D); the result was that AJ suffered a lot more from competition in mice which it infected 
after AS(pyrlA) than in mice which it infected simultaneously. Also, mice that initiated 
immune responses against AS(pyrlA) were protected against AJ to the extent that they 
experienced lower parasite burdens than mice infected with AJ alone (Figure 5.41)). The 
asymmetry in these infections - with AJ being able to overgrow AS(pyrlA) when inoculated 
after AS(pyrlA), but not vice versa - could have been because immune responses against AJ 
had a stronger effect on AS(pyrlA) than immune responses against AS(pyrlA) had on AJ: 
hence the fact that AS(pyrlA) suffered most from mixed infections and AJ was able to 
become the dominant clone even in infections in which it arrived 11 days after AS(pyrlA). 
Alternatively, however, it is possible that AS(pyrlA) is more affected by low amounts of 
resources than AJ. 
This study confirms the widely held belief that many malaria cases are caused by newly 
inoculated parasite clones against which there is no effective immunity (e.g. Lines & 
Armstrong 1992; Mercereau-Puijalon 1996; Smith et al. 1999b; Beck et al. 2001; Ofosu-
Okyere et al. 2001; Kun et al. 2002; Cattamanchi et al. 2003). In malarious areas, people are 
very commonly infected with antigenically different malaria clones, and it is thought that 
these contribute to a build-up of protective immunity. Occasionally, however, a clone is 
encountered against which there is minimal immunity, so that this novel clone can grow up 
exponentially and cause disease. This situation is very similar to the mice infected with AS, 
which upon super-infection with the antigenically different clone CB experienced higher 
parasite burdens than those infected with AS alone. In case of the antigenically more similar 
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clones AS(pyrlA) and AJ, however, such effects were not seen: in fact mice infected with 
AS(pyrlA) were protected against AJ, so that they experienced lower parasite burdens than 
mice infected with AJ alone. 
Virulence evolution theory generally assumes that in mixed parasite infections, virulent 
clones are competitively superior to prudent clones. Although some of these models envisage 
coexistence of different clones with competitive suppression of at least one of the clones 
(e.g. Sasaki & Iwasa 1991; Van Baalen & Sabelis 1995; Frank 1996), other models assume 
that infected hosts cannot be re-infected at all (Bremermann & Thieme 1989), or that virulent 
clones take over hosts already infected with less virulent clones, out-competing these clones 
instantly (e.g. Levin & Pimentel 1981; Nowak & May 1994). Clearly, these latter two 
scenarios receive little empirical support on the basis of this study: in experiment 2, where 
AJ was more virulent than AS(pyrlA), causing more anaemia in the mice it infected, it 
suffered greatly from competitive suppression. Even though it was the dominant clone in the 
end, it is very unlikely that it obtained more transmission from these mixed infections than 
the avirulent clone AS(pyrlA), because AJ parasite densities were between 2 and 3 orders of 
magnitude lower than they were in single AJ infections (Figures 5.51 7, I); furthermore, most 
mosquito transmission in P. chabaudi infections occurs over the first 2 weeks (Chapter 6), so 
that the competitive suppression early on undoubtedly resulted in huge transmission losses 
for the virulent clone. Thus, where the avirulent parasite came first, it was competitively 
superior to the virulent clone, a result flatly contradicting evolutionary theory. 
Such reversal of competitive dominance could explain how virulence polymorphisms are 
maintained in the field, and why avirulent parasites could persist (Mackinnon & Read 
2004b). It must be noted, however, that although AS(pyrlA) was dominant in infections in 
which it was inoculated first, it suffered more from competition overall than AJ: thus, even 
in mice infected with AS(pyrlA) 3 days before Al, and in mice simultaneously infected, did 
it suffer from competitive suppression, so that it did relatively worse over the whole range of 
infections that were studied, as such supporting evolutionary theory. How general this 
phenomenon is, however, remains to be seen. As this study clearly demonstrated, it is not 
only virulence and timing of infection that determine the outcome of competition, but also 
how antigenically diverse competing clones are. Thus, it is well possible that avirulent 
parasites could be so antigenically different from their virulent competitors, that they 
actually transmit at a higher rate from mixed infections when the immune system focuses 
primarily on the virulent clone (e.g. Almogy et al. 2002; Read et al. 2002; Hughes & 
Boomsma 2004). 
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6. Within-host competition between malaria parasites affects between-
host fitness 
6.1. Abstract 
Mixed infections in malaria are common, and result in competition between co-infecting 
strains. Such competition has important implications for the evolution of virulence, the 
spread of drug resistance and the medical consequences of vaccine escape mutants. 
Evolutionary theory generally assumes that within-host competitiveness is directly related to 
transmission success, but experimental evidence for this claim is severely lacking. I studied 
the relationship between within-host competitiveness and transmission to the mosquito 
vector for parasites in mixed-clone infections of the rodent malaria Plasinodium chabaudi in 
laboratory mice. I tracked individual clones throughout the infection using real-time 
quantitative PCR and assessed transmission by feeding infected mice to mosquitoes. I 
present results that suggest a linear relationship between within-host competitiveness and 
relative transmission to the mosquito, so that competition reduces transmission. In addition, 
parasites transmitted at a much lower absolute rate from mixed than single infections. I 
suggest that this reduced transmission is due to transmission blocking immunity. 
6.2. Introduction 
Genetically diverse parasite infections are common (Read & Taylor 2001), and in malaria 
are the rule rather than the exception (e.g. Arnot 1998; Babiker et al. 1999). Mixed infections 
result in competition between co-infecting strains of the same parasite species, and such 
competition has at least three important medical consequences. First, competition is 
predicted to generate selection for increased virulence (Bremermann & Pickering 1983; 
Sasaki & Iwasa 1991; Van Baalen & Sabelis 1995; Frank 1996; Gandon 1998; Mosquera & 
Adler 1998). This is due to a process analogous to the 'the tragedy of the commons' (Hardin 
1968), whereby competition favours virulent parasites that rapidly outgrow prudent 
parasites, even if this means that host life expectancy is reduced so that all parasites do 
worse. Second, competition between drug-resistant and -sensitive malaria parasite strains has 
been implicated as a main determinant in the spread of drug resistance (Hastings & 
D'Alessandro 2000), and it has been shown that interfering with such competition could 
artificially enhance the fitness of drug-resistant mutants and thus enhance the spread of 
resistance (Hastings & DAlessandro 2000; Chapter 7, De Roode et al. 2004a [Thesis 
Appendix]). Third, where vaccines are used to control disease, it is well known that vaccine 
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escape mutants can arise and spread (e.g. Kew et al. 2002), and it is generally assumed that 
this is because of a competitive advantage of such mutants in vaccinated hosts (e.g. Bull 
1994). 
Even though these medical consequences of within-host competition have been thoroughly 
investigated mathematically, experimental evidence to support them is extremely scanty. 
One of the most important assumptions these models make is that there is a direct 
relationship between within-host competitiveness and transmission to the host population 
(i.e. fitness). Logical as this relationship may seem, experimental evidence to support this 
claim is scarce; and where there is experimental evidence, such a relationship is not at all 
obvious (e.g. Nakamura et al. 1992). 
There are many biological mechanisms of'parasite-host systems that could negate a direct 
relationship between within-host competitiveness and transmission. First, parasites could 
facultatively increase their relative investment in transmission in the presence of 
competitors, a mechanism well recognised in some theoretical studies (e.g. Van Baalen & 
Sabelis 1995). If this occurs, it is possible that competitively suppressed genotypes may 
transmit as well as, or even better than, dominant genotypes. Malaria parasites, for example, 
are known to increase their investment in transmission when conditions for asexual 
replication worsen (Paul et al. 2003) - for instance in response to sub-curative levels of anti-
malaria drugs (Buckling et al. 1997) - and it is possible that they do likewise in response to 
the presence of competitors. 
Second, immune responses are complex, and generating immunity against a mixture of 
parasite genotypes could be either more or less effective than generating immunity against an 
infection consisting of a single parasite. If the immune response generated against one 
genotype also affects other parasites, transmission of individual clones could be reduced. On 
the other hand, if immunity against a mixture of parasites is less effective (Taylor et al. 
1998), or when immune responses against the different parasites occupying a mixed 
infection down-regulate each other (Cox 2001), overall transmission from mixed infections 
could be enhanced. It is an interesting possibility that under the latter scenario competitively 
suppressed clones could actually have an advantage if the immune system focuses on the 
more abundant dominant clone (De Roode et al. 2004b [Chapter 4, Thesis Appendix]; 
Hughes & Boomsma 2004), leaving the suppressed parasite to transmit freely for at least 
some period of time. 
Third, vector-borne parasites could face trade-offs between competitiveness in different 
hosts: thus they may be the better competitor in their mammalian host, but the worse in the 
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invertebrate vector. Such between-host trade-offs certainly exist for virulence in Schistosoma 
mansoni, where strains with high virulence in the mouse host caused low virulence in their 
molluscan host (Davies et al. 2001); there was also no relationship between the virulence of 
a range of Plasmodium chabaudi clones in their mouse and mosquito hosts (Ferguson et al. 
2003b). It is thus clear that a direct relationship between within-host competitiveness and 
transmission, as assumed by theoretical models, might not exist. 
Here, I study the relationship between within-host competitiveness and transmission for 
Plasmodium chabaudi in laboratory mice. I study mixed infections consisting of a virulent 
and an avirulent parasite clone, in two different mouse strains. Asexual parasites were 
tracked throughout the mouse infection with clone-specific real-time quantitative PCR, while 
transmission was assessed by feeding mice to mosquitoes. In malaria, asexual haploid 
parasites circulate and replicate in the blood, and only a small subset of these form 
gametocytes, the stages that are transmitted to mosquitoes. In the mosquito mid-gut 
gametocytes mature into gametes, which fuse to form diploid zygotes (e.g. Sinden et al. 
1996). These develop into oocysts on the mid-gut wall, in which genomic replication results 
in haploid - sporozoites that travel to the salivary glands, from where they can infect a new 
mammalian host. Although parasite fitness is commonly defined as the number of secondary 
infections resulting from an infection (e.g. Anderson & May 1982; Frank 1996; Levin 1996), 
I used two surrogate measures of fitness: for each parasite clone, I determined both the 
proportions of mosquitoes that it infected and the numbers of parasites per infected 
mosquito. 
6.3. Material and methods 
6.3.1. Parasites and hosts 
I used two genetically distinct Plasmodium chabaudi chabaudi clones, denoted AS(pyrlA) 
and AJ, AS(pyrlA) being less virulent than AJ (De Roode et al. 2004b [Chapter 4, Thesis 
Appendix]). For simplicity AS(pyrlA) will be referred to as AS from hereon. 
Vertebrate hosts were ten weeks old C5713116J and CBA/Ca inbred female mice (Harlan, 
England), which were kept as described (De Roode et al. 2004b [Chapter 4, Thesis 
Appendix]), and which will be referred to as C57 and CBA from hereon. 
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Mosquito hosts were 2-5 days old female Anopheles stephensi mosquitoes, maintained  on a 
glucose solution (10% glucose, 0.05% 4-Aminobenzoic acid) in an insectary at 24°C and 
80% humidity and a 12 L: 12 D cycle. 
6.3.2. Experimental design 
The experiment consisted of 3 treatments for both C57 and CBA mice: infections with AS 
alone, infections with AJ alone, and mixed AS+AJ infections. Each treatment group had 10 
mice at the start of the experiment, resulting in 60 mice in total. Mice infected with just AS 
or AJ received 106  parasite-infected red blood cells, whereas mice infected with both clones 
received 2 x 106  parasites, made up of 106  AS and 106  AJ parasites (De Roode et al. 2004b 
[Chapter 4, Thesis Appendix]). On days 7, 14 and 21 post-infection (P1), 3 mice of each 
treatment group (2 mice for AJ in CBA mice on day 21 P1) were fed to 30 mosquitoes each; 
these days were chosen because in a previous experiment (De Roode et al. 2004b [Chapter 4, 
Thesis Appendix]) I found high gametocyte numbers on these days. 
6.3.3. Virulence, asexual and sexual parasites in mice 
I recorded mouse live weights and red blood cell densities as measures of virulence 
(Mackinnon et al. 2002b; De Roode et al. 2004b [Chapter 4, Thesis Appendix]), and 
monitored parasite asexual densities and gametocyte densities as described (De Roode et al. 
2004b [Chapter 4, Thesis Appendix]). Individual clones in mixed infections were tracked 
using real-time quantitative PCR (see below); DNA was extracted from 5 .tl blood samples 
using the BloodPrep ® kit (Applied Biosystems) on the ABI Prism ® 6100 Nucleic Acid 
PrepStation according to manufacturer's instructions. Measurements were taken on days 2, 
4, 6, 7, 9, 11, 13, 14, 16, 18, 20 and 21 PT, between 9.00 a.m. and 12.00 noon, when 
peripheral blood almost exclusively harboured haploid ring stage parasites. 
6.3.4. Transmission to mosquito 
On each of the days 7, 14 and 21 P1, 3 mice from each treatment group were fed to 
mosquitoes: those mice were chosen that had considerable gametocyte numbers the day 
before (range: 133 - 11888 gametocytes/tl). Mice were anaesthetised using 
Rompun/Vetalar, injected intramuscularly at a dose of 2.5 Al per g mouse, and put on top of 
a carton container covered with net and containing 30 mosquitoes. Mosquitoes were given 
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20 minutes to feed, after which mice were killed. Mosquitoes that had not taken a blood meal 
were removed from the pots, and those that died during the following 8 days were likewise 
removed. 
Mid-guts were excised from mosquitoes at 8 days post-feed. The infection status 
(presence/absence of oocysts) of individual mosquitoes was determined by 40x-100x phase 
contrast microscopy and, when present, numbers of oocysts were counted. Individual oocyst-
bearing mid-guts were placed into microtubes containing cetyltrimethylammonium bromide 
(CTAB) buffer and Proteinase K at a final concentration of 1 mg/mi, and allowed to digest 
for at least an hour at 56°C. DNA was extracted using a standard phenollchloroform 
extraction, precipitated with propan-2-ol, washed twice in 70% ethanol and air-dried. The 
DNA was then re-suspended in 10 Al of sterile H 20, boiled for 5 min and stored at -80 °C 
until required for PCR. Numbers of AS and AJ genomes present on mosquito mid-guts were 
determined using real-time quantitative PCR. 
6.3.5. Real-time quantitative PCR 
In collaboration with A.S. Bell, two clone-specific real-time quantitative PCR assays were 
developed, utilising hydrolysis probe detection and the ABI PrismTM  7000 Sequence 
Detection System (Applied Biosystems). These assays exploited sequence polymorphisms in 
the ama] gene of the two P. chabaudi clones (S.J. Cheesman, unpublished results); the ama] 
gene codes for the red blood cell invasion protein apical membrane antigen 1. AS-specific 
primers had the sequences 5' GGAAAAGGTATAACTAPTCAAAATTCTAAGGT 3' (forward) 
and 5' AATTGTTATAGGAGAAATGTTTACATCTGTTTG 3' (reverse), and AJ-specific 
primers 5' GGAAAAGGTATAACTAATCAAAAATCTACTAA.A 3' (forward) and 5' 
GTGTTATAGGAGAAATGTGTACATCTGTTTT 3' (reverse) (polymorphisms in bold). 
Amplicon sequences, internal to the primer sites, were identical for the two clones, with the 
AS amplicon 129 bp and the AJ amplicon 127 bp in length. A fluorescent probe (5' 6-
FAN-ATCCTCCTTCTCTTACTTTC-MGB 3 1 ) was used for quantification, hybridising to 
the non-polymorphic region within the ama] gene amplicon of both clones. 
Standard reaction conditions for hydrolysis probes on the ABI PrismTM  7000 SDS platform 
(initial denaturation 95°C/1 min and 45 cycles of denaturation 95°/15 s and 
annealing/extension 60 °C/1 mm) were employed for both assays. Concentrations of the 
clone-specific primers (0.3 4aM) and common probe (0.2 .tM) were the same for both assays 
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and each utilised TaqMan ®  Universal PCR Master Mix (hot start) in a total reaction volume 
of 25 p1 incorporating 2 p1 of DNA: 
Absolute quantification of AS and AJ genome numbers was realised by comparing the cycle 
thresholds of the unknown samples against a standard curve. DNA standards, covering 5 
orders of magnitude, were generated from duplicate DNA extractions of mouse blood 
samples bearing known numbers of haploid parasites: 8.55 x 105 / 2 p1 down to 8.55 x iO° / 2 
p1 for AS, and 2.14 x 105 I 2 p1 down to 2.14 x 100  / 2 p1 for AJ. Standards were extracted 
from the same volume of blood using the ABI Prism ® 6100 Nucleic Acid PrepStation as 
described above. Duplicates of each standard (or triplicates for lower template numbers) 
were included in each quantitative PCR run. The assays were tested for specificity, 
sensitivity and repeatability. Each clone-specific assay amplified only its target-template 
with no amplification of non-target clone DNA, mouse or mosquito DNA. Both assays were 
found to be able to detect fewer than 5 genome copies per 2 p1 DNA sample (corresponding 
to fewer than 100 parasites per p1 mouse blood or 25 genome copies per mosquito mid-gut). 
Using AS primers, fewer than 5 AS parasites could be detected in the presence of 10,000 AJ 
parasites, and using AJ primers fewer than 5 AJ parasites were detectible in the presence of 
10,000 AS parasites, thus showing that the assay was both highly sensitive and specific. 
As gametocytes and asexual parasites have exactly the same genes, these real-time 
quantitative PCR assays cannot distinguish between asexual parasites and gametocytes, but 
instead reveal the total number of all blood-stage parasites of the target clone. In data 
analyses, however, I treated these total counts as estimates of asexual numbers: gametocyte 
densities were 2-3 orders of magnitude lower than asexual parasite densities, thus forming a 
negligible component of overall parasite numbers. 
6.3.6. Trait definition 
6.3.6.1. 	Virulence 
I determined the minimum weights and minimum red blood cell densities that mice reached; 
mice fed to mosquitoes and killed on day 7 were excluded from the analysis, as minimum 
weights and red blood cell densities were mostly reached after day 7. 
6.3.6.2. Asexual and sexual parasite densities 
I expected most gametocytes to be produced around days 7, 14 and 21 PT (De Roode et al. 
2004b [Chapter 4, Thesis Appendix]). Gametocytes take about 36-54 hours to mature 
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(Gautret et al. 1996): as mice were fed to mosquitoes around 16.00 hours in the afternoon on 
days 7, 14 and 21, I analysed the corresponding asexual densities as monitored around 9.00 
hours the day before (days 6, 13 and 20). 
6.3.6.3. The relationship between fitness in mouse and mosquito host 
I analysed the proportions of mosquitoes infected with AS or AJ arid the numbers of AS and 
AJ parasites per PCR-positive mosquito: in these analyses asexual densities of AS and AJ in 
the mouse a day before the feeds were included as covariates, to assess whether asexual 
density in the mouse host was a good predictor of transmission to mosquitoes. I also 
determined the proportion of AS in the parasite population in mosquitoes (either as the 
average of all mosquitoes that fed on a single mouse, or as the total number of AS parasites 
divided by the total number of AS and AJ parasites in the total mosquito population) and 
compared these to the proportions of AS in the asexual parasite populations in mice. This 
analysis was aimed at assessing whether the gene frequency of a clone in the mouse host was 
a good predictor for its gene frequency in the mosquito host. I also analysed the overall 
transmission from mixed infections as the proportions of mosquitoes infected, or the 
numbers of oocysts per infected mosquito to find out if overall transmission of a parasite 
population was affected by its genetic constitution. In these analyses gametocyte densities 
were included as covariates. 
6.3.7. Statistical analysis 
All analyses were carried out using ANOVAs, ANCOVAs and generalised linear models in 
R (V. 1.6.2). Where necessary, data were log transformed to meet the normality and 
homogeneity of variance assumptions of these statistical models. Proportions of infected 
mosquitoes and numbers of genomes and oocysts were analysed using models with binomial 
and Poisson error distributions respectively. For most analyses, quasi-binomial, quasi-
poisson or negative binomial error distributions were necessary to correct for overdispersion 
(Crawley 2002). Because mouse, and not mosquito, was the proper replication unit in this 
experiment, numbers of genomes or oocysts were averaged over the total number of infected 
mosquitoes that fed on one mouse to get rid of pseudo-replication (Crawley 2002; Grafen & 
Hails 2002). 
Maximal models were fitted first, including all possible interactions and covariates when 
appropriate. Models were minimised by removing non-significant terms (p>0.05), beginning 
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with the interactions. As p-values based on F-tests in ANOVA tables are inaccurate in 
analyses with binomial and poisson error distributions (Crawley 2002), I based significance 
on deletion of model terms followed by model comparison as described (Crawléy 2002). 
C57 	 CBA 
(B) 	- AS in mixed 
AJ in mixed 
7 	
(A) I 
0 	7 	14 	21 	0 	7 	14 	21 
Day post-infection 
Figure 6.1. Log parasite densities over time (mean ± 1 s.e.m.) for C57 mice (left panels) and CBA 
mice (right panels). The top row shows AS and AJ parasite densities in mixed AS+AJ infections (A 
and B), the middle row compares AS parasite densities in single AS infections with those in mixed 
AS+AJ infections (C and D), and the bottom row compares AJ parasite densities in single AJ 
infections with those in mixed AS+AJ infections (E and F). Data points on days 1, 3, 5, 6 and 7 are 
based on 10 replicate mice (except for AJ and AS+AJ in C57 mice: 9 mice each); data points on days 
9, 11, 13 and 14 are based on 7 replicate mice (except for AJ and AS+AJ in C57 mice: 6 mice each; 
AS+AJ in CBA mice: 6 mice on days 11, 13 and 14; AJ in CBA mice: 5 mice on days 13 and 14); 
data points on day 16, 18, 20 and 21 are based on 4 replicate mice (except for AJ and AS+AJ in C57 
mice and AS+AJ in CBA mice: 3 mice each; AJ in CBA mice: 2 mice). As the limit of detection was 
100 parasites per /Ll blood, y-axes start at 2. 
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6.4. Results 
One C57 mouse infected with AJ and one infected with AS+AJ had delayed parasite peaks; 
they probably received a lower dose than the other mice in their respective treatment groups 
(Timms et al. 2001); as timing was important in this experiment, these mice were removed 
from the experiment and subsequent analysis. One CBA mouse infected with AS+AJ was 
euthanised on day 9, when it was extremely anaemic. One infected with AJ died on day 13, 
and another was removed from the experiment on day 16, as its tail's heavy scar tissue made 
obtaining blood from it impossible. 
6.4.1. Virulence 
As expected, AS was less virulent than AJ, causing less anaemia in both mouse strains (F 1 ,24  
= 15, p=O.00l); in contrast with previous results (De Roode et at. 2004b [Chapter 4, Thesis 
Appendix]), however, AS did not cause less weight loss than AJ (p>0.05). Mixed infections 
were as virulent as the virulent clone AJ (F 1 , 21 = 2.75, p=O.11 for anaemia; F 121 = 0.94, 
p=0.34 for weight loss); on the mosquito feed days 7, 14 and 21 there were no differences in 
anaemia between either of the 3 treatments (Treatment: p>0.05). 
CBA mice suffered more anaemia (Strain: F ] , 24 = 12.6, p=0.002)  and weight loss (Treatment: 
F1 , 24 = 13.9, p=O.00l) than C57 mice; on day 14, CBA mice were more anaemic than C57 
mice (Strain: F 1 , 21 = 18.2, p=O.00l), but this was not the case on days 7 and 21 (p>0.05  for 
both). 
6.4.2. Dynamics of asexual and sexual parasites 
In both mouse strains, AJ produced higher numbers of parasites in mixed infections than AS 
during the first two weeks of infection (Figure 61A, B). In C57 mice, AS then disappeared 
below detectible levels, whereas in CBA mice it started to overgrow AJ, and became the 
numerically dominant clone up until day 21 when the experiment was terminated (Figure 
6.113). Compared to single infections, AS produced fewer parasites in mixed infections in 
C57 mice for the entirety of the infection (Figure 6. 1C), thus showing it suffered from 
competition. In CBA mice, however, this was true only for the first 16 days, after which AS 
produced more parasites in mixed infections than it did on its own (Figure 6. 1D), thus 
showing facilitation at that time, not competition. AJ also suffered from competition, though 
to a lesser degree than AS. In C57 mice, it produced fewer parasites in mixtures than on its 
Chapter 6— Transmission from mixed infections 	 103 
- AS single infections 
-- - AJ single infections 

















own between days 6 and 13, after which it produced about as many in single and mixed 
infections (Figure 6.1E). In CBA mice, AJ also suffered from competition between days 6 
and 13, and again between days 16 and 21 (Figure 6. iF), when AS was the dominant clone. 
As expected, gametocytes in C57 mice were produced with peaks on days 7 and 14, after 
which they disappeared below detectible levels (Figure 6.2A). In CBA mice there was also a 
large peak of gametocytes on day 7 for all 3 infection types; AS infections produced many 
more gametocytes on day 14 than AJ and AS+AJ infections (Figure 6.213); AS+AJ infections 
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Figure 6.2. Log gametocyte densities over time (mean ± 1 s.e.m.) for C57 mice (A) and CBA mice 
(B) infected with single AS, single AJ or mixed AS+AJ infections. For mixed infections gametocyte 
densities reflect overall numbers of AS and AJ gametocytes, as the real-time quantitative PCR assay 
used cannot distinguish between AS and AJ gametocytes (see text). As the limit of detection was 100-
parasites per Al blood, y-axes start at 2. See Figure 6.1 for the number of mice on which each data 
point is based. 
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6.4.3. Transmission success to mosquito vector 
6.4.3.1. Proportions of mosquitoes infected with AS or AJ 
Summarised over the whole infection (thus taking data from days 7, 14 and 21 together), AS 
and AJ infected fewer mosquitoes from mixed than from single infections (Figure 6.3A, B). 
This was a result of two effects. First, clones had lower asexual densities due to competition, 
which led to lower transmission (Figure 6.3A, B; p<0.001 for AS, p=0.003 for AJ). Second, 
transmission from mixed infections was lower per se, so that for a given asexual density both 
clones infected fewer mosquitoes from mixtures than from single infections (p=0.04 for both 
AS and AJ). AS infected much fewer mosquitoes from mixed than from single infections on 
day 7 in both mouse strains (Figure 6.3C, D; p=0.008). On day 14, it also infected fewer 
mosquitoes from mixtures in CBA mice, but slightly more from mixtures in C57 mice 
(Figure 6.3E, F; Treatment x Strain interaction: p=0.004). Analysed for days 7 and 14 
separately, AJ infected slightly fewer mosquitoes from mixed infections (Figure 6.3E, F), but 
this reduction was not significant (p=O. 15, p=O.11 for days 7 and 14 respectively). 
6.4.3.2. Numbers of parasites per infected mosquito 
Over the whole experiment 359 out of 1289 mosquitoes contained oocysts and were thus 
clearly infected, but only 268 of these gave positive PCR results (Table 6.1). Moreover, 
observations of AS and AJ genomes and the genome numbers themselves were generally 
very low (Figure 6.4), so that analysis of these numbers in some cases resulted in problems 
with normality of error distributions. Average parasite numbers for AS and AJ were based 
only on mosquitoes that showed positive PCR results for AS, AJ or both. 
Over the whole infection, both AS and AJ had lower parasite numbers in mosquitoes that fed 
on mixed infections than in those that fed on single infections (Figure 6.4A, B). As with the 
proportions of infected mosquitoes, this was not due to lower asexual densities in mixed 
infections in mice alone: AS certainly had lower numbers in mosquitoes when asexual 
densities were low (p<0.001), but for a given asexual density AS and AJ obtained lower 
parasite numbers in mosquitoes from mixed than from single infections (Figure 6.4A, B; 
p=0.002 for AS, p=0.03 for AJ). On day 7 AS had marginally lower parasite numbers in 
mosquitoes from mixed infections than single infections (Figure 6.4C, D; p=0.09); on day 14 
it had far lower numbers in mosquitoes that fed on mixed than single infections in CBA 
mice, whereas in C57 mice there was no such difference (Figure 6.4E, F; Treatment x Strain 
interaction: 0=0.006). AJ produced fewer parasites in mosquitoes fed on mixtures than those 
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fed on single infections on day 7 (Figure 6.4C, D; p=0.04), but not so on day 14 (Figure 
6.4E, F; p=O.l4). 
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Figure 6.3. Relationships between the proportions of mosquitoes infected with AS or AJ and their 
corresponding asexual parasite densities in mice a day before mosquito feeding. Graphs show the 
proportions of mosquitoes infected with AS or AJ when fed on mice with single AS or AJ ('AS 
alone'; 'AJ alone') or mixed AS+AJ ('AS in mixed'; 'AJ in mixed') infections, summarised over days 
7, 14 and 21 (A, B), or for day 7 (C, D), 14 (E, F) and day 21 (G, H) separately. Presence of AS and 
AJ in mosquitoes was assessed with real-time PCR. When no symbols are present in a graph, it means 
that no parasites were detected in any of the mosquitoes. 
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Table 6.1. Numbers of dissected mosquitoes that fed on mice infected with AS, AJ or a mixture of 
AS+AJ, and in which parasites were detected by the presence of oocysts or by PCR detection. Non-
italicised numbers refer to individual mice, whereas italicised numbers are subtotals and totals. 
C57 mice CBA mice 
Dissected Oocyst positive 
PCR positive
(both clones) Dissected Oocyst positive PCR positive 
Day7 26 26 25 18 13 13 
AS 24 15 15 20 14 4 
20 13 12 7 4 3 
70 54 52 45 31 20 
20 19 4 30 15 9 
AJ 20 19 16 23 1 0 
17 1 0 16 13 13 
57 39 20 69 29 22 
22 0 0(0) 8 0 0(0) 
AS+AJ 16 5 4 (4) 27 1 2 (0) 
65 15 12 59 1 2 
Total 192 108 84 173 61 44 
Day 14 0 -- 13 29 3 27 18 
AS 29 4 1 25 10 9 
26 0 0 30 15 11 
84 7 1 82 43 33 
28 25 21 29 12 12 
AJ 29 24 18 28 5 5 
22 18 14 27 0 0 
79 67 53 84 17 17 
31 11 7(3) 28 3 0(0) 
AS+AJ 29 4 2(1) 23 2 1(0) 
.... 
87 37 29 67 11 4 
Total 250 111 83 233 71 54 
Day2l 27 0 0 27 0 0 
AS 26 1 0 26 1 0 
26 0 0 25 0 0 
79 1 0 78 1 0 
AJ 27 0 0 25 0 0 
27 0 0 
79 0 0 51 2 2 
22 0 0(0) 28 1 1(0) 
AS+AJ 22 0 0 (0) 27 0 0 (0) 
27 0 0(0) 28 3 0jL 
71 0 0 83 4 1 
Total 229 1 0 212 7 3 
Overall 	Total 671 220 167 618 139 101 
Over C57 and CBA 1289 359 268 
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Figure 6.4. Relationships between numbers of AS and AJ parasites per infected mosquito and their 
corresponding asexual parasite densities in mice a day before mosquito feeding. Graphs show the 
numbers of AS and AJ parasites in mosquitoes fed on mice with single AS or AJ ('AS alone'; 'AJ 
alone') or mixed AS+AJ ('AS in mixed'; 'A.J in mixed') infections, summarised over days 7, 14 and 
21 (A, B), or for day 7 (C, D), 14 (E, F) and day 21 (G, H) separately. AS and AJ numbers in 
mosquitoes were quantified using real-time PCR, and plotted points are the averages of all PCR-
positive mosquitoes fed on single mice. When no symbols are present in a graph, it means that no 
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6.4.3.3. Relative proportions of clones in mice and mosquitoes 
I compared the relative proportions of AS of the total parasite populations in mosquitoes and 
compared them with the relative proportions in mice the days before the feeds. Relative 
proportions were calculated in two ways. The first way determined the proportion of AS in 
each PCR-positive mosquito and then averaged these per mouse. The second way summed 
the AS parasites over all the mosquitoes fed on a single mouse and then divided this number 
by the overall AS+AJ parasites summed over those mosquitoes. As there were not many 
mosquitoes for which I obtained positive genome counts, I decided to pooi all the results 
over host strain and day together, and do the analysis on those pooled results. For both ways 
of calculating, the observed proportions of AS in mosquitoes were linearly related to the AS 
proportions in the mice a day before mosquito feeds (Figure 6.5A, B). Thus, these results 
suggest that a clone present in a mixed infection in the mouse transmitted to the mosquito at 
the same relative frequency. 
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Figure 6.5. The relationship between the proportions of AS parasites in the mosquito, and mouse one 
day before a feed day. Shown are the proportions of AS in mosquitoes based on the average per 
mosquito (A) and based on the overall numbers of AS parasites over all the mosquitoes fed on a single 
mouse (B). In both cases the observed least squares regression line does not differ from the expected 
line based on the hypothesis that the proportions in the mosquito are linearly related to the proportions 
in the mouse. Regression lines: (A) proportion in mosquito = 0.15 (±0.21) + 0.89 (±0.35) * 
proportion in mouse, R2 = 0.50, p=0.02; (B) proportion in mosquito = 0.075 (±0.24) + 0.85 (±0.42) * 
proportion in mouse; R2 = 0.37, p=O.OS. Regression lines in both (A) and (B) do not differ from the 
linear equation: proportion in mosquito = 0 + 1.0 * proportion in mouse (p>0.05 for both). 
Chapter 6— Transmission from mixed infections 	 109 
6.4.4. Overall transmission from single and mixed infections 
The above analysis showed that both AS and AT obtained lower transmission from mixed 
infections than from single infections and that this reduction could not be attributed to a 
reduction in asexual parasite densities alone: I showed that for a given density AS and AT 
still infected fewer mosquitoes from mixed than single infections. This suggests that the 
overall transmission from mixed infections was lower than that from single infections, and 
this was indeed the case. On day 7, fewer mosquitoes became infected when feeding on 
mixed infections than on either AS or AJ single infections (Figure 6.6A, B; p=0.034). This 
difference did not occur because of lower gametocyte densities in mixed infections (Figure 
6.2A, B): more mosquitoes became infected with higher gametocyte densities (p=0.022), but 
for a given gametocyte density, mixed infections still infected fewer proportions of 
mosquitoes than single infections (p=0.002). Per gametocyte, the numbers of oocysts per 
infected mosquito were also lower for mixed infections (p=0.002 for both day 7 and over the 
whole infection). On day 14 mixed infections infected as many mosquitoes as did AT 
infections (p>0.05); in C57 mice these numbers were higher than for AS single infections, 
whereas in CBA mice they were lower (Figure 6.6C, D; Treatment x Strain interaction: 
p=0.002). Thus, clone AS suffered great transmission reductions in mixed infections in CBA 
mice: these mixed infections had much lower gametocyte densities than AS single infections 
(Figure 6.213), so that they infected far fewer mosquitoes. 
On days 7 and 14 C57 mice infected more mosquitoes than CBA mice. Again this was not 
due to differences in gametocyte numbers (Figure 63A, B): per gametocyte, C57 mice 
infected more mosquitoes than did CBA mice (p=0.05 for both days 7 and 14). Infected 
mosquitoes that had fed on CBA mice also had lower numbers of oocysts than those that had 
fed on C57 mice (p=0.008 and p=0.004 for day 7 and the whole infection respectively). 
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Figure 6.6. Proportions of mosquitoes that became infected when feeding on mice infected with either 
AS, AJ or a mixture of AS and AJ. Shown are proportions for C57 mice (left) and CBA mice (right), 
on days 7 (A and B). 14 (C and D) and 21 (E and F). Within each graph, asterisks denote treatments 
that are significantly different from the other treatments in the same graph. Proportions are based on 
the means of 3 mice for each data-point, except for AJ in graph F (2 mice only). Crosses denote 
proportions of zero. Error bars are 95% confidence limits based on the binomial distribution (Rohlf & 
Sokal 1981). 
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6.5. Discussion 
This experiment showed strong transmission losses from mixed infections. Both clones AS 
and AJ obtained much lower transmission from mixed infections than from single infections, 
both in terms of the numbers of mosquitoes they infected as well as the numbers of parasites 
per infected mosquito. This transmission reduction was the result of two effects. First, it was 
shown that the relative proportion of a clone in the asexual parasite population in the mouse 
was a good predictor for the relative proportion of that same clone in the mosquito. This 
means that competition led to reduced parasite densities in the mouse and consequently 
lower transmission. Second, the overall transmission from mixed infections was lower than 
from single infections, so that for a given parasite density, clones still transmitted less well 
from mixed than from single infections. Thus, these results suggest that relative between-
host fitness is directly related to relative within-host competitiveness in this malaria model, 
although overall transmission can be much reduced. 
Even though these results are based on a relatively small number of mosquitoes, there is at 
least no suggestion that a reverse relationship between within-host competitiveness and 
transmission exists, i.e. no evidence of increased relative transmission from mixed 
infections. We thus have no reason to believe that P. chabaudi parasites facultatively 
increase their investment in transmission stages in response to the presence of competitors as 
they do in response to sub-curative drug levels (Buckling et al. 1997). This accords well with 
mixed infections of the P. chabaudi clones CR and ER, in which there was also no evidence 
for such a facultative increase in transmission stage production (Taylor & Read 1998). 
It thus seems safe to suggest that these results confirm the oft-held theoretical assumption 
that within-host parasite competitiveness is a good predictor for parasite transmission. This 
assumption has been the basis of models asserting that within-host competition is a crucial 
determinant in the spread of drug resistance (Hastings & D'Alessandro 2000), and that 
vaccine escape mutants can arise because they are competitively superior and transmit better 
than strains against which vaccines protect (e.g. Bull 1994). In previous experiments I 
showed that in P. chabaudi there is a direct relationship between virulence and 
competitiveness (Chapter 3). The current experiment then suggests that there is also a direct 
relationship between virulence and transmission from mixed infections. Such a relationship 
has been paramount to a large body of theory predicting that competition in mixed infections 
leads to selection for increased virulence (Bremermann & Pickering 1983; Sasaki & Iwasa 
1991; Van Baalen & Sabelis 1995; Frank 1996; Gandon 1998; Mosquera & Adler 1998). It 
is important to note that in this experiment I did not find that the avirulent clone AS suffered 
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more transmission loss than the virulent clone AJ. However, AS was much more virulent in 
this experiment than in previous experiments (Chapters 3, 4 and 5, De Roode et al. 2004b 
[Thesis Appendix]): it caused as much weight loss as AJ and consequently suffered less from 
competition over the whole infection than in previous experiments. This increased virulence 
is very likely the result of several blood passages of the parasite prior to the experiment, as 
serial passaging increases virulence in P. chabaudi (Mackinnon & Read 1999b; Mackinnon 
& Read 2004a). Thus, had AS been less virulent, it would probably have suffered more from 
competition and thus suffered more transmission loss. 
Contrary to my expectations (De Roode et al. 2004b [Chapter 4, Thesis Appendix]), AS 
suffered more transmission loss from mixed infec5tions in CBA mice than in C57 mice. I had 
expected the reverse, as in CBA mice AS actually benefited from the presence of AJ later on 
in the infection (after about 16 days), when it produced more parasites in mixed than in 
single infections. In this, as well as in a previous experiment (De Roode et al. 2004b 
[Chapter 4, Thesis Appendix]), this facilitation coincided with a large peak of gametocytes 
around day 21, and it was hypothesised that this could result in transmission of AS parasites 
at that time. However, these gametocytes resulted in hardly any mosquito infections at all, 
with only 4 mosquitoes out of a total of 83 infected. Gametocytes have often been found to 
become less infective over time (Dearsly et al. 1990; Naotunne et al. 1990), and this is 
probably the result of transmission blocking immunity (Naotunne et al. 1990). These results 
thus show that the longer persistence of AS in mixed infections in CBA mice did not result 
in extra transmission: this questions the idea that antigenic variation of parasites is a means 
to prolong infection in order to obtain more transmission (e.g. Antia & Lipsitch 1997). One 
other reason that AS suffered extra much transmission loss from CBA mice is that whereas 
in single infections it produced large numbers of transmissible gametocytes on day 14, in 
mixed infections these numbers were drastically reduced due to the presence of AJ. 
In this study, mixed-clone infections - on a per gametocyte basis - generally infected much 
lower proportions of mosquitoes than did single-clone infections, and resulted in lower 
numbers of oocysts in infected mosquitoes. This could be due to immunity in the mosquito 
host, the mouse host, or both. Between the ingested gametocyte and the oocyst stages in the 
mosquito, malaria parasites undergo huge mortality (Vaughan et al. 1992): this is at least 
partly due to the mosquito's immune system (Sinden 2002; Dimopoulos 2003). Mosquito 
immune responses include digestive enzymes in the mid-gut and melanotic encapsulation of 
early oocysts, and some of these responses are believed to be quite specific (Dimopoulos 
2003). Possibly, mosquito immunity is more effective against a mixed infection of AS and 
AJ parasites than against single AS or AT infections: this could be due to AS and AJ sharing 
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some antigens or because of them having some immunological properties that make immune 
responses against them synergistic. 
Mixed infections could also be less transmissible due to strain-transcending transmission 
blocking by the mouse's immune system. Transmission blocking immunity in malaria 
reduces infectivity to the mosquito vector by reducing gametocyte survival (Harte et al. 
1985), gamete fertilisation (Gwadz 1976) and sporogonic development in the vector (Winger 
et al. 1988), and in the rodent malaria P. berghei occurs as early as day 6 P1 (Fleck et al. 
1994). Transmission blocking is often mediated by antibodies killing gametes or zygotes, or 
preventing fertilisation and ookinete mid-gut penetration (Carter 2001; Kaslow 2002). With 
so many antigen-targets, it seems likely that there will be considerable cross-immunity 
between AS and AJ. Indeed, if the transmission blocking antigens of clones AS and AJ are 
very similar, immunity could work synergistically against these clones. A corollary of this 
argument is that if two clones were very antigenically different, overall transmission from 
mixed infections could actually be enhanced, something that has indeed been observed with 
two different P. chabaudi clones (Taylor et al. 1997b, see Chapter 8 for discussion). 
Transmission blocking immunity is an attractive explanation for the results observed here, 
because it could also explain the differences between C57 and CBA mice. CBA mice 
suffered more anaemia and weight loss, and this could be due to CBA mice having different 
immunological responses (as hypothesized in De Roode et al. 2004b [Chapter 4, Thesis 
Appendix]). C57 and CBA mice show different immune responses when infected with 
Schistosoma japonicum infections (Hirata et al. 2002), and with P. chabaudi these strains 
also differ in the levels of cytokines they produce (A.L. Graham et al., unpublished results). 
Thus, it is well possible that C57 and CBA mice also have different levels of transmission 
blocking immunity, with CBA mice blocking transmission more effectively. 
Despite this attractive explanation of transmission blocking immunity, there are alternative 
explanations for the reduced infectivity of mixed infections observed here. For example, 
fertilisation of AS and AJ gametes could result in disrupted oocyst formation; if this was 
true, I would expect fewer oocysts to be AS/AJ cross-progeny than of the parental types, 
which is testable by genotyping individual oocysts (Ranford-Cartwright et al. 1991; Taylor 
et al. 1997a). Another possibility is that AS and AJ clones competed through interference (as 
observed in bacteria, see for example Riley & Gordon 1999) by excreting some substances 
that had negative effects on gametocyte infectivity or sporogonic development of the other 
clone. Finally, mixed infections could have affected mouse blood in such a way that 
mosquitoes took smaller blood meals or blood meals of lower quality (Ferguson et al. 
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2003a), effectively reducing the number of gametocytes. This could not have been because 
mixed infections were more anaemic, because mixed infections did not have lower red blood 
cell densitiesthan single infections on the mosquito feed days. Higher anaemia also could 
not explain that CBA mice infected fewer mosquitoes: only on one of the feed days (day 14) 
did they have fewer red blood cells than C57 mice. 
The analysis of this experiment was made difficult by the fact that not many mosquitoes 
became infected, and that a lot of infected mosquitoes were not PCR positive, let alone had 
high numbers of sporozoites that could be reliably analysed. Ookinete (Beier et al. 1992) and 
oocyst numbers in the field (Pringle 1966; Beier et al. 1987; Billingsley et al. 1994) are 
usually very low and lower than in the lab (Medley et al. 1993). However, the oocysts that 
are present generally contain many sporozoites, in the order of thousands (Pringle 1966; 
Beier et al. 1987). In contrast to this study, in which oocyst positive mosquitoes were often 
PCR negative, real-time PCR detected P. falciparurn parasites in A. stephensi mosquitoes 
when oocysts were not visible microscopically (A.S. Bell, unpublished results). It thus seems 
that the oocysts observed here had either very low sporozoite numbers, were degrading, or 
had not yet developed properly. Perhaps if I had analysed the oocysts a few days later, more 
sporozoites would have been present, but it is also possible that the poor transmission 
observed in the current study is an effect of the serial passaging of the clones used prior to 
the experiment. 
Serial passaging in many parasites results in a reduction of the parasites' ability to transmit 
properly and efficiently (Ebert 1998), and certainly occurs in in vitro passaged P. falciparum 
isolates (Day et al. 1993). It also happens in P. chabaudi parasites that are blood-passaged 
from mouse to mouse, circumventing mosquito transmission (A.S. Bell, unpublished 
results): when a heavily blood passaged and poorly transmitting P. chabaudi line was 
transmitted through mosquitoes only once, it reverted to its original wildtype's ability to 
transmit properly and efficiently (A.S. Bell, unpublished results). If this was the case for 
clones AS and AJ as well, the described experiment could be repeated with mosquito 
passaged AS and AJ lines, possibly resulting in more infected mosquitoes and higher 
numbers of sporozoites. Such an experiment could then be used to more robustly confirm the 
conclusions drawn here. This is certainly necessary: that mixed infections were less 
infectious than single infections is a finding that is not predicted by any of the existing 
evolutionary models. As such, this study illustrates the great need of experimentally testing 
widely held theoretical assumptions. 
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7. Competitive release of drug resistance following drug treatment of 
mixed malaria infections 
Published as: De Roode, J. C., Culleton, R., Bell, A. S. & Read, A. F. 2004 Competitive release of 
drug resistance following drug treatment of genetically diverse Plasmodium chabaudi infections. 
Malaria Journal 3:33. (See Thesis Appendix) 
7.1. Abstract 
Malaria infections are often genetically diverse, potentially leading to competition between 
co-infecting strains. Such competition is of key importance in the spread of drug resistance. I 
studied the effects of drug treatment on within-host competition using the rodent malaria 
Plasmodium chabaudi. Mice were infected simultaneously with a drug-resistant and a drug-
sensitive clone and were then either drug-treated or left untreated. In the absence of drugs, 
the sensitive clone competitively suppressed the resistant clone and reduced its transmission 
to the mosquito vector. Drug treatment, however, allowed the resistant clone to fill the 
ecological space emptied by the removal of the sensitive clone, allowing it to transmit as 
well as it would have done on its own. These results show that under drug pressure, resistant 
strains can have two advantages: (1) they survive better than sensitive strains and (2) they 
can exploit the opportunities presented by the removal of their competitors. When mixed 
infections are common, such effects could increase the spread of drug resistance. 
7.2. Introduction 
Malaria infections often consist of more than one parasite genotype (e.g. Snewin et al. 1991; 
Daubersies et al. 1996; Babiker et al. 1999). Humans represent ecological niches for co-
infecting malaria parasites, with shared predators (immune responses) and limited resources, 
so that competition between co-infecting malaria strains is likely to be intense (Read & 
Taylor 2001). Such competition could strongly affect the relative transmission of drug-
resistant strains, and thus the spread of drug resistance (Hastings & D'Alessandro 2000). 
Resistant and sensitive strains will co-occur in the same host both when resistance mutations 
first arise de novo, and when hosts acquire resistant and sensitive strains from one mosquito 
bite simultaneously or from different mosquito bites. In the absence of drug treatment, the 
transmission success of the resistant strain will depend on its intrinsic fitness and competitive 
ability. However, if drug treatment does occur, the resistant strain has two potential fitness 
advantages. First, it will better survive the drug than the sensitive strain. Second, treatment 
can remove drug-sensitive competitors, thus freeing up ecological space for the resistant 
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strain to occupy. This second effect, well recognised in theory, has the potential to greatly 
enhance the rate of spread of drug resistance in a population (Hastings & D'Alessandro 
2000). However, there is no direct experimental evidence that removal of competitors by 
drug treatment does enhance the transmission of drug-resistant parasites. Here I report what 
I believe to be the first experimental demonstration that competitive release of drug-resistant 
strains can occur following drug treatment. 
I studied mixed infections of drug-sensitive and -resistant malaria clones of the rodent 
malaria Plasmodium chabaudi. This parasite is commonly used as a model for human 
malaria (Cox 1988), and has been extensively used to study drug resistance (Carlton et al. 
2001). In the absence of drugs, the drug-resistant strain has been shown to suffer from 
competition from a -sensitive strain (Chapters 3-6, De Roode et al. 2004b [Thesis 
Appendix]). Here, I compare competition between the two strains in drug-treated and 
untreated mice. 
7.3. Material and methods 
I used two genetically distinct Plasmodium chabaudi chabaudi clones: AS(pyrlA), which is 
resistant to the antifolate drug pyrimethamine (Walliker et al. 1975), and AJ, a. sensitive 
clone. Hosts were eight weeks old CBA/Ca inbred female mice (Ann Walker, University of 
Edinburgh; Harlan, England). Two experiments were performed. In the first, two groups of 
five mice were infected with 106  AS parasites, and two groups with 106  AS + 106  AJ 
parasites, as described in Chapter 4. One group from each of these two infection types was 
drug-treated within three hours of inoculation and again on days 1, 2 and 3 PT (post-
infection), using an oral administration of 8 mg pyrimethamine per kg mouse body weight. 
The untreated mice are the same ones as described in Chapter 4. 
I monitored asexual parasite densities and gametocyte densities - the latter being the 
transmission stages to the mosquito - as described in Chapter 4. Real-time quantitative PCR 
was used to distinguish and quantify AS and AJ parasites in mixed infections (Chapter 2, 
Cheesman et al. 2003; De Roode et al. 2004b [Thesis Appendix]). This protocol cannot 
distinguish between asexual parasites and gametocytes, but I used real-time PCR data as 
estimates of asexual densities: gametocyte densities were 2-3 orders of magnitude lower than 
asexual densities and thus a negligible component of overall parasite numbers. For each 
infection, I defined the acute phase as that involving the first wave of parasites, and the 
chronic phase as beginning when parasite numbers recovered after the collapse of the first 
wave around day 12. All parasites had disappeared below detectable levels after 50 days. 
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In the second experiment (the experiment described in Chapter 6), two groups of nine mice 
were infected as above with either AS parasites or AS+AJ parasites. The subsequent 
transmission success of AS was assayed by allowing batches of 30 starved Anopheles 
stephensi mosquitoes to feed on 3 mice from each group on each of days 7, 14, and 21 PT, as 
described previously (e.g. Ferguson et al. 2003b). Eight days after the feeds, mosquitoes 
were dissected, and DNA was extracted from midguts carrying oocysts. Real-time 
quantitative PCR was subsequently used to determine the prevalence of AS in these 
mosquitoes. 
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Figure 7.1. Log asexual AS parasite densities over time in untreated (A) and drug-treated (B) mice 
infected with AS alone or a mixture of AS+AJ, and total numbers of AS parasites produced over acute 
(C) and chronic (D) phases. All data points (mean ± 1 s.e.m.) are based on 5 replicate mice, except for 
mixed infections in untreated mice in (A) (4 mice on day 11 and 3 mice from day 12 onwards) and (C) 
and (D) (3 mice). As the limit of detection was 100 parasites per jsl blood, y-axes in (A) and (B) start 
at2. 
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7.4. Results 
Two untreated mice infected with AS+AJ died on days 10 and 11 P1 respectively, and were 
excluded from the analysis. 
In untreated mice, AS produced far fewer parasites during the acute phase in mixed 
infections with AJ than it did alone (Figures 7. 1A, Q. However, in drug-treated mice, where 
AJ was entirely removed by pyrimethamine (none of the PCR reactions performed were 
positive for AJ), AS produced as many parasites in mixed infections as it did alone (Figures 
7.113, C; Drug treatment x Alone/Mixed interaction: F 1 , 14=14.4, p=0.002). Thus, AS was 
competitively suppressed in mixed infections in untreated mice, but this suppression was 
negated when mice were treated with pyrimethamine, which effectively removed AJ. 
During the chronic phase, AS was more numerous in untreated mice in mixed infections than 
in single-clone infections (due to the parasite peak around day 21; Figures 7.1A, D). Thus, 
in untreated mice in the chronic phase, AS did not suffer from competition, and actually 
benefited from the presence of AJ (facilitation). In drug-treated mice, however, AS parasites 
were similarly numerous in mixed- and single-clone infections (Figures 7.113, D; Drug 
treatment x Alone/Mixed interaction: F 1 , 14=13.8, p=0.002). 
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Figure 7.2. Log gametocyte densities over time (mean ± 1 s.e.m.) for untreated (A) and drug-treated 
mice (B) respectively. In (A) gametocyte densities for mixed AS+AJ infections reflect overall AS+AJ 
gametocytes, as the real-time PCR assay does not distinguish between these (see text); in (B) all 
gametocytes are produced by AS, as AJ was cleared from mixed infections. All data points are based 
on 5 replicate mice, except for mixed infections in untreated mice in (A): 4 mice on day 11 and 3 mice 












Chapter 7— Competitive release of drug resistance 	 120 
The large peak of AS parasites in the chronic phase in the untreated mixed infections around 
day 21 (figure 7.IA) coincided with a large peak of gametocytes, the transmissible stages of 
the parasite (figure 7.2A). This was in contrast with single AS infections in untreated mice, 
and infections in drug-treated mice, where gametocytes were mainly produced around day 14 
(figures 7.2A, B). Overall, gametocyte numbers were the same for all four infection types 
(p>0.05 for both Drug treatment and Alone/Mixed). Whether AS really suffered from 
competitive suppression by Ai in untreated mice thus depends on how many of the 
gametocytes around day 21 were of the AS genotype, and on how transmissible they were. 
The second experiment assayed transmission to mosquitoes on days 7, 14 and 21 P1. I found 
that AS infected far fewer mosquitoes from mixed infections than from single infections 
(Figure 7.3; Alone/Mixed: p=0.002), indicating that gametocytes produced around day 21 
had a low transmissibility, probably as a result of transmission-blocking immunity 
(Naotunne et al. 1990). Thus, the competitive suppression of the resistant clone in untreated 













Figure 7.3. Proportions of AS infected mosquitoes that fed either on mice infected with AS alone or 
mice infected with a mixture of AS+AJ (mean and 95% confidence interval) in the second 
experiment. Means are based on 9 mice (3 on day 7, 3 on day 14 and 3 on day 21 P1) from which 
totals of 205 (AS alone) and 216 (mixed AS+AJ) mosquitoes took a blood meal. Infection with AS 
was assessed by real-time PCR. 
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7.5. Discussion 
These results show that drug treatment of malaria infections can severely affect ecological 
interactions between co-infecting strains. The drug-resistant clone was competitively 
suppressed by the drug-sensitive clone in untreated mice, in terms of both within-host 
growth and transmission to the mosquito vector. However, drug treatment removed that 
competitive suppression, and allowed the resistant clone to fill the ecological space emptied, 
giving it a substantial and additional fitness benefit in addition to the simple survival 
advantage conferred by resistance. Thus, under drug pressure, resistant strains can have two 
advantages: they survive better than sensitive strains and they can exploit the opportunities 
presented by the removal of their competitors. I studied competition between two unrelated 
clones, and thus not the situation in which a resistant clone arose de novo (White & 
Pongtavornpinyo 2003), but it seems likely that the competitive release following drug 
therapy would also apply there. 
Competitive release following drug treatment will greatly enhance the spread of drug 
resistance (Hastings & DAlessandro 2000). Also, with only the resistant strain left in the 
host, the probability of outbreeding is reduced, thus reducing the chances of meiotic 
recombination destroying multi-locus resistance (Dye & Williams 1997). In combination, 
these two processes could enhance the spread of drug resistance, especially in areas with 
high numbers of strains per infection (Hastings & DAlessandro 2000). 
Of course, this is an argument for judicious use of drugs, not their non-use. Clearance of 
drug-sensitive strains from mixed infections might enhance the spread of drug resistance, but 
this has to be offset against the short-term public health benefits, such as reducing overall 
malaria prevalence. In these experiments, AJ was also the more virulent clone (Chapters 3, 4 
and 6. De Roode et at. 2004b [Thesis Appendix]), and when it was cleared from mixed 
infections by drug treatment, mice were less sick (results not shown). 
Mice were drug-treated before symptoms occurred, resulting in competitive release. This 
situation perhaps best mimics the case of prophylactic drug use, or what might occur to new 
co-infections in high transmission areas where drug use is common. Many more complex 
experiments will be necessary to determine if competitive release occurs when treatment 
follows symptoms, and in semi-immune individuals. The facilitation observed in chronic 
infections (Figures 7.1A, D) suggests the situation might be very complex. 
Within-host competition in P. chabaudi is now firmly established (e.g. Snounou el al. 1992; 
Taylor et al. 1997a; De Roode et at. 2004b [Thesis Appendix]). Evidence for competition 
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between coinfecting genotypes in human malaria infections is necessarily indirect, but 
consistent with this (Read & Taylor 2001). In older children and adults, for example, parasite 
densities do not increase with increasing numbers of clones, thus indicating that parasite 
clones are not regulated independently (Smith et al. 1999a). Given this, and the high 
frequency of mixed infections in human malaria (e.g. Snewin et al. 1991; Daubersies et al. 
1996; Babiker et al. 1999; Felger et al. 1999) often consisting of both resistant and sensitive 
genotypes (Babiker et al. 1991b), and the fact that genetic diversity can be altered by 
antimalaria prophylaxis (Beck et al. 1999), it is highly likely that what I have observed in a 
rodent model also occurs in human malaria. Indeed, a recent study has already implicated 
release of within-host competition as a key-factor in the spread of drug resistance in Uganda 
(Talisuna et al. 2003). 
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8. General discussion 
Full discussions of specific findings have been provided with each chapter. Here, I highlight 
some general themes, conclusions, and practical applications. I also discuss some possible 
future directions. 
8.1. Findings 
The thesis started off with a quest to find a method to quantify different malaria genotypes in 
mixed infections. It was found that quantitative real-time PCR was a good technique to do 
this, providing accurate estimations of the clonal densities of different Plasmodium chabaudi 
strains in the blood of laboratory mice (Chapter 2, Cheesman et al. 2003 [Thesis Appendix]). 
This method is especially useful, since it relies on sequence polymorphisms between 
different clones: as such polymorphisms are known for a whole suite of P. chabaudi clones, 
the technique can be transferred to different clone combinations, something that is now well 
under way (A.S. Bell, unpublished results). 
Real-time PCR was then used to ask which biological factors are important determinants of 
within-host competition between malaria strains. Using three clones with very similar 
genetic backgrounds, but differing in their virulence, I showed a relationship between 
virulence and competitiveness (Chapter 3), as generally assumed by theoretical models on 
the evolution of virulence. Virulence was certainly not the only determinant of within-host 
competition, however, as shown by subsequent chapters. Chapters 4 (De Roode et al. 2004b 
[Thesis Appendix]) and 6 showed that host genotype is an important factor too: in resistant 
C57 mice, an avirulent clone was rapidly competitively excluded by a virulent clone, 
whereas in less resistant CBA mice it persisted and indeed overgrew the virulent clone latr 
on during the infection. In Chapter 5, using two different pairs of clones, I showed that 
timing of infection is also crucially important. Clones generally did not suffer from 
competition when infecting mice first; but they did when infecting mice simultaneously with, 
or later than their competitor. Most strikingly, sequential infection could turn over 
competitive hierarchies completely, so that clones that were the inferior competitor in 
simultaneous co-infections, were the dominant competitor if they infected mice first. 
I studied the result of within-host competition on between-host transmission (Chapter 6), 
showing that competitive suppression in the mammalian host translated into a proportional 
reduced transmission to the mosquito vector. This suggests that the observed competitive 
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suppression of avirulent P. chabaudi clones in Chapters 3-5 would indeed have resulted in 
reduced transmission to the mosquito vector. 
Tentatively, I conclude that these experiments confirm that within-host competition plays an 
important role in the evolution of virulence, as suggested by a large body of theoretical 
studies: virulent clones were competitively superior to avirulent parasites (Chapter 3), and 
competitive superiority most likely translated into transmission to the mosquito vector 
(Chapter 6). This suggests that where mixed infections are common - as is the case with 
malaria - virulent parasites should be selected for; the result would be evolution towards 
increased disease severity. Chapters 4 and 5 would also support this view: even though an 
avirulent clone persisted in CBA mice, and overgrew a virulent clone later during the 
infection (Chapters 4, 6), this did not result in increased transmission (Chapter 6). Also, even 
though the avirulent clone became competitively dominant when infecting mice before the 
virulent clone (Chapter 5), over all the infections studied it did relatively worse than the 
virulent clone. These results thus suggest that overall, virulent clones had a competitive 
advantage. 
8.2. Different clones: a different story? 
One of the major caveats of this thesis is that it is based on a limited number of parasites, 
mostly using AS and AJ clones (but see Chapter 5). Now that real-time quantitative PCR has 
proven to be an accurate technique, useful for the study of mixed malaria infections, it is 
time to move on to study more mixed infections consisting of different clone. 
Further study using different clones is certainly necessary. As became clear in Chapter 5, it is 
not only the relative virulence of clones that determines competitive dominance, but also 
how antigenically different they are. It was suggested that competition between clones that 
are controlled by very similar immune responses should be stronger than competition 
between clones that are controlled by very different immune responses. 
Evidence that antigenic diversity of mixed infections is indeed important comes from a 
comparison of results obtained with different experiments using different P. chabaudi clone 
combinations. Infections consisting of clones CR and ER, for instance, were more virulent to 
mice than infections of either CR or ER alone (Taylor et al. 1998), and also infected more 
mosquitoes (Taylor et al. 1997b). This is in contrast with mixtures consisting of AS and AJ, 
as described in this thesis, which were as virulent as the virulent clone AJ (results not shown) 
and which infected fewer mosquitoes than single-AS or -AJ infections (Chapter 6). These 
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apparent contradictions could be explained by the fact that CR and ER are antigenically 
different, whereas AS and AJ are antigenically similar. Experiments have shown that mice 
immunised with CR are better protected against CR than against ER and that mice 
immunised with ER are better protected against ER than against CR (Buckling & Read 
2001). This was not only true for asexual parasites, but also for transmissibility to the 
mosquito: thus, CR gametocytes in ER-immunised mice were more transmissible than in 
CR-immunised mice, and ER gametocytes were more transmissible in CR-immunised mice 
than in ER-immunised mice. In contrast to clones CR and ER, AS and AJ are probably 
controlled by more similar immune responses; this assertion is based on the fact that mice 
immunised with AS cleared AJ almost as effectively as AS, and mice infected with AJ 
cleared AS almost as effectively as AJ (S.J. Cheesman, pers. comm.). Indeed, I found 
(Chapter 5) that mice infected with AS first and then with AJ 3 or 11 days later, had lower 
parasite densities than those with AJ alone, showing a protective effect of AS infection 
against AJ infection. 
The implication is that a mouse infected with CR and ER will have to mount two specific 
immune responses simultaneously, a process that could be more costly than mounting one 
response only, thus causing increased virulence (Taylor et al. 1998), or less effective,, thus 
causing mixed infections to become more transmissible (Taylor et al. 1997b). That mice 
indeed have trouble mounting two effective immune responses simultaneously is supported 
by the fact that when starting as the minority clone, both CR and ER eventually overgrew 
their competitor in mixed infections, presumably because the mouse's immune system 
focused on the initial majority clone (Taylor et al. 1997a). In contrast with CR and ER, 
clearing AS and AJ simultaneously is no more costly or less effective than clearing AS or AJ 
alone: the result would be virulence as high as the most virulent single infection, and no 
enhanced transmission to mosquitoes, exactly as observed. 
Using clones AS and CB, regulated by distinct immune responses, also suggested that 
antigenic diversity is important. It was shown that mice infected with CB 3 days after AS 
experienced more parasites than those infected with AS alone (Chapter 5), apparently 
because the immune system focused on AS, thereby not being able to control CB 
simultaneously. The fact that the reverse did not happen - AS being able to 'invade' mice 
'already infected with CB - shows that the situation may be very complex, and only 
strengthens the claim that more study on this subject is needed. 
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8.3. Practical implications: Darwinian medicine 
Some scientists - notably those building atomic bombs - argue that science should only be 
about having fun, about having pleasure in finding things out (Feynman 1999). However, 
with the current climate of governments cutting down on scientific funding, such a view may 
be hard to maintain. So does the presented research have any practical implications? 
8.3.1. Reducing clone multiplicity 
For quite some time now, scientists have argued that understanding how diseases evolve 
should help us in designing ways to control them (Ewald 1980; Williams & Nesse 1991; 
Ewald 1994; Nesse & Williams 1994; Stearns 1999; Zimmer 2003). Thus, understanding 
why malaria is virulent could help in designing ways to make it less virulent, to - as some 
have put it - tame it (Zimmer 2003), or at least to not make it worse. As many theoreticians 
assert that within-competition between parasite strains drives the evolution of virulence 
upwards, it has been suggested that reducing clone multiplicity should have favourable 
consequences (e.g. Adler & Mosquera Losada 2002; Galvani 2003). This is because a lower 
incidence of mixed infections should result in less within-competition and therefore less 
selection for increased virulence. Based on the results in this thesis, suggesting that within-
host competition indeed drives evolution upwards, it seems plausible that reducing clone 
multiplicity could have beneficial effects for global malaria burdens. 
This is probably good news, as prophylaxis and drug treatment have been shown to reduce 
clone multiplicity (Beck et al. 1999; Basco & Ringwald 2001), and so has use of the 
experimental Spf66 vaccine in Tanzanian and Gambian children (Beck et al. 1997; Haywood 
et al. 1999); intuitively one would also expect insecticide impregnated bed nets to reduce 
clone multiplicity, but this is not always the case (Fraser-Hurt et al. 1999). It must be noted, 
however, that reductions of clone multiplicity could also have negative consequences: it has, 
for example, been suggested that clone multiplicity is an important factor in building up 
acquired immunity against malaria, and a reduction of clone multiplicity could interfere with 
this (e.g. Beck et al. 1997; Snow et al. 1997; Beck et al. 1999; Basco & Ringwald 2001). 
Moreover, the actual presence of circulating strains could directly interfere with the 
establishment of others (Smith et al. 1999b), so that reducing clone multiplicity could result 
in higher disease incidence. 
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8.3.2. Vaccination 
It has been suggested that vaccination could have beneficial effects on the evolution of 
virulence. This is because vaccination would reduce the number of susceptible people, 
thereby reducing the occurrence of super-infection, and thus within-host competition, 
consequently leading to reduced virulence (Nowak & Sigmund 2002). However, this 
argument is based on the assumption that vaccines are perfect, completely preventing• 
infection with a pathogen. 
Future malaria vaccines, however, may well be imperfect, reducing malaria burdens and 
symptoms, but not preventing infection. Four types of malaria vaccine are currently 
recognised: infection- and transmission-blocking vaccines, and anti-disease and -parasite 
vaccines. Of these, anti-disease and -parasite vaccines will most likely result in immunity 
that suppresses parasite densities or reduces disease, but does not prevent infection. As both 
suppression of parasite densities and reducing disease symptoms could artificially negate the 
evolutionary costs of high parasite growth rate (i.e. killing the host before transmission is 
realised), it has been suggested that these vaccines could select for increased virulence 
(Gandon et al. 2001; Gandon et al. 2003; Read et al. 2004). Experimental studies have now 
shown that serial passage of P. chabaudi parasites in immune hosts results in more virulent 
parasites than serial passage in naive hosts (Mackinnon & Read 2004a), supporting this 
claim. The most likely explanation for this is that virulent parasites are selected for because 
they are competitively superior to avirulent parasites (Chapter 3): that they have an even 
greater relative advantage in immune hosts, supports the idea that virulent parasites may 
have a stronger competitive advantage in resistant hosts, as made in Chapter 4. 
Further experiments to test this assertion directly using mixtures of parasites in vaccinated 
and unvaccinated hosts would be important to predict the consequences of vaccination on the 
evolution of virulence. Even though an avirulent clone suffered more from competitive 
suppression in a resistant mouse strain than in a susceptible strain (Chapter 4), it did actually 
not suffer more transmission loss than from the susceptible strain (Chapter 6), confirming 
that more study is needed. 
8.3.3. Drug resistance 
In Chapter 7 (De Roode et al. 2004a [Thesis Appendix]), I showed that competitive 
interactions can be drastically altered by drug treatment. Thus, in the absence of drugs, a 
drug-resistant clone was competitively suppressed by a drug-sensitive clone, so that it 
Ri 
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obtained far lower transmission than it would have done alone. Drug treatment, however, 
removed the superior drug-sensitive competitor, leaving the resistant clone to fill up the 
ecological space thus emptied. It has been suggested that such competitive release could 
strongly enhance the spread of drug resistance (Hastings & DAlessandro 2000), especially 
in areas where mixed malaria infections are common. This suggests that, under certain 
circumstances, it would be wiser not to use drugs, so as to prevent the enhanced spread of 
drug resistance. Of course, the benefits of drug use for the individual should be offset against 
the risks for society. 
8.4. Future directions 
Research is never really finished, and the results described in this thesis may lead to many 
new questions, such as the following. 
First, as already discussed in detail, it would be important to study competition using 
different combinations of clones, to find out how generally virulent clones are competitively 
superior to prudent clones. As I am writing this thesis, experiments are already underway to 
address this question, using 4 different clones (AS, CW, AJ, AT), resulting in 6 different 
clone combinations (AS+CW, AS+AJ, AS+AT, CW+AJ, CW+AT and AJ+AT; A.S. Bell, 
J.C. de Roode & A.F. Read, unpublished results). 
Second, it could be asked how important the immune system is in mediating within-host 
competition. If immune-mediated competition were indeed important, then we would expect 
human interventions such as vaccination to have a large impact on within-host competition 
and the subsequent evolution of virulence. This question is also already being addressed by 
studies on competition between AS and AJ in mice with or without intact T-cell repertoires 
(L. Râberg, J.C. de Roode & A.F. Read, unpublished results). 
Third, within-host competition should be studied in semi-immune mice. So far, I have 
studied competition in naive mice, but in malaria-endemic areas, many, if not all, people are 
semi-immune. As different clones will be affected to different extents by pre-existing 
immunity, this could strongly affect the outcome of within-host competition. Experiments 
could be done with mice immunised with P. chabaudi, followed by drug-treatment (e.g. 
Mackinnon & Read 2003; 2004a), or indeed with mice immunised with blood-stage vaccines 
(K. Grech, R. Anders, S.J. Cheesman R. Carter & A.F. Read, unpublished results). Such 
experiments could also be used to ask whether host resistance results in stronger within-host 
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competition. Different mouse strains with different levels of resistance could also be used to 
address this question. 
Fourth, besides repeating the experiment on within-host competition and between-host 
fitness (Chapter 6), competition between malaria clones could be studied over the whole 
course of the malaria life cycle, including all stages in the mosquito vector. This would be 
important, because parasites with different host species in their life cycle are often 
constrained in their evolution by traits that might have different optima in different hosts 
(Gandon 2004). There is, for example, no relationship between P. chabaudi parasite 
virulence in mouse and mosquito (Ferguson et at. 2003b), and the same could be true for 
competitiveness. Competition in the mosquito is probably very strong: it has been claimed 
that naturally infected Anopheles gambiae mosquitoes usually do not carry more than 5 
oocysts, and that parasite transmission through the mosquito is so tenuous that as little as 
five parasites survive (Sinden 2002); many mosquitoes that become infected with P. 
falciparum indeed never obtain salivary gland infections (Beier et at. 1990), and mosquito 
salivary glands have been shown to harbour fewer parasite genotypes than midguts (Arez et 
at. 2003). 
Fifth, it would be important to design field studies to test whether within-host competition is 
also a driving force for virulence evolution in human malaria populations; this would also be 
a necessity to support the practical implications of this thesis as outlined above. One way to 
do this would be to study several areas, some with a high and some with a low incidence of 
mixed infections. It could then be asked whether, on average, parasites from areas with many 
mixed infections are more virulent than those from areas with fewer mixed infections. One 
problem with such studies would be how to measure parasite virulence ethically. Host 
factors, such as mutations conferring resistance to malaria infection (Cockburn et at. 2004), 
also affect disease severity; and even groups of people that live geographically close together 
in areas with different incidences of mixed infections can have dramatic differences in their 
susceptibility to malaria (Paganotti et al. 2004), obscuring parasite virulence effects. One 
way around this problem would be to isolate malaria strains from people living in different 
areas and to study in vitro correlates of virulence instead, such as multiplication rate 
(Chotivanich et at. 2000) and rosetting (Rowe et at. 1995). In due course, when parasite 
virulence phenotypes can be related to specific genes, frequencies of those genes could also 
be used to test whether virulence genes are more strongly selected in areas with high rather 
than low incidences of mixed infections. 
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Finally, it would be crucial to study within-host competition in different host-parasite 
systems. This thesis presented the first experiment thus far to test for a relationship between 
virulence and within-host competitiveness; for a real progress in the field of virulence 
evolution, however, such a relationship needs to be studied in different host-parasite systems 
as well. Only if a relationship between virulence and competitiveness generally exists for 
different parasite species (so that Patricks Nasty play a more general role than in rodent 
malaria alone), can we conclude that within-host competition is an important factor in the 
evolution of virulence. Only if that is true, will it make sense to even try to predict the 
consequences of human interventions on the subsequent evolution of virulence. In my view 
therefore, a recent publication questioning whether virulence evolution theory could be used 
to 'tame our pathogens' (Ebert & Bull 2003; Zimmer 2003) is dramatically premature, and 
very likely based on a lack of empirical data. 
In conclusion, this thesis has given us some answers, but raised a lot more questions. Not 
that that is a bad thing; indeed, as Theodosius Dobzhansky once remarked (1973): "Imagine 
that everything is completely known and that science has nothing more to discover: what a 
nightmare!" 
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IFA control experiments and correction factors 
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calculate AS and GB parasite densities in Chapter 5) 
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Schematic clone history of parasites used 
Wild-caught 	 Wild-caught 	 Wild-caught 
thicket rat I I 	thicket rat I I 	thicket rat 
Isolate AS 	 Isolate AJ 	 Isolate CB 
	
Cloning 	 Cloning 	 Cloning 
Clone AS 
('ASmoderate ') 	I I 	Clone AJ 	 Clone CB 
Pyrimethamine 
selection 
Clone AS(pyrl A) 
('ASaviruient') 
Passage through thicket 
rats, mice and 
mosquitoes 
Clone AS(pyrl B) 
('ASvi ru ient') 
Clones were used as follows. 
Chapter 2: AS, AS(pyrlA) (sometimes denoted AS) and AJ 
Chapter 3: AS, AS(pyrlA), AS(pyrlB) (denoted AS moderate , ASav iruient and ASvjm ient), and AT 
Chapter 4: AS(pyrlA) (denoted AS) and AJ 
Chapter 5: AS and CB; AS(pyrlA) and AJ 
Chapter 6: AS(pyrlA) (denoted AS) and AJ 
Chapter 7: AS(pyrlA) (denoted AS) and AJ 
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IFA control experiments and correction factors 
A. F. Read' * & M. A. Anwar 2 
Institutes of Evolution, Immunology and Infection Research, School of Biological Sciences, 
University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK 
Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3P5, UK 
Background 
Immuno-fluorescent antibody assays (IFA) can generate a biased estimate of the ratio of the 
two clones (Taylor et al. 1997). This may be for a number of reasons. First, the antibodies 
may vary in their affinities to their respective protein targets. Second, the expression of the 
target antigen may differ between clones. The timing of schizogony, and presumably 
therefore the expression of MSP- 1, the target antigen, are known to differ between AS and 
CB (McLean 1986). Finally, there may be some perceptual bias when counting positive 
parasites fluorescing at different wavelengths and intensities. To test for any biases, we 
performed a number of control experiments, where we mixed known concentrations of 
parasites and compared the ratio obtained from WA with that of the mixture. 
Materials and methods 
To investigate any biases in the estimates of clonal frequencies obtained by IFA, volumes of 
blood from mice infected with known concentrations of AS or CB parasites were mixed in 
vitro to generate samples with a range of known clonal frequencies. We then independently 
estimated those frequencies by WA and compared them with the 'expected' frequencies. 
Note that these 'expected' values are themselves not without error. Much of this error will be 
random (e.g. noise in pipetted volumes), but where blood from a single mouse is used to 
generate a series of mixtures, error in the estimate of the concentration of parasites in that 
mouse will generate systematic differences for that series between the expected frequencies 
and those estimated by WA. To look for bias due to the WA, we thus need to look for 
consistent differences between observed and expected frequencies across a number of series 
of mixtures. 
Six separate series - hereafter referred to as trials - were conducted. In trials 1-3, infected 
blood came from a single mouse for each clone and was used to generate 14 or 15 different 
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mixtures. A different pair of mice was used in each of the three trials. A further three trials 
went as follows. Blood was taken from four donor mice for each clone and used to generate 
7 or 8 different mixtures, with the blood from any one mouse being used in a maximum of 
two mixtures. This entire procedure was then repeated one hour and then two hours later on 
the same eight mice to generate a total of three separate series of mixtures (trials 4-6 below). 
Thus, the potential problem of introducing consistent bias into the values of the 'expected' 
clone frequencies though non-independent estimates of parasite concentration varies 
somewhat between the trials. In what follows, we take the conservative view, and report 
results for all 67 mixtures and separately for the mixtures within each trial. 
In all trials, mice were bled 1130 and 1330 hrs GMT, smears made, blood count samples 
made, then 0.5m] of blood was mixed with PBS, and mixtures made from that. These 
mixtures were then rinsed and pipetted onto multispot slides, and clonal frequencies 
estimated by WA exactly as described for the experimental samples. Mixtures ranged from 
1.5% to 92.4% CB. 
Results 
The frequency of CB was overestimated by WA for 88% the mixtures - all of the mixtures in 
trials 1 and 3, all but one of the mixtures in trials 4-6, and 11 of the 15 mixtures in trial 2 
(Figure 1). On average, the frequency of CB was overestimated by 10.7% (95% c.i. 7.9-
13%). The magnitude of the overestimate was uncorrelated with the total number of parasites 
scored by WA, or the expected proportion CB. 
Whatever the cause of this bias, we can correct for it statistically. We seek a method of 
adjusting the proportion of WA positive parasites that were scored as CB (PCBIFA), such that 
the adjusted proportion (PCBIf a.ad) and expected proportion (pCB,) are on average equal - 
i.e. are related by a linear OLS regression with a slope of 1 and and intercept of zero. This 
was done using the relationship 
PCBiFAadj = m / [m + n(2.49 -0.005n)] 	 (1) 
where m is the number of CB positive parasites counted and n the number of AS positive 
parasites. The derivation of (1) is outlined in the Appendix. Using the values so obtained, 
gives the least squares regression 
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PCBMIX = 1.01* (PCBWAa1j ) - 0.008, 	 (2) 
a relationship which is not significantly different from the required pCB A = PCBIFA. adj (95% 
c.i. intercept: -0.05-0.03; slope: 0.922-1.098). When the WA data were adjusted using 
equation (1), there was no evidence any consistent difference between observed and 
expected pCB, with 33 overestimates and 34 underestimates (mean difference (±s.e.) 
between PCBIF A .adj and pCB =0.004 ±0.082, t66 = .373, p=0.71). Thus, observed clonal 
proportions adjusted using (1) equal expected clonal proportions, on average (Figure 2). 
The data from these control experiments also gives some estimate of the accuracy of the 
clonal frequencies estimated by WA and equation 1. Much of the unexplained variance about 
the 1:1 line in figure 2 is explained by differences between experiments (F 5,=10.58, 
p<0.0001; adding experiment as a factor takes the r 2 of equation 2 from 0.89 to 0.99). 
Assume that the experiment effect arises from errors in the estimates of parasite 
concentrations used to calculate clonal frequencies in the mixtures. The within-experiment 
error then gives an indication of the accuracy of the corrected estimates of pCB, particular in 
trials 1-3 which contained no within-experiment variation in parasite concentrations. Within 
those three trials, and using the adjusted values, the mean (± s.d.) absolute deviation between 
expected and observed was 0.044 (±0.037), with half the estimates being less than 3% off the 
expected values and 90% being out by less than 8%. In fact, the accuracy maybe better than 
that: these estimates assume there is no error when making the mixtures themselves (e.g. that 
blood volumes are measured without error). 
Thesis Appendix - IFA control experiments 	 157 
Bivariate Scattergram 
Split By: expt 




















0 	.1 	.2 	.3 	.4 	.5 	.6 	.7 	.8 	.9 
obs from IFA prCB 
o Group for 15.600 
o Group for 27.400 
C) Group for 28.400 
o Group for 1130.000 
Group for 1230.000 
Group for 1330.000 
Figure 1. Proportion of parasites that were CB as estimated from IFA and the proportion expected, 
with data for each trial shown separately. Line is equality. 
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Figure 2. Filled squares = values corrected using (4); open circles = obs. uncorrected WA ratios. 67 
points, x-axis = corrected ratio, using (4); y=exp ratio from mixtures. 
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Derivation of Equation 1 
We begin by attempting to find regression equations relating the number of parasites IFA-
positive parasites of each clone to the number expected, given the frequency of each clone in 
the mixture and the total number of IFA-positive parasites. These regressions lines should 
pass through the origin and thus have the general form 
v=/3x , 	 (Al) 
where y is expected count, and x the observed count. Estimates of the slope fi can then be 
used to estimate the true count. 
The relevant data for CB are shown in Fig 3a. Armitage and Berry (1987 p.  272-273) give 
three methods of estimating fin this sort of situation. The OLS estimate of slope (b) 
assumes that the residual variance of y is independent of x, which is clearly inappropriate 
here. If the residual standard deviation of y increases in proportion to x, as it does here, the 
best estimate of /3 is b2 = (j'/x)/n. The average (±s.e.) value of b2 across the six trials is 
0.784 (±0.036), which in this case is in fact comparable to the OLS slope (0.81 ±0.036). 
Across all 67 mixtures, b2=0.772 and b=0.800. Thus, for clone CB, we can estimate the 
correct CB count as 
0.784*(IFA count of CB parasites) 	 (A2) 
The situation with the AS counts is not quite so simple, with a prounced curvilinear 
relationship between the number of AS-positve parasites counted and the number expected 
(Figure 3b). Indeed, the squared term in a least squares second order polynomial forced 
through the origin are significant across all the data and for five of the six trials. A variety of 
standard transformations did not satisfactorily linearise the relationship, so we seek the 
quadratic analogy of Al: 
y=/3x 
Here we take the least squares coefficients (b, c) as unbiased estimators off and y  Unlike 
the CB counts, the residual variance of y is independent of x for the AS data. Across all 
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points, there is no correlation between the observed counts and the absolute value of the 
residuals from the 2nd order polynomial (F j , 65  =0.68, p=0.41) or the squared deviations (17 1 , 65 
=0.13, p=0.72), and nor is there for any of the independent experiments (p>O.!S in all cases). 
The average (±s.e.) values of b' and c across the six trials are 1.95 (±.174) and -0.004 
(±001) respectively; the analogous values across all 67 mixtures are 1.72 and -0.003. 
Thus, for clone AS, we can estimate the correct AS count as 
1 .95*(IFA count of AS parasites) - 0.004*(JFA count of AS parasites) 2 . 	 (A3) 
Putting together (A2) and (A3) gives (1). 
A variety of other approaches were also tried. Models assuming the count of one clone was 
correct and attempting to adjust the other were unable to statisfactorily relate observed and 
expected frequencies. Another approach is to fit a quadratic forced through 0,0 and 1,1 to 
the observed and expected clonal frequencies (Taylor et al. 1997). This relationship has the 
form 
PCBMIX = PCBI FA + a * PCBIJA * (pCBIFA— 1) 	 (A4) 
and requires that we estimate the coefficient a However, values obtained by least squares 
either across all 67 mixtures (0.578) or by averaging the value obtained for each trial (0.5), 
or by taking the most extreme trial values (0.223, 0.959), all consistently generated 
relationships between adjusted pCB and expected pCB with slopes significantly less than 1. 
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Regression Plot 
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Figure 3: Observed number of IFA positive parasites of each clone against the number expected for 
all 67 control mixtures, for (a) clone CB and (b) clone AS. In both cases, the plotted lines are 
respectively, OLS first and second order polynomials forced through the origin. 
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SUMMARY 
We studied infection dynamics of Plasmodium chabaudi in mice infected with 3 genetically distinct clones - I less virulent 
than the other 2 - either on their own or in mixtures. During the acute phase of infection, total numbers of asexual 
parasites in mixed-clone infections were equal to those produced by the 3 clones alone, suggesting strong in-host 
competition among clones. During the chronic phase of the infection, mixed-clone infections produced more asexual 
parasites than single-clone infections, suggesting lower levels of competition than during the acute phase, and indicating 
that a genetically diverse infection is harder to control by the host immune system. Transmission potential over the whole 
course of infection was lower from mixed-clone infections than from the average of the 3 single-clone infections. These 
results suggest that in-host competition reduces both growth rate and probability of transmission for individual parasite 
clones. 
Key words: malaria, Plasmodium chabaudi, virulence, evolution, competition, mixed infections. 
INTRODUCTION 
Human malaria infections often consist of different 
parasite genotypes occupying the same host (Babiker 
et al. 1991; Conway, Greenwood & McBride, 1991; 
Arnot, 1998; Babiker, Ranford-Cartwright & Wall-
iker, 1999; Felger et al. 1999; Smith et al. 1999), but 
the effect of multiplicity on virulence is unclear (re-
viewed by Read & Taylor, 2001). Previous exper-
iments conducted in our laboratory with the rodent 
malaria model Plasmodium chabaudi have shown that 
mixed-clone infections with 2 parasite clones can re-
sult in higher virulence (Taylor, Mackinnon & Read, 
1998; Timms, 2001), and can leave transmission 
unchanged or even increased (Taylor, Walliker & 
Read, 1997; Tirnms, 2001). 
Here we studied experimental mixed infections of 
3 genetically distinct clones, 2 of which were viru-
lent, and the third avirulent. We infected laboratory 
mice with I of these clones, or with a mixture of them, 
to address the following questions: (i) is within-host 
growth of individual clones reduced by the presence 
of other clones, (ii) is transmission reduced by the 
presence of other clones, and (iii) do hosts experi-
ence more virulence from mixed infections than 
from single infections? 
* Corresponding author. Tel: +44(0)131 650 6468. Fax: 
+44 (0) 131 650 6564. E-mail: j.de.roode@ed.ac.uk  
MATERIALS AND METHODS 
Parasites and hosts 
We used 3 cloned P. chabaudi lines, denoted AS, AT 
and ER (Beale, Carter & Walliker, 1978), originally 
derived from different isolates from thicket rats. 
Between isolation from the field and use in this ex-
periment, AS, AT and ER had been blood passaged 
in mice 8, 7 and an unknown number of times, re-
spectively. These clones were chosen for their dif-
ferent growth rates and virulence, AS having a much 
slower growth rate and virulence than AT and ER 
which were similar (Mackinnon & Read, 1999). 
Hosts used for the experiment were 6-week-
old C57131/6 inbred female mice (B&K Universal, 
England), fed on 41B maintenance diet (Harlan, 
England) and drinking water supplemented with 
005 % para-amino benzoic acid (PABA) to enhance 
parasite growth (Jacobs, 1964). Mice were kept in a 
12:12 h light-dark cycle. 
Experimental design and inoculation of mice 
with parasites 
We used 2 main treatments. One treatment was 
single-clone infections of clone AS, AT or ER, the 
óthei one was mixedclone infections with-one: of-
the following clone ratios in the inocula: 8AS: 
IAT:IER, IAS:8AT:IER, IAS:IAT:8ER and 
I AS: I AT: I ER. We chose highly skewed ratios as 
well as an evenly distributed ratio, to see if starting 
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conditions were important for the outcome of compe-
tition. Inoculations consisted of the same total num-
ber of parasites (10 parasite-infected red blood cells 
in Oi ml) and were delivered i.p.; they were pre-
pared from donor mice by diluting blood in a calf-
serum solution (50% heat-inactivated calf-serum, 
50% Ringer's solution [27 miu KC1, 27 mivi CaC1 2 , 
015 M NaCl], 20 units heparin/ml of mouse blood). 
The single-clone infection of AS consisted of 4 mice, 
while all other groups consisted of 5. 
Monitoring of parasite densities and 
gametocyte densities 
Thin blood smears were made from tail blood every 
2 days from day 4-16, 3 times a week from day 24 
to 35 and twice a week from day 39 to 70 post-
inoculation (p.i.). After staining with Giemsa, the 
proportion of red blood cells infected with asexual 
parasites (parasitaemia) and gametocytes (gameto-
cytaemia) were counted microscopically using 1000 x 
magnification. When asexual parasitaemia was high, 
about 500 red blood cells were counted in at least 4 
microscopic fields, whereas with lower parasitaemias 
10 microscopic fields were counted for the number 
of parasites per field, and the average number of cells 
per field was calculated. Gametocytaemia was as-
sessed from approximately 50 microscopic fields 
(corresponding to 25-30 000 red blood cells), using 
polarized light, which highlights mature gameto-
cytes against a dark background. Red blood cell 
densities were estimated by flow cytometry (Coulter 
Electronics) from a 1: 50000 dilution of a 2 sl sam-
ple of tail blood into Isoton solution on days 0, every 
2 days from day 4 to 14, on days 17, 19 and 21 and 
then weekly from day 28 to 70 p.i. Asexual parasite 
density and gametocyte density were calculated from 
the product of red blood cell density and parasitaemia 
or gametocytaemia. On some days, parasitaemia, but 
not red blood cell density, was recorded, in which 
case the average red blood cell density on the pre-
vious and ensuing measurements was used for these 
calculations. 
Monitoring of virulence 
We used maximum weight loss and maximum red 
blood cell loss in the mouse as indicators of mor-
bidity, which has been shown to correlate with 
mortality (Mackinnon, Gaffney & Read, 2002). Red 
blood cell density was measured as described above, 
and mouse weights were recorded on days 0, 4, every 
day from day 6 to 14, days 17, 19, 21, 24 and weekly 
from day 28 to 70 p.i. 
Monitoring of clone dynamics using PCR-detection 
Samples of 2 ul of mouse blood from the tail were 
stored in 200 ul of PBS solution (BDH) until DNA 
extraction, 1-4 h later, using red blood cell lysis 
buffer (Boehringer). PCR was performed as de-
scribed by Taylor, Walliker & Read (1997), with the 
exception that we used 2 l for the outer reaction, 
and 3 1u1 of 10 x diluted outer reaction product for 
the inner reaction. Products were analysed on 2% 
metaphor agarose gels (FMC Bioproducts) using 
ethidium bromide staining. AS showed a band of 
approximately 300 bp, AT showed a band of ap-
proximately 320 bp and ER showed a band of 
359 bp. At least 2, and usually 3 PCR reactions were 
performed on blood samples taken on days 4, 6, 8, 
12, 17, 19, 21, 24, 26, 28, 31, 33, 35 and 39. 
Statistical analyses 
Trait definition. The areas under the asexual para-
site and gametocyte density by time curves (Fig. IA, 
B) from days 0-12, days 12-39 and from days 39-
70 p.i. were calculated as measures of the total 
number of parasites or gametocytes produced during 
acute, first and second part of the chronic phase of 
the infection, respectively, and are referred to as 
'total parasite densities' and • 'total gametocyte den-
sities'. We chose day 12 as the end of the acute phase 
as most infections were over their first peak at that 
point and started to rise again (results for individual 
mice not shown). Day 39 was chosen as the second 
break point because all infections had reached low 
parasitaemias by then. In the analysis, total ga-
metocyte densities over days 12-3 9 and 39-70 were 
grouped together; this made the residual errors from 
the analysis follow a normal distribution, meeting 
the statistical assumption of normality. Data on 
asexual parasite density and gametocyte density 
were log10 transformed prior to analyses to reduce 
overdispersion in the distribution. As the threshold 
for detecting parasites by microscopy was around 
1/10 red blood cells, when observed values of 
asexual parasite or gametocyte numbers.were zero, 
they were replaced with 1/10 red blood cells so that 
zero values fell within the normal distribution range. 
As indicators of virulence, the minimum weight and 
red blood cell density for each mouse were sub-
tracted from the average of their values on days 0 and 
4 to give 'maximum weight loss' and 'maximum red 
blood cell loss'. 'Last day seen' was defined for each 
clone as the day on which the last positive PCR re-
sult was obtained. 
Hypothesis testing 
The main aim of the analysis was to determine 
whether mixed-clone infections could be predicted 
by the 3 following alternative hypotheses. (1) The 
'Average all' hypothesis: mixed-clone infections 
equal the average of the 3 single-clone infections, 
i.e. there is competition such that each clone in a 
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Fig. 1. Average log 10 asexual parasite density (A) and log 10 
gametocyte density (B) through time in mice infected with 
either clone AS, AT or ER of Plasmodium chabaudi or a 
mixture of these 3 clones. Numbers represent the means of 
4 mice (AS), 5 mice (AT, ER) and 19 mice (Mixed). 
Because parasite and gametocyte densities of 0 were set to 
iO (see text), the y-axis starts at 4. 
total infection load. The value from each single-
clone infection was weighted by one third and sum-
med to give the predicted value of the mixed-clone 
infections. (2) The 'Average virulent' hypothesis: 
mixed-clone infections equal the average of AT and 
ER single-clone infections, i.e. the avirulent clone 
(AS) is out-competed, and the 2 virulent clones 
dictate the infection. (3) The 'Sum' hypothesis: 
mixed-clone infections equal the sum of all single-
clone infections, i.e. clones do not compete, and 
virulence is as high as the sum of the virulence in-
duced by each clone on its own. 
To test these hypotheses, the means of mixed-
clone infections were compared with predicted 
means by the method of linear contrasts using the 
CONTRAST statement in PROC GLM of SAS  
(SAS/STAT, 1990). This method applies the ap-
propriate weights, as dictated by the hypothesis 
(e.g., in the case of the 'Average all' hypothesis, 033 
for each single-clone infection, and —1 for the 
pooled mixed-clone infections), to the design matrix 
of the linear equations, and then tests the signifi-
cance level from the sum of squares of these equa-
tions as usual. Note that this method allows for error 
on the predicted means (which were determined 
from the single-clone infections) as well as that on 
the observed means. 
We also tested for differences in the rate of decline 
in the heights of the peaks of parasite densities 
through time. This was done by fitting a model to all 
data on parasite density peaks that occurred 
throughout the infection with fixed effects for treat-
ment (4 levels), day of peak (linear covariate), an 
interaction between these and a random effect for 
mouse to account for non-independence between 
repeated measures on the same mouse (PROC 
MIXED in SAS). 
Before testing our hypotheses, we tested for dif-
ferences among single-clone infections, and among 
mixed-clone infections, using analysis of variance in 
PROC GLM of SAS, with a treatment factor with 3 
levels (1 for each clone) or 4 levels (1 for each mixed-
clone infection). Treatment and subtreatment means 
were compared by t-tests based on the residual 
variance after fitting the model. We also analysed 
'last day seen', to determine whether mixed-clone 
infections were indeed still mixed-clone infections. 
RESULTS 
During the 70-day period of the experiment, para-
site densities exhibited up to 6 peaks (average of 
38±013), which decreased in height and frequency 
through time (Fig. lA). Most of the gametocytes 
were produced during the first and second wave of 
asexual parasites (Fig. 113). Afterwards they were 
detectable only during subsequent peaks in asexual 
parasite densities. One mouse in the group in-
oculated with lAS: 1AT: 8ER died on day 10 p.i. 
This mouse had a relatively, but not exceptionally, 
high parasitaemia (346%) on day 8 p.i., but its initial 
weight was lower than the weights of the other mice 
in the same group. 
Differences among single-clone infections and among 
mixed-clone infections 
Mice infected with AS produced lower parasite 
densities over days 0-12 and 1 2-39, produced more 
gametocytes over the whole course of infection, and 
lost less weight and red blood cells than AT and ER 
(P=002, P=004, P<001, P<0001, P<0001 re-
spectively) which themselves did not differ. AT and 
ER only differed in their total number of gameto-






















Fig. 2. (A) Total number of asexual parasites produced 
during the acute phase of infection (days 0-I 2) for single-
clone infections (AS, AT, ER), mixed-clone infections 
(Mixed) and the predicted numbers based on the 'Average 
all' (Av. all), 'Average virulent' (Av. vir.) and 'Sum' 
Among mixed-clone infections, mice in the 
IAS:IAT: IER treatment lost significantly less 
weight (P<005), had lower total parasite density 
over days 0-12 (P<005) and lower total gametocyte 
density over days 12-39 (P<005) than the other 
mixed-clone infections, but were similar for other 
traits. We therefore decided to pool the 4 different 
mixed treatments together prior to further hypoth-
esis testing. 
Survival of individual clones 
In both single-clone infections and mixed-clone in-
fections, AS disappeared below the PCR detection 
level before AT and ER (182 days for AS, 289 and 
310 days for AT and ER single-clone infections, 
P<000I; 184 days for AS, 269 and 220 days for 
AT and ER in mixed-clone infections, P<0001). 
There was no interaction between treatment and clone 
effects, showing that clone AS was present for less 
time than AT and ER in both single-clone and mixed-
clone infections. This could be explained by lower 
parasite densities, since there was a strong relation-
ship between parasite density and PCR-positive rate 
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Fig. 3. Best-fit regression lines between parasite density at 
primary and recrudescent peaks (log 10 transformed) and 
day p.i. for mice infected with single-clone infections (-
•, U, A) or mixed-clone infections of Plasinodiurn 
chabaudi clones AS, AT and ER (---, 0). 
(Sum) hypotheses. Bars represent ±1 s.r. Significance 
levels for testing whether predicted values under the 
'Average all', 'Average virulent' or 'Sum' hypotheses 
differ from 'Mixed' are denoted as: 	P<0001; 
**Ø.Øfl <P<001; * 001 <P<005, t 005 <P<01. 
(B) As for (A), but for first part of chronic infection (days 
12-39). (C) As for (A), but for second part of chronic phase 
of infection (days 39-70). Note that no significance symbol 
is present for the 'Sum' hypothesis, because this 
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Fig. 4. (A) Total number of gametocytes produced during 
the acute phase of infection (days 0-12) for single-clone 
infections (AS, AT, ER), mixed-clone infections (Mixed) 
and the predicted numbers based on the 'Average all' (Av. 
all), 'Average virulent' (Av. vir.) and 'Sum' (Sum) 
clones were present after day 39 p.i. (when PCR 
sampling stopped), even though we still detected 
parasites by microscopy. We therefore do not know 
whether most infections from these days onwards 
were in fact still mixed-clone infections. 
Hypothesis testing 
Total asexual parasite densities during the acute 
phase (days 0-12; Fig. 2A) of mixed-clone infections 
did not differ from parasite densities predicted un-
der the 'Average all' or 'Average virulent' hypoth-
eses (P>010 for both), but were far lower than 
those under the 'Sum' hypothesis (P.<0001). Be-
tween days 12 and 39 the total number of parasites in 
mixed-clone infections was higher than that under 
the 'Average all' hypothesis, lower than that 
under the 'Sum' hypothesis, but the same as that 
under the 'Average virulent' hypotheses (P<0001, 
P<0001 and P=0-07 respectively). After day 39 
parasite densities in mixed-clone infections were 
much higher than those predicted by the 'Average 
all' and 'Average virulent' hypotheses (P=002, 
P=0-03 respectively), although whether they were 
actually the same as those under the 'Sum' hypoth-
esis, could not be tested statistically, as their vari-
ances differed greatly (Fig. 2C). The greater number 
of parasites in mixed-clone infections after day 12 
was partly attributable to there being more peaks in 
mixed-clone infections (41 ±Oio) than single-clone 
infections (34±0-19, P<001). It was also partly 
due to higher individual peaks since the rate of de-
cline in the height of peak densities through time was 
significantly slower than in single-clone infections 
(Fig. 3; P<0001). 
Over days 0-12 total numbers of gametocytes in 
mixed-clone infections did not differ from those 
under the 'Average all' or 'Average virulent' hy-
potheses (Fig. 4A; P=027, P=052 respectively), 
but were much lower than those under the 
'Sum' hypothesis (P<0-001). Between day 12 and 
day 70 mixed-clone infections produced as many 
gametocytes as predicted under the 'Average all' 
and 'Average virulent' hypotheses (Fig. 413; P= 
0-06, P=0-59 respectively), but far less than pre-
dicted under the 'Sum' hypothesis (P<00001). 
Taken over the whole infection, mixed-clone infec-
tions had lower numbers of gametocytes than those 
predicted under the 'Average all' hypothesis 
(Fig. 4C; P=0-03), but they were not different 
from those under the 'Average virulent' hypothesis 
(P=068). They were again lower than those under 
the 'Sum' hypothesis (P<0001). 
Maximum weight loss (Fig. 5A) was as predic-
ted by the 'Average all' and 'Average virulent' 
hypotheses. See Fig. 2(A) fora description of annotations. 
(B) As for (A), but for chronic phase (days 12-70). (C) As 









































Fig. 5. Maximum weight loss (A) and maximum red 
blood cell loss (B) in single-clone infections (AS, AT, ER), 
mixed-clone infections (Mixed) and as predicted under the 
'Average all' (Av. all), 'Average virulent' (Av. vir.) and 
'Sum' (Sum) hypotheses. See Fig. 2 (A) for a description 
of annotations. 
hypotheses (P=009, P=062). Maximum red 
blood cell loss (Fig. SB) was higher than predicted 
by the 'Average all' hypothesis, but as predicted by 
the 'Average virulent' hypothesis (P<0001, P= 
026). Both maximum weight loss and maximum red 
blood cell loss were much lower than predicted by 
the 'Sum' hypothesis (P<0001 for both). 
DISCUSSION 
During the acute phase, parasite densities in mixed-
clone infections were as high as the average of all 3 
(Average all' hypothesis) or the 2 virulent single-
clone infections ('Average virulent' hypothesis), and 
much lower than predicted by their sums ('Sum' 
hypothesis). This indicates that during this phase, 
when parasite densities are high, clones must com-
pete strongly for ecological space. After the acute 
phase, especially well into the chronic phase, when 
densities decrease, parasite densities in mixed-clone 
infections started to be higher than those predicted 
by the 'Average all' and 'Average virulent' hypoth-
eses, indicating that competition lessened. However, 
parasite densities were still not as high as those pre-
dicted by the 'Sum' hypothesis, suggesting that 
some level of competition persisted. Our PCR re-
sults showed that, in general, all 3 clones survived 
the acute phase, suggesting that all 3 clones were 
affected by competition, though to what degree we 
cannot tell. 
The fact that parasite clones in these mixed-clone 
infections suffered from competition, is not surpris-
ing, as there are several mechanisms by which this 
could happen. First, mice became very anaemic 
(probably through a combination of both parasite 
rupture, as well as phagocytosis of red blood cells 
and decreased red blood cell production (Cox, 1988; 
Jakeman et al. 1999; Menendez, Fleming & Alonso, 
2000)), possibly resulting in competition between 
clones for remaining red blood cells. Yap & Steven-
son (1994) showed that by artificially preventing 
anaemia through blood transfusion during and after 
peak parasitaemia in P. chabaudi, the patency of in-
fection could be prolonged for up to 5 days after peak 
parasitaemia. Mice infected with Plasmodium cha-
baudi are also known to become hypoglycaemic (e.g. 
Li, Seixas & Langhorne, 2001), so low levels of 
glucose could also limit parasite growth and enhance 
competition. 
Secondly, parasite clones could adversely affect 
each other through strain-transcending immunity. 
During the acute phase, immunity is thought to be 
largely non-specific (Li etal. 2001 ; Taylor-Robinson, 
1995), although clone-specific immunity also plays a 
role (Jarra & Brown, 1989; Snounou etal. 1989) and 
antibodies seem to target parasitized red blood 
cells for phagocytosis through a very parasite clone-
specific process (T1ota et al. 1998). This means that 
if one clone provokes an immune response, it could 
adversely affect another. This has also been inferred 
for mixed-species and mixed-clone P!asmodiurn in-
fections (Bruce etal. 2000). During the chronic phase 
there also seems to be a Th2 antibody-mediated 
response (Li etal. 2001; Phillips etal. 1997; Taylor-
Robinson, 1995). We noticed that during this phase, 
mixed-clone infections seemed to be harder to 
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infections (they had more and higher parasite peaks), 
suggesting an inefficient immune clearance due to 
the fact that the host is faced with antigenic variants 
of several, rather than one, parasite clones. Several 
malaria species, e.g. P. knowlesi (Brown & Brown, 
1965), P.falciparum (Biggs et al. 1991 ; Roberts et al. 
1992) and P. chabaudi (McLean, Macdougall & 
Phillips, 1990; McLean, Pearson & Phillips, 1982; 
Phillips et al. 1997), have been shown to undergo 
antigenic variation, leaving them to grow relatively 
unimpeded until new specific antibodies are directed 
against them. Bruce et al. (2000) also invoked anti-
genic variation, among other mechanisms, to account 
for sequential episodes of infection in mixed-species 
and -clone infections in Plasmodia infecting humans. 
Regardless of the underlying mechanism, it is 
clear that the 3 clones suffered from being in a 
mixed-clone infection, and this was also true for ga-
metocytes, the life-stages that are transmitted to 
mosquitoes. Never did gametocytes reach densities 
as predicted by the 'Sum' hypothesis, thus demon-
strating competition in the same way as with asexual 
parasites. It is important to note that we looked at 
gametocyte numbers, not infectivity to mosquitoes: 
therefore we looked at potential transmission rather 
than actual transmission. 
One notable result here was that the avirulent 
clone (AS) had higher total gametocyte densities 
than the virulent clones AT and ER. In previous 
studies, it was found that less virulent clones had less 
transmission potential than more virulent clones 
(Mackinnon & Read, 1999). However, the lower 
gametocyte production in the virulent clones in this 
experiment was entirely due to there being no ga-
metocytes during the acute phase when red blood 
cell density was very low (days 10-12). A similar cost 
to gametocytogenesis of high virulence, possibly 
mediated through red blood cell supply, was ob-
served by Mackinnon et al. (2002). 
Our results are in some ways in contrast with 
previous experiments carried out in P. chabaudi. In 
the current experiment, mice with mixed-clone in-
fections had as much weight and red blood cell loss 
as predicted under the 'Average virulent' hypoth-
esis. This is in contrast to Taylor et al. (1998), 
who found an increased virulence of mixed infec-
tions of 2 similarly virulent P. chabaudi clones. 
Timms (2001) also found that virulence increased 
with some 2-clone infections, but not with other 
clone pairs. 
We also found that the per clone potential trans-
mission in the current experiment was lower in 
mixed-clone infections than in single-clone infec-
tions, whereas Taylor et al. (1997) found that the 2 
clones in a mixed-clone infection produced more 
gametocytes and infected more mosquitoes than 
when on their own. Transmission from mixed-clone 
infections might truly be variable: Ferguson & Read 
(2002), for example, showed higher gametocyte  
production in mixed-clone infections in one repli-
cate, but not in the other replicate of an experiment. 
In the field, different relationships between diversity 
of infections and virulence are also common (Read & 
Taylor, 2001). 
It is, however, equally possible that different 
combinations of clones and different numbers of 
clones have different outcomes for clone compe-
tition, transmission and virulence. We are currently 
developing the techniques in our lab to study a 
whole range of clone combinations to address this 
question. This is a necessary step if we are ever to 
understand the impact of mixed-clone infections on 
virulence in the field. 
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Abstract 
A technique that can distinguish and quantify genetically different malaria parasite clones in a mixed infection reliably and with speed 
and accuracy would be very useful for researchers. Many current methods of genotyping and quantification fall down on a number of 
aspects relating to their ease of use, sensitivity, cost, reproducibility and, not least, accuracy. Here we report the development and validation 
of a method that offers several advantages in terms of cost, speed and accuracy over conventional PCR or antibody-based methods. Using 
real-time quantitative PCR (RTQ-PCR) with allele-specific primers, we have accurately quantified the relative proportions of clones present 
in laboratory prepared ring-stage mixtures of two genetically distinct clones of the rodent malaria parasite Plasmodium chabaudi chabaudi. 
Accurate and reproducible measurement of the amount of genomic DNA representing each clone in a mixture was achieved over 100-fold 
range, corresponding to 0.074% parasitised erythrocytes at the lower end. To demonstrate the potential utility of this method, we include 
an example of the type of application it could be used for. In this case, we studied the growth rate dynamics of mixed-clone infections of 
P. chabaudi using an avirulentivirulent clone combination (AS (PYR) and AJ) or two clones with similar growth rate profiles (AQ and 
AJ). The modification of the technique described here should enable researchers to quickly extract accurate and reliable data from in-depth 
studies covering broad areas of interest, such as analyses of clone-specific responses to drugs, vaccines or other selection pressures in 
malaria or other parasite species that also contain highly polymorphic DNA sequences. 
© 2003 Elsevier B.V. All rights reserved. 
Keywords: Plas,nodiu,n chabaudi; Real-time quantitative PCR; Parasite clone 
1. Introduction 
Quantitative information on the genetic composition of 
the parasites present in malaria infections is important in 
many situations. For example, in the study of mixed infec-
tions containing drug-resistant and drug-sensitive parasites, 
in studies designed to investigate the competitive fitness of 
avirulent versus virulent genotypes, in vaccine trials, or in 
studies aimed at investigating 'strain-specific' immune re-
sponses to different parasite clones. 
To date, progress on fundamental studies of this nature, 
has been hampered by the lack of a reliable and robust 
technique that can rapidly distinguish and accurately quan-
tify genetically distinct parasite clones of the same species 
present in a mixed infection. Existing methods have signif-
icant drawbacks: monoclonal antibody-based methods are 
* Corresponding author. Tel.: +44-131-650-5547. 
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able to distinguish different parasites clones by virtue of 
their variant surface antigens, but, in order to be quantita-
tive, they require labour intensive microscopic analysis us-
ing reagents that are often in scarce supply. Standard PCR, 
although sensitive, cannot reliably quantify mixed genotype 
infections as it is based on the analysis of end-point ampli-
fication products [1]. 
Real-time quantitative PCR (RTQ-PCR) circumvents the 
limitations imposed by standard PCR by identifying the po-
sition in the PCR reaction where the amount of DNA in-
creases logarithmically from just above background to the 
plateau phase (called the log-linear phase). Continuous mon-
itoring of PCR samples by fluorescence then allows the small 
fraction of cycles that fall within the log-linear range to be 
used to provide reliable information on the initial template 
concentration. 
- Many application-specific RTQ-PCR instruments and-flu-
orescence detection systems are now available for research 
and diagnostics [2]. These packages offer real advantages 
over standard PCR in terms of their user-friendliness, speed 
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of operation and sensitivity of measurement. With the abil-
ity to quantify accurately over six to seven orders of mag-
nitude, many systems are now capable of quantifying the 
amount of targeted DNA sequence to less than 1000 copies. 
This has made accurate quantification of very low parasite 
densities [3] as well as gene expression studies possible [4]. 
We report here, an adaptation to RTQ-PCR that has made 
it possible to measure accurately the relative proportions 
of parasites carrying different alleles of the same gene in 
mixed infections of genetically distinct clones of P. chabaudi 
chabaudi. The experiments described in this paper have two 
aims: (1) to test the ability of the technique to accurately and 
reliably quantify the proportions of two genetically distinct 
clones in a laboratory prepared mixture containing known 
proportions of each clone, and (2) provide a working exam-
ple of the type of biological question that could be addressed 
by this technique. In the latter case, we have analysed the 
growth rate profiles of a virulent and avirulent clone com-
bination (AJ:AS (PYR)) or a virulent/virulent clone combi-
nation (AJ:AQ) in laboratory mice. Although this method 
was developed for use with the P chabaudi rodent malarfa 
model for the purpose of studying clone-specific immune 
or drug-responses, the teèhnology should be readily trans-
ferable to human malaria parasites or other parasite species 
whose genetic material contains a high degree of DNA se-
quence polymorphism. 
For researchers interested in using this technique to deter -
mine the relative proportions of genetically distinct malaria 
clones present in clinical samples, however, an important 
point should be noted; because quantitation depends on use 
of allele-specific primers as the defining points of allelic 
variation, prior knowledge of all the clone genotypes present 
in a sample would be an essential prerequisite to ensure that 
unknown or novel parasite variants did not escape detec-
tion. Use of a primary PCR-based typing technique prior to 
quantitation may help circumvent such problems [5,6]. 
2. Material and methods 
2.1. Preparation of blood mixtures from individual mice 
and DNA extraction 
The origins of the cloned lines of P chabaudi chabaudi 
"isolates" AS and AJ and the pyrimethamine-resistant clone 
AS (PYR) used in this study are described in [7,8]. Blood 
samples were collected from 5- to 8-week-old inbred female 
CBA mice infected with AS (PYR) or AT clones. The par-
asite clones were harvested at the ring stage of the devel-
opmental cycle prior to DNA synthesis [9], to try to ensure 
that each parasite contained a single haploid genome. 
The percentage parasitaemia of each clone was 7.4% for 
AS (PYR) and 18.7% for AT as detennined by microscopic 
analysis of Giemsa-stained thin blood smears obtained from 
mouse-tail blood. Red blood cell numbers in each sample 
were calculated by flow cytometry using a Coulter counter. 
Blood samples infected with AS (PYR) or AJ clones were 
collected by exsanguination of individual mice under gen-
eral anaesthesia and diluted in citrate saline, pH 7.2. The 
blood samples were then adjusted using blood taken from an 
uninfected mouse so that each sample contained the same 
number of parasites with the same red blood cell density 
(7.4 x 107 parasites in 1 x 10 9 RBC). These two suspensions, 
containing equal numbers of AS (PYR) or AJ parasite clones 
were mixed in different proportions in replicate ranging 
from 0.25% AS (PYR):99.75% AT through to 99.75% AS 
(PYR):0.25% AT. Blood samples were centrifuged briefly 
to pellet the erythrocytes, and the supematant removed be-
fore the samples were frozen at —70°C prior to DNA ex-
traction. Genomic DNA was extracted using the High Pure 
PCR Template Preparation Kit (Roche). 
2.2. Preparation of blood mixtures from mouse-tail blood 
and DNA extraction 
The percentage parasitaemia of each clone was deter -
mined by microscopic analysis of Giemsa-stained thin blood 
smears obtained from mouse-tail blood at 3 1 % for AS (PYR) 
and 33.9% for AT. Thirty microliters of AS (PYR) and 27 p.! 
of AT-infected mouse-tail blood was diluted to a final volume 
of 1500 p.l in citrate saline. Each solution was used to pre-
pare mixtures of AS (PYR) and AJ clones at ratios of 1:99, 
10:90, 50:50, 90:10 and 99:1. Ten-fold and 100-fold dilu-
tion of these mixtures were prepared using uninfected blood 
from a control mouse as diluent to represent parasitaemias 
of 3 and 0.3%. Blood samples were centrifuged briefly to 
pellet the erythrocytes, and the supernatant removed before 
the samples were frozen at —70 °C prior to DNA extraction 
using Instagene Matrix (BioRad). 
2.3. Design of allele-specific primers 
The primers used in these experiments were designed 
to amplify a fragment of the Merozoite Surface Protein 1 
(MSP-1) of P. chabaudi chabaudi clones AS ([10]; acces-
sion no. L22982) AJ or AQ (Cheesman and Carter, unpub-
lished sequence data). The MSP-1 gene, located on chro-
mosome 8 [11] contains regions of high sequence diversity 
between clones that facilitate the design of allele-specific 
primers that can act as clone-specific genetic markers. The 
primer pairs were designed to yield PCR products of similar 
sizes for AS (PYR), Al and AQ alleles. Many of the pri-
mers used during the course of this work lacked the high 
degree of specificity required for RTQ-PCR and were dis-
carded. The following primers produced allele-specific 
amplicons free of primer-dimer or non-specific product 
contaminants. AS (PYR) forward and reverse primers sequ-
ences: 5'-ACAGTAACACAAGAAGGAAC-3' and 5'-GA-
TACTFGTGYFGATGCTGCI-3'. AT forward and reverse 
primer sequences: 5'-ACCAGCACAAGAAGCAACAA-3' 
and 5'-TTGCGGGTFCTGTFGAGGCT-3'. For the AQ and 
AT reactions a different set of AT primers were used: 
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AJ forward: 5'-ACTGAAGCAACAACACCAGC-3' and AJ 
reverse: 5'-GTFGTITGATGCACTFGCGGCITFC-3'. AQ 
forward and reverse primer sequences: 5'-TFACACCCCAA-
ACCGCTAC-3' and 5'-GTAGTrGTFCCTGTGGCAG-3'. 
Primers were made by OswelI Research Products Ltd. and 
were HPLC purified. Primer pairs were designed with the aid 
of Primerfinder Software (http://eatwonus.swmed.edu/tim/  
primerfinder!) to minimise the possibility of seif-dimerisa-
tion or heterodimerisation that could lead to non-specific 
PCR amplicons. 
2.4. Preparation of genomic DNA standards 
for RTQ-PCR 
DNA standards were prepared by the following method 
to increase the quantity of genomic DNA recovered so that 
highly concentrated stocks of standard were available for 
long-term use. 
Whole blood samples infected with AS (PYR) or AJ para-
site clones were collected from five mice and used to prepare 
genomic DNA [7]. Briefly, mouse white blood cells were 
removed by column purification using CF1 1 (Sigma) and 
PlasmodipurTM filters (Euro-Diagnostica). Parasites were 
isolated from host erythrocytes by saponin lysis and genomic 
DNA prepared by phenol—chloroform extraction. DNA stan-
dards were treated with RNAse before re-extracting with 
phenol—chloroform. The purity and quantity of the DNA 
was determined by fluorimetry, UV spectrophotometry, and 
electrophoresis of serially diluted ethidium-bromide stained 
samples on agarose gels. Standards consisting of 10-fold se-
rial dilutions of genomic DNA were freshly prepared from 
concentrated stocks for each RTQ-PCR experiment. 
Accurate quantification of the clones present in the mixed 
infection experiments described here necessitated very care-
ful measurement and dilution of each standard (AS (PYR), 
AJ and AQ) to ensure they were close to equal in their DNA 
concentration. We found that fluorometric analysis was the 
most reliable determinant of DNA concentration and IJV 
spectrophotometry the best determinant of DNA quality. 
2.5. PCR 
PCR was performed using a Roche LightCycler [12]. Ten 
microliter reactions were set up using FastStart DNA Master 
SYBR Green I kit reagents according to the manufacturers 
instructions in LightCycler capillaries (Roche). 
Prior to the work described here, reaction components 
and cycling conditions were optimised to give reliable and 
reproducible results. Magnesium chloride and primer con-
centration, denaturation, annealing and elongation rates and 
times were varied to determine the conditions under which 
only-the -specific--amplicon-was produced -The -average am 
plification efficiencies of the reactions were closely matched 
for each set of standards because small differences can re-
sult in large errors in quantification between samples. The  
average amplification efficiency, E, was determined from the 
slope of the standard curves produced in each experiment 
using the equation E = 101/ope PCR reactions where the 
amplicon doubles at every cycle have an optimal efficiency 
of 2.0 compared to reactions where no amplification occurs 
and the efficiency is 1.0. Factors that may influence the am-
plification efficiency include, for example, insufficient opti-
misation of reaction conditions, poor template quality, poor 
primer design, or the presence of PCR inhibitors in the re-
action. 
Reactions were set up with AS- or AJ-specific primer 
sets containing 0.4 M forward and reverse primers and 4.5 
and 3.5 mM M902, respectively. All samples were analysed 
in replicate within each LightCycler run. The amplification 
program comprised 40 cycles with the following steps: an 
initial "Hot Start" at 95°C for 600 s followed by 95°C with 
a Os hold, cooling at 20°C/s to 59°C with a 6s hold for AS 
(PYR) or cooling at 20°C/s to 61 °C with a 6 s hold for AJ, 
heating at 20°C/s to 72°C with a 7 s hold. The fluorescent 
signal produced from the amplicon was acquired at the end 
of the polymerisation step at 72°C. Heating at 20°C/s to 
95°C with Os hold, cooling at 20°C/s to 65°C and heating at 
0.2 °C/s to 95°C in a continuous acquisition mode produced 
the melting curve daia. 
Samples of a 10-fold serial dilution of AS (PYR) or AJ 
gDNA in the range 60-0.006 ng were used as quantifica-
tion standards for the LightCycler calibration curve. Sam-
ples prepared from artificial mixtures of parasite clones were 
analysed in replicate within the same run. Maximum recov-
ery filter tips (AXYGEN® Scientific) and "No Stick" micro-
tubes (Alpha Laboratories) were used in these experiments. 
LightCycler data were analysed by the Fit Points method. 
Reactions that were set up to measure the proportion of 
AJ and AQ clones present in a sample used the same reaction 
conditions as described for the AS (PYR) and AJ clones 
except 4mM M902  was used for AQ and 3.5 mM M902 
for AJ reactions. The annealing temperature used for AJ and 
AQ reactions was 63°C with a 6s hold. 
2.6. P chabaudi mixed-clone inftction experiments 
Two sets of three CBA female mice were infected with 
a mixture consisting of 1 x 106  parasites of clones of AS 
(PYR) and AJ (Group 1) or 2.5 x 106  parasites of clones 
AQ and AJ (Group 2). Each Group 1 mouse received a 
total of 2 x 106  parasites and each Group 2 mouse 5 x 
106  parasites. Parasitaemias were monitored and recorded 
over the course of the infection by microscopic analysis of 
Giemsa-stained thin blood smears. Five microliters of tail 
blood was collected from Group 1 mice and 10 pA of tail 
blood from Group 2 mice into citrate saline on days 3-8 
post-infection. The samples were centrifuged briefly and the 
RBC pellets -stored-at "70 °Cpriorto DNkextractionusinl 
the Instagene Matrix (BioRad) kit for AS (PYR) and Al 
samples and the High Pure PCR Template Preparation Kit 
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3. Results 
3.1. Allele-specific melting peaks and cross-reaction tests 
A critical assumption underlying these experiments is that 
the primers used to detect AS (PYR) and AJ MSP-1 alle-
les are specific for each clone. To test this we conducted 
a cross-reaction test where AS (PYR) genomic DNA was 
amplified with AS- and AT-specific primers, and AJ ge-
nomic DNA was amplified with AT- and AS-specific primers  
(Fig. la and b). These results show the allele-specific melt-
ing peak produced by each clone. Only the clone-specific 
allele was amplified in each case. Use of the 'wrong' primer 
set produced either no signal or melting peaks characteristic 
of primer-dimer formation. No non-specific PCR products 
were produced when the correct clone-specific primers were 
used, as judged by analysis of the melting peaks produced 
by the LightCycler software. Cross-reaction tests were also 
conducted on AQ and AT DNA; in each case only the correct 
allele-specific melting peak was detected (data not shown). 
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Fig. 1. Fluorescence melting curve data derived from cross-reaction tests performed to confirm the specificity of AS (PYR) and AJ primers for their 
target sequence. (a) The AS-specific melting peak produced by the pure AS (PYR) clone using AS-specific primers and the signal produced using pure 
AJ genomic DNA. (b) The AJ-specific melting peak produced by the pure AJ clone using AJ-specific primers and the non-specific signal produced using 
AJ-specific primers with pure AS (PYR) genomic DNA. 
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Table I 
The proportions of AS (PYR) and Al clones quantified by RTQ-PCR from duplicate mixtures (Experiments 1 and 2) containing different proportions of 
AS (PYR) and AJ blood-stage parasite clones 
Expected 
% AS clone % AJ clone 
Measured in Experiment I 
% AS clone 	% Al clone 
Measured in Experiment 2 
% AS clone 	% AJ clone 
Mean of Experiments I and 2 
% AS clone 	% Al clone 
o ioo 0.00 100.00 	- 0.00 100.00 0.00 100.00 
0.25 99.75 0.00 100.00 0.69 99.31 0.35 99.65 
0.50 99.5 0.38 99.62 0.78 99.22 0.58 99.42 
99 0.00 100.00 0.00 100.00 0.00 100.00 
2 98 2.03 97.97 1.97 98.03 2.00 98.00 
6 94 0.00 100.00 5.81 94.19 2.90 97.10 
20 80 18.31 81.69 19.07 80.93 18.69 81.31 
32.5 67.5 32.68 67.32 33.84 66.16 33.26 66.74 
50 50 46.16 53.84 46.23 53.77 46.20 53.80 
67.5 32.5 66.33 33.67 68.97 31.03 67.65 32.35 
80 20 81.38 18.62 74.07 25.93 77.72 22.28 
94 6 93.86 6.14 92.65 7.35 93.26 6.74 
98 2 97.75 2.25 98.39 1.61 98.07 1.93 
99 1 98.96 1.04 98.70 1.30 98.83 1.17 
99.5 0.5 100.00 0.00 99.34 0.66 99.67 0.33 
99.75 0.25 99.62 0.38 99.50 0.50 99.56 0.44 
100 0 100.00 0.00 100.00 0.00 100.00 0.00 
0 0 0.00 0.00 0.00 0.00 0.00 0.00 
3.2. Measurements of MSP-1 AS and Af alleles in 
laboratory prepared blood mixtures containing 
known proportions of each clone 
Mouse blood infected with 7.4 x 107  ml of parasites 
representing clones of P chabaudi chabaudi AS (PYR) or 
AJ both at an RBC density of 1 x 10 9 RBC/ml (i.e. 7.4% 
parasitaemia) was used to make duplicate artificial mixtures 
containing different proportions of each clone. The propor-
tions of the mixtures tested ranged from 0.25 to 100% AS 
(PYR) or AJ. In the lower range, for example, mixtures 
comprised 0.25% AS (PYR) and 99.75% AT or the reverse, 
0.25% AJ and 99.75% AS (PYR). 
Table 1 shows the actual proportions obtained by 
RTQ-PCR for duplicate Experiments 1 and 2, together 
with the mean value obtained for both experiments. The 
results show that the mean proportions of AS (PYR) and 
AT clones quantified in both experiments correlates well 
with the proportions expected from the mixtures. Data from 
the individual experiments show, however, that some of the 
reactions measuring in the lower ranges occasionally pro-
duced no specific PCR product (e.g. in Experiment 1 the 
value expected for AS (PYR) of 0.25% was quantified at 
0%). Given that the accuracy of measurement in the higher 
ranges (above 2%) is very good, we attribute such discrep-
ancies to the errors involved in measuring and dispensing 
very small volumes accurately during the actual preparation 
of the blood mixtures themselves. 
All samples analysed in this experiment, with the ex-
ception -of the standards, contain - mouse host nucleated cell 
DNA. To ensure that both primer sets did not cross-react 
with the mouse DNA, we also analysed samples contain-
ing no parasites. No ainplicon was produced by either set  
of AS (PYR) or AT primers from such material (Table 1). 
The standard curves produced for AS (PYR) and AT DNA 
in these experiments were linear over the four-log range of 
DNA concentration from 6 pg to 60 ng that was used (data 
not shown). The average amplification efficiencies (E) for 
both sets of standards were checked to ensure that they were 
comparable in order to reduce the likelihood of quantifica-
tion bias in the parasite mixtures analysed here. The average 
amplification efficiencies were calculated at 1.978 for AS 
(PYR) and 1.980 for AT. 
3.3. Sensitivity of measurement 
We investigated whether the technique was sensitive 
enough to accurately quantify material containing a 50:50 
mixture of AS (PYR) and AJ clones over two orders of 
magnitude below those used in the initial experiments (i.e. 
corresponding to 7.4, 0.74 and 0.074% parasitaemia or 
74,000, 7400 and 740 parasites in the fraction of the sample 
analysed). The results, shown in Table 2, demonstrate that 
even at the lowest level tested (740 parasites), the deviation 
from the expected value was less than 11%. We also tested 
whether using DNA samples prepared by a less expensive, 
quicker method (Instagene Matrix (BioRad)) using small 
quantities of mouse-tail blood would also produce accu-
rate results on the LightCycler (Roche) system. For this 
experiment, artificial blood mixtures were prepared from 
mouse-tail blood in the proportions AS:AJ; 1:99, 10:90, 
90:10, 99:1 and 50:50. These suspensions were used to - - 
-- prOvide 10 and 1 ­00fóld dilution series to - iepresent 
parasitaemias of 30, 3 and 0.3%, respectively. DNA was 
extracted from these samples using Instagene Matrix (Bio-
Rad). Each sample was quantified twice and the proportion 
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Table 2 
RTQ-PCR values obtained from genomic DNA samples extracted from blood mixtures derived from individual mice containing equal numbers of parasite 
clones AS (PYR) and AJ over 100-fold range 
Calculated total number of AS Mean concentration of Mean concentration of Expected % Mean % AS Mean % AJ 
or AJ parasites in fraction of AS clone detected (ng/p.1) AJ clone detected (ng/p.l) AS or AJ detected detected 
sample analysed 
74000 0.5135 0.598 50 46.2 53.8 
7400 0.032 0.03165 50 50.3 49.7 
740 0.007315 0.00594 50 55.2 448 
of AS (PYR) measured was based on the mean of these ex-
periments. The observed proportion of AS (PYR) was then 
plotted against the expected proportion of AS (PYR), as 
shown in Fig. 2. The results show that DNA extracted from 
mouse-tail blood using Instagene Matrix gives accurate 
estimates of the proportions of AS (PYR) and AJ clones 
present in the artificial mixtures, over a range of 30, 3 and 
0.3% parasitaemia. All data points fit almost on a straight 
line of expected values. 
3.4. Analysis of between run variation 
In the experiments described so far we have shown that 
RTQ-PCR using allele-specific primers is both accurate and 
sensitive. We also investigated how robust the method was 
in terms of how well random errors within the system ap-
pear to be controlled between runs. Ten-fold serial dilutions 
(10- to 100,000-fold) of P chabaudi Pd and AQ DNA were 
made on five independent occasions. Each dilution series 
was amplified with AQ- or Pd-specific MSP-1 primers on the 
LightCycler (Roche) in five independent runs. The Cross-
ing Points, defined as the position in the reaction where the 
fluorescence of the PCR products become greater than the 
background signal from the SYBR Green 1 fluorescent dye, 
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Fig. 2. Analysis of the sensitivity of the RTQ-PCR technique- using 
artificial mixtures containing known proportions of AS (PYR) and AJ 
clones obtained from mouse-tail blood. Artificial mixtures containing AS 
(PYR) and AJ parasite clones were prepared in these proportions: AS:AJ; 
50:50, 10:90, 1:99, 99:1 and 90:10. Each mixture was further diluted 
to make artificial mixtures representing 30, 3 and 0.3% parasitnemia in 
the same proportions. The observed proportion of AS (PYR) detected is 
plotted against the expected proportion of AS (PYR). 
ware. Fig. 3a and b shows the mean values and standard 
deviation of each dilution series of AQ and Pd DNA. Both 
curves are linear over a five-log range. The percentage rela-
tive standard deviation (% rsd = (standard deviation/mean) 
x 100), a measure of the overall precision of the method 
was calculated at <3.6% for AQ and <2.3% for AJ DNA 
across the sample dilution range, indicating that the method 
is extremely robust across a wide range of dilutions for both 
clones. 
3.5. Real-time quantitative PCR analysis of mixed-clone 
infections of AS and AJ or AQ and AJ in laboratory mice 
Mixed infections of AS (PYR) and AJ (Fig. 4a) and AQ 
and Pd clones (Fig. 4b) were analysed using RTQ-PCR in 
three individual mice per group. The initial inoculum con-
tained a 50:50 mixture of each clone, i.e. AS and Pd (Fig. 4a) 
or AQ and Al (Fig. 4b). For the Group 1 mice, AJ rapidly 
dominated the infection over AS (PYR), but the proportion 
remained stable between the 3rd and 8th day of infection in 
all three mice. In the Pd + AQ mixture, AJ also dominated 
the infection, but less than in the AS + AT mixture, and 
the proportions also remained stable between days 3 and 8 
post-infection. 
In both examples of mixed-clone infections, viz. AS + AJ 
and AJ + AQ, the proportions of each clone remained 
remarkably constant during the course of infection and 
between replicate infections in different mice. This is par-
ticularly striking, given the variation observed in terms of 
the day and peak level of parasitaemia, as was especially 
noticeable for the Pd + AQ combination (Fig. 4b). The 
observation suggests a rather tight biological and genetic 
control over the dynamic behaviour of the parasite clones 
in a malaria infection. Use of isogenic lines of laboratory 
mouse with cloned 'strains' of rodent malaria parasite has 
revealed biological phenomena that could not have been 
detected in natural human malaria infections. 
4. Discussion 
The aim of these experiments was to establish if we could 
adapt RTQ-PCR to accurately identify and measure the pro-
portions of two genetically distinct clones of the rodent 
malaria parasite P. chabaudi chabaudi in a laboratory pre-
pared blood-stage infection. This approach has not, to our 
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Fig. 3. Reproducibility of the RTQ-PCR using MSP-1 AJ or AQ allele-specific primers. Five 10-fold serial dilutions of AJ or AQ DNA templates were 
prepared and amplified on five independent occasions. The means of the five Crossing Points are plotted for each concentration of DNA used. Error 
bars represent the standard deviation of each dilution within the series. The precision of the measurements, expressed as the percentage relative standard 
deviation (% rsd) was calculated at (AQ): undiluted DNA sample, 1.46%; 1/10 dilution, 3.62%; 1/100 dilution, 2.65%; 1/1000 dilution, 2.06%; 1/10,000 
dilution, 1.82%; 1/100.000 dilution, 1.43%. (AJ): Undiluted DNA sample, 2.10%; 1/10 dilution, 1.13%; 1/100 dilution, 0.54%; 1/1000 dilution, 1.39%; 
1/10,000 dilution, 150%; and 1/100,000 dilution, 2.35%. 
knowledge, been attempted before in this context, and was 
made possible by the use of primers designed against MSP-1 
gene sequences containing large regions of variability be-
tween the clones used in this study, AS (PYR), AJ and AQ. 
Artificial blood mixtures containing a calculated number 
of parasite clones demonstrated that the technique is ac-
curate and sensitive enough to measure over a wide range 
of different proportions ranging from 0.25% AS (PYR) 
and 99.75% AJ or the reverse, 0.25% AJ and 99.75% 
AS (PYR). 
We used two different methods to prepare DNA for these 
experiments to determine whether the real-time method re-
quired highly purified template DNA such as was made us-
ing the High Pure PCR Template Preparation Kit (Roche) for 
accuracy or would give comparable results with templates 
prepared by less rigorous methods using smaller blood vol-
umes (Instagene Matrix (BioRad)). 
LightCycler data derived from DNA samples prepared by 
both methods gave results that were accurate over two orders 
of magnitude below the starting concentration. 
The precision of the technique was tested over a five or -
ders of magnitude dilution series with AQ and AJ genomic 
DNA diluted and amplified on five separate occasions. The 
percent relative standard deviation, even at the greatest dilu-
tion (1/100,000) was only 1.43% for AQ and 2.35% for AJ, 
indicating that the technique is repeatable over a wide range 
of DNA concentration. The precision across the whole di-
lution series was calculated to be less than 4% rsd for AQ 
primers and less than 2.5% rsd for AJ primers. 
To demonstrate an application of the technique, we in-
vestigated the dynamics of mixed infections of P. chabaudi 
clones AJ with AQ or AJ with AS (PYR) in inbred CBA 
female mice. The starting inocula consisted of a 50:50 
mixture of the parasites of each clone. In the AJ and AQ 
mixture, there was a moderate predominance of AJ over 
AQ, leading to about 70% AJ by day 8 of infection. In the 
AJ and AS (PYR) mixture, the predominance of AJ over AS 
(PYR) was much stronger leading to 90-95% AJ by day 8 
of the infection. In each combination, there was remarkable 
consistency in the behaviour of the mixed clones between 
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Fig. 4. The mixed infection dynamics of P chabaudi clones AS (PYR) and AJ ((a); Group I mice) and AQ and AJ ((b); Group 2 mice) measured using 
RTQ-PCR. Individual mice were inoculated with a mixture of I x 106  parasites of clones AS (PYR) and AJ (Group 1) or 2.5 x 10 6  parasites of clones 
of AQ and AJ (Group 2) representing a total of 2 x 106 or 5 x 106  clones, respectively. (a) shows the proportion of parasite clones quantified for AS 
(PYR) and AJ, and (b) AQ and AJ clones at days 3-8 post-infection together with the corresponding parasitaemia for the course of each infection. 
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individual infections. The relationships between the growth 
of AS (PYR) and Al in the mixtures reflects the differ-
ence in growth rate we have observed between these two 
clones when examined in single-clone infection situations, 
with AJ consistently outgrowing AS (data not shown). Our 
data shows that AS (PYR) grows even more slowly than 
expected when in competition with Al. The method is thus 
shown to be able to explore behaviour of the parasites not 
previously available to observation. 
Having verified in these pilot experiments, the utility of 
the RTQ-PCR adaptation using AS (PYR), Al and AQ clones 
of P chabaudi, we have also confirmed the general appli-
cability of the technique to other clone combinations (e.g. 
AS (PYR) and CB and Al and CB clones of P chabaudi 
chabaudi, (results not shown). It is now our intention to 
use this technique to genotype and quantify the relative 
proportions of parasites present in mixed-clone infections 
of P. chabaudi within the context of 'strain-specific' im-
munity and drug-resistance. Our adaptation of the standard 
RTQ-PCR technique using allele-specific primers, should 
also provide scope for use with other malaria parasite species 
in more diverse situations. 
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Host heterogeneity is a determinant of competitive 
exclusion or coexistence in genetically diverse 
malaria infections 
Jacobus C. de Roode*,  Richard Culleton, Sandra J. Cheesman, Richard Carter 
and Andrew F. Read 
Institute of Cell, Animal and Population Biology, University of Edinburgh, Kings Buildings, West Mains Road, 
Edinburgh EH9 3JT, UK 
During an infection, malaria parasites compete for limited amounts of food and enemy-free space. Compe-
tition affects parasite growth rate, transmission and virulence, and is thus important for parasite evolution. 
Much evolutionary theory assumes that virulent clones outgrow avirulent ones, favouring the evolution 
of higher virulence. We infected laboratory mice with a mixture of two Plasmodium chabaudi clones: one 
virulent, the other avirulent. Using real-time quantitative PCR to track the two parasite clones over the 
course of the infection, we found that the virulent clone overgrew the avirulent clone. However, host 
genotype had a major effect on the outcome of competition. In a relatively resistant mouse genotype 
(C57B116J), the avirulent clone was suppressed below detectable levels after 10 days, and apparently lost 
from the infection. By contrast, in more susceptible mice (CBA/Ca), the avirulent clone was initially 
suppressed, but it persisted, and during the chronic phase of infection it did better than it did in single 
infections. Thus, the qualitative outcome of competition depended on host genotype. We suggest that 
these differences may be explained by different immune responses in the two mouse strains. Host genotype 
and resistance could therefore play a key role in the outcome of within-host competition between parasite 
clones and in the evolution of parasite virulence. 
Keywords: Plasmodium chabaudi; malaria; virulence; within-host competition; evolution; host genotype 
1. INTRODUCTION 
According to a large body of theory, competition within 
hosts generates selection for pathogens that do more dam-
age to their host (i.e. are more virulent; Levin & Pimentel 
1981; Bremermann & Pickering 1983; Frank 1992, 1996; 
Van Baalen & Sabelis 1995; Gandon 1998; Mosquera & 
Adler 1998; Ebert 1999; Read etal. 2002). Parasite fitness 
in singly infected hosts is assumed to be maximized when 
the benefits of host exploitation (increased transmission 
rate) balance the costs (increased host mortality) (Levin & 
Pimentel 1981; Anderson & May 1982; Bremermann & 
Pickering 1983; May & Anderson 1983; Sasaki & Iwasa 
1991; Frank 1992, 1996; Antia et al. 1994; Van Baalen & 
Sabelis 1995; Antia & Lipsitch 1997). But, in genetically 
diverse infections, parasites that slowly exploit hosts will 
be outcompeted by those that exploit hosts more rapidly. 
Even if host life expectancy is reduced so that all parasites 
do worse, prudent parasites do disproportionately worse 
and are thus eliminated by natural selection. 
The majority of mixed-infection models of virulence 
assume that more virulent strains have a competitive 
advantage. Logical as this may seem, there is hardly any 
experimental evidence to suggest that this is indeed the 
-- case, -and- some evidence that the opposite is-irue (Read & 
Taylor 2001). Within-host competition is certainly wide-
spread and is mediated by limited resources, strain-tran-
scending immune responses (apparent competition) or 
Author for correspondence (j.de.roode@ed.ac.uk ).  
direct interference between competing genotypes (Read & 
Taylor 2001). In rodent malaria, for example, both 
resource and apparent competition probably play a role 
(Snounou etal. 1989, 1992; Hellriegel 1992; Taylor et al. 
1997a; Taylor & Read 1998; Read & Taylor 2001; De 
Roode et al. 2003). But, while strains with a higher growth 
rate probably will do better in resource competition, they 
could also become a preferred target of strain-specific 
immune responses, giving less-abundant genotypes an 
advantage (Bruce et al. 2000; Read et al. 2002). 
If there is a lack of experimental evidence to suggest 
that virulent clones are competitively superior to avirulent 
clones, there is even less evidence that any superiority is 
consistent across genetically different hosts. Numerous 
studies have shown that disease virulence varies with host 
genotype, with some host types being more susceptible to 
severe disease than others (e.g. Stevenson et al. 1982; 
Ebert & Hamilton 1996; Ebert et al. 1998; Imhoof & 
Schmid-Hempel 1998; Carius et al. 2001; Mackinnon et 
al. 2002). This variation in resistance is likely to be 
reflected in variation in the strengths of resource- or 
immune-mediated competition between parasites within 
hosts. Indeed, one study has now shown that this is the 
case: an experiment on the endophyte Epichlof bromicola 
parasitic on the grass Brornus erectus showed that parasit 
strains that competitively excluded some strains on one 
host genotype were excluded themselves on another (Wille 
et al. 2002). 
Here, we ask whether host genotype is also an important 
determinant of competitive outcome in a model of human 
disease. We studied mixed infections of virulent and 
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avirulent clones of the rodent malaria parasite Plasmodium 
chabaudi in two different strains of laboratory mice. Based 
on the theory outlined above, we predicted that the viru-
lent parasite clone would rapidly outgrow the avirulent 
clone in both mouse strains. This did occur in one mouse 
strain,but in the other competitive suppression was transi-
ent, with the avirulent clone persisting to do better in the 
chronic phase of the infection than it would have done on 
its own. 
2. MATERIAL AND METHODS 
Parasites and hosts 
We used two genetically distinct P. chabaudi chabaudi clones, 
denoted AS(pyrlA) and AJ. AS(pyrlA) was derived through 
pyrimethamine selection from clone AS (Walliker a aL 1975). 
Both AS and AJ were originally isolated from thicket rats (Beale 
et al. 1978). For simplicity AS(pyrlA) will be referred to as AS 
from here on. We chose AS and Aj clones because they differ 
in their growth rates and virulences (Mackinnon & Read 1999), 
with AS producing fewer parasites and causing less virulence 
than AJ. 
Hosts were eight-week-old C57B116J and CBAICa inbred 
female mice (Ann Walker, University of Edinburgh). They were 
fed on 41 B maintenance diet (Harlan, UK) and their drinking 
water was supplemented with 0.05% para-amino benzoic acid 
to enhance parasite growth (Jacobs 1964). They were kept in a 
12 L: 12 D cycle. We will refer to these mouse strains as C57 
and CBA from here on. 
Experimental design and inoculation of mice 
with parasites 
The experiment consisted of three treatments for both C57 
and CBA mice: infections with AS alone infections with AJ alone 
and mixed AS+AJ infections. Each treatment group had five 
mice, resulting in 30 mice in total. Mice infected with just AS 
or AJ received 106  parasites, whereas mice infected with both 
clones received 2 x 106  parasites, made up of 106  AS and 106 
AJ parasites. The latter quantity was chosen because in our 
analysis we wanted to compare the performance of a clone on its 
own with its performance in a mixed infection, requiring equal 
numbers of each parasite clone at inoculation. Although mice 
that were infected with both clones received a double dose of 
parasites, we know from previous work that a twofold difference 
in parasite numbers has a negligible effect on parasite dynamics 
and virulence (Timms et al. 2001). 
We prepared inoculations from donor mice by diluting blood 
in 0.1 ml of calf serum solution (50% heat-inactivated calf 
serum, 50% Ringer's solution (27mM of KCI, 27mM of CaCl 2 
and 0.15 M of NaCl) and 20 units of heparinml mouse 
blood), and injected them via the intraperitoneum. All pro-
cedures were carried out under Home Office guidelines. 
Monitoring of virulence and infections 
To monitor virulence, we recorded mouse live weights and 
densities of red blood cells (using flow cytometry; Beckman 
Coulter). Both body mass and red blood cell density decrease 
dramatically during infection, and these decreases correlate with 
host mortality and thus virulence (Mackinnon a al. 2002). 
To monitor production of asexual parasites and gametocytes 
(the sexual transmission stages) we took thin blood smears from 
tail blood. These were fixed with methanol and stained with 
Giemsa to determine levels of asexual parasitaemia and  
gametocytaemia using 1 000x microscopy. When asexual parasi-
taemia was high, we counted 500 red blood cells in at least four 
microscopic fields. With lower parasitaemias and gametocytae-
mias we counted at least 20 microscopic fields (corresponding 
to at least 10 000 red blood cells), and calculated the average 
number of cells per field. Gametocyte numbers were counted 
using polarized light. We calculated parasite densities and 
gametocyte densities as the products of parasitaemias and game-
tocytaemias, respectively, and red blood cell densities taken on 
the same day. 
We took measurements every day from day 0 to day 23 post-
infection (P1), three times a week from day 23 to day 48 P1, 
once a week from day 48 to day 69 P1 and on day 83 P1, when 
the experiment was terminated. Measurements were taken 
between 09.00 and 10.30, when peripheral blood almost exclus-
ively harboured haploid ring stages of the parasites. 
Monitoring of individual clones in mixed 
infections 
We collected 5 ii samples of tail blood from mice harbouring 
mixed infections in citrate saline. After 1 min of centrifugation 
at 13 000 r.p.m., we removed the supernatant and stored the 
pelleted blood at —70 °C for subsequent DNA extraction using 
Instagene Matrix (BioRad). We used real-time quantitative PCR 
to measure the DNA concentrations of both AS and AJ in these 
samples (Cheesman a al. 2003) and calculated the proportions 
of AS and AJ in the total parasite population. Absolute numbers 
of AS and AJ were then calculated by multiplying these pro-
portions by the overall parasite density on the same day. 
We took blood samples on the same days that we took our 
other measurements, but performed PCRS only when parasitae-
mias were higher than 0.1%, which is the lowest level at which 
we can accurately estimate AS and AJ proportions (Cheesman 
a al. 2003). Our real-time quantitative PCR protocols cannot 
distinguish between asexual parasites and gametocytes, and so 
they estimate the densities of all parasites. In our data analyses, 
we treated these as estimates of asexual density. Gametocyte 
densities were two to three orders of magnitude lower than 
asexual-parasite densities, and gametocytes are thus a negligible 
component of overall parasite numbers. 
Trait definition 
Prior to statistical analysis we defmed and constructed the fol-
lowing traits that described part of or all of the infection. For 
measures of virulence we determined the 'minimum weight' and 
'minimum density of red blood cells' that mice reached. Mice 
that died were included in our analysis of minimum weights and 
red blood cell densities, using weight and red blood cell density 
on the day of death as the minima they reached. For all other 
traits, these mice were excluded from the analyses. 
Parasite levels in mice rose and fell several times, with the first 
peak being substantially higher and lasting for longer than the 
other peaks. For each mouse, we calculated the period until the 
end of the first wave, and defined this as the acute phase of the 
infection. The subsequent period, the chronic phase, was 
defined as starting on the day that parasite numbers began to 
recover after the collapse of the first wave (day 15.6 ± 0.55 P1; 
mean ± 1 s.c.). To calculate the numbers of parasites present 
during the whole infection and during the acute and chronic 
phases, we calculated the areas under the relevant parasite den-
sity by day P1 curves. As our limit of detecting parasites was ca. 
100 tl ',we treated observations of zero parasites as being 100 
parasites We could accurately quantify AS and AJ 
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proportions of 0.01 at levels of 0.1% parasitaemia or higher 
(Cheesman et al. 2003); below that we set the clone densities 
at our limit of detection (100 111 '). Parasite densities in single 
infections were set to the same level when parasitaemias were 
lower than 0.001%. 
For gametocytes, we chose slightly different ways of calculat-
ing densities, as they showed different dynamics from asexual 
parasites, having a first wave before day 9 and one or several 
thereafter. We therefore calculated the total gametocyte den-
sities over days 0-9 and days 10-83 P1, as well as the total den-
sity over the whole infection. We were able to analyse overall 
numbers of gametocytes only, as our real-time quantitative PCR 
protocol does not distinguish between AS and AJ gametocytes 
(see § 2d). 
Statistical analysis 
We analysed all traits mentioned in § 2e using ANOVAs and 
ANCOVAs in MINFTAB (v. 13.30, Minitab Inc.). The explana-
tory variables used were mouse 'strain' and infection 'treatment'. 
Strain had two factor levels (C57 and CBA); treatment had up 
to three factor levels (AS, AJ and AS+AD, depending on the 
analysis. For all our models we first fitted the maximal model 
including covariate (when relevant), treatment, strain and an 
interaction between treatment and strain. We then minimized 
the models by removing non-significant terms (p> 0.05), begin-
ning with the interaction. 
We log-transformed initial and minimum densities of red 
blood cells as well as all parasite and gametocyte densities prior 
to analysis, to meet the necessary normality and homogeneity-
of-variance assumptions. 
Follow-up experiment 
To confirm the most important findings of this study, we 
infected groups of five C57 and five CBA mice with AS+AJ, 
exactly as described in § 2b, and took blood samples from them 
on days 6 and 13 P1. We then extracted DNA and analysed 
these DNA samples with real-time quantitative PCR, to deter-
mine whether both clones were present, and in what pro-
portions. 
3. RESULTS 
One C57 mouse infected with AJ died on day 12 and 
one infected with AS+AJ died on day 7; two CBA mice 
infected with AS +AJ died on days 10 and 11 P1. AJ infec-
tions induced greater weight loss and lower minimum red 
blood cell densities than AS infections (treatment: 
F1 , 17 = 25.4, p < 0.00 1; and treatment: F118 = 25.3, 
p < 0.001, respectively), regardless of mouse genotype 
(strain and treatment x strain n.s.). Thus, as found pre-
viously, AS was the less virulent clone. 
(a) AS and 41 parasite densities 
In mixed infections in both C57 and CBA mice, there 
were substantially more AJ than AS parasites during the 
first 10-14 days (figure la,b). After day 10, AS disap-
peared below detectable levels in C57 mice and never 
reappeared. It persisted, however, in the three CBA mice 
that survived the first two weeks. One of these experienced 
separate AS and AJ parasite waves around days 35 and 55 
P1 (figure 2a). In the other two mice, AS started to over-
grow AJ around days 22 and 18, respectively (figure 2b,c). 
Later in the infection AJ overgrew AS again in one of these 
(figure 2c). 
Formal analysis confirmed this picture. During the 
acute phase in both mouse strains, AS was competitively 
suppressed by AJ, producing far fewer parasites in mixed 
infections than it did alone (figures 1 c,d and 3a; treatment: 
= 155, p < 0.001). This suppression was greater in 
CBA than in C57 mice (treatment x strain: F1 , 3 =9.11  
p = 0.01). In C 5 7 mice, AS disappeared below detectable 
levels before the end of the acute phase, showing competi-
tive exclusion. 
In CBA mice, AS was also competitively suppressed 
during the acute phase, but it was not excluded from the 
infection. During the chronic phase, it produced more 
parasites than it would have done on its own (figures 1 d 
and 3b; treatment: F1 , 13 = 6.8, p = 0.022; treatment 
x strain: F1 , 13 = 34) p < 0.001), thus showing that, after 
the chronic phase, AS actually benefited from the presence 
of AJ (that is, facilitation, not competition). During both 
the acute and chronic phases, AS produced more parasites 
in CBA mice than in C57 mice, whether it was alone or 
in a mixture (figure 3a,b; strain: F1 , 13 = 125 3 p < 0.001; 
F1 , 13 = 52, p < 0.001, respectively). 
During the acute phase, AJ produced roughly the same 
numbers of parasites in mixed and single infections, in 
both C 5 7 and CBA mice (figures leJ and 3c; treatment: 
F1 , 2 = 1.42, p=0.25), thus showing that, unlike AS, AJ 
did not suffer from competition. Like AS, it produced 
more parasites in CBA than in C57 mice (strain: 
F1 , 14 = 27, p < 0.001). During the chronic phase, AJ pro-
duced slightly fewer parasites in C57 mice, but more in 
CBA mice, than it did on its own (figure 3d; 
treatment x strain: F1 , 12 = 8.1, p = 0.0 15). When analysing 
these numbers for CBA mice only, however, there was no 
difference between single and mixed infections (treatment: 
F1 ,6 = 2.7, p = 0.15), thus showing that, unlike AS, AJ did 
not experience facilitation during this phase. 
Follow-up experiment 
In the follow-up experiment, we infected another five 
C57 and five CBA mice with AS+AJ, and sampled these 
on day 6 and day 13 P1. In both mouse strains AS was 
present on day 6. By day 13, however, AS had disappeared 
below detectable levels in the peripheral blood of C57 
mice (figure 4a), but was still present in CBA mice (figure 
4b), actually overgrowing AJ at this time. These results 
thus confirmed the qualitatively different dynamics of 
mixed infections in C57 and CBA mice observed in the 
main expenment. 
Overall parasite densities 
During the acute phase, infections in C57 mice con-
sisted of fewer parasites than those in CBA mice (figure 
3e; strain: F1 ,20 = 110, p < 0.001). In both mouse strains, 
AJ and AS +AJ infections produced more parasites during 
the acute phase than did AS infections (treatment: 
F2 ,20 = 74, p < 0.001). 
During the chronic phase, AJ and AS+AJ infections 
produced more parasites than did AS infections (figure 3f, 
treatment: F2 , 20 =28, p<0.001). AJ and AS+AJ infec-
tions also differed from each other, but differently in the 
two mouse genotypes: in C57 mice AS+AJ infections pro-
duced slightly fewer parasites than AJ infections, whereas 
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Figure 1. Log parasite densities over time (mean ± 1 s.e.) for (a,c,e) C57 mice and (b,d,f) CBA mice; (a) and (b) show AS 
(solid line) and AJ (dashed line) parasite densities in mixed AS+AJ infections; (c) and (d) compare AS parasite densities in 
single AS (solid line) and mixed AS+AJ (dashed line) infections; (e) and (f) compare AJ parasite densities in single AJ (solid 
line) and mixed AS+AJ (dashed line) infections. All data points are based on five replicate mice, except for single AJ 
infections in C57 mice (four mice after day 12), mixed AS+AJ infections in C57 mice (four mice after day 7) and mixed 
AS +AJ infections in CBA mice (four mice on day 11 and three mice from day 12 onwards). As the limit of detection was 100 
parasites tl' blood, y-axes start at 2. 
in CBA mice they produced more (figure 3f, 
treatment x strain: F2 , 20 = 11 1  p = 0.00 1). Owing to these 
higher numbers in CBA mice during the chronic phase, 
AS+AJ infections produced more parasites in CBA mice 
over the whole of the infection than did AJ infections 
(treatment x strain: F2 , 24 = 26, p < 0.001). 
(d) Gametocyte densities 
In C57 mice, most gametocytes were produced during 
the first 9 days of the infection, with AS having lower den-
sities than AJ and AS+AJ (figure 5a; treatment: 
F2 , 27 = 11.71, p< 0.001), whereas in CBA mice most 
gametocytes were produced after day 9 PT, when AJ pro-
duced fewer gametocytes than AS and AS +AJ (figure 5b; 
treatment: F2 , 20 = 5.0, p = 0.0 17; strain: F1 , 20 = 6.04, 
p = 0.023; treatment x strain: F2 , 20 = 6.1, p = 0.009). In 
C57 mice, gametocyté peaks in mixed infections mostly 
resembled those in AJ infections, the numerically domi-
nant clone (figures 5a and la). In CBA mice, mixed infec-
tions produced gametocyte dynamics that did not 
resemble gametocyte production in either AS or AJ single 
infections, but which peaked during a period when both 
clones were present in high numbers (figures Sb and lb). 
Summarized over the whole infection, AJ produced most 
gametocytes in C57 mice, but fewest in CBA mice, in  
which AS produced most (strain: F1 , 20 = 8.6, p = 0.008; 
treatment x strain: F2 , 20 = 8.3, p = 0.002). 
4. DISCUSSION 
Our results show that host genotype affects the outcome 
of within-host competition between pathogen strains. In 
C57 mice, the avirulent clone disappeared below detect-
able levels from the peripheral blood after 10 days of the 
infection and produced far fewer parasites than it would 
have done on its own. This competitive suppression 
almost certainly reduced the clone's transmission poten-
tial: the period of greatest gametocyte production in single 
infections occurred after day 10 P1 (figure 5a). As the avi-
rulent clone never reappeared during the course of our 
study, it seems that it was competitively excluded, some-
thing we have not observed before (Taylor et al. 1997b; 
Taylor & Read 1998; Read et al. 2002; A. F. Read and 
M. A. Anwar, unpublished data). By contrast, the virulent 
clone did not suffer at all from competition in mixed infec-
tions. 
In CBA mice, the avirulent clone was also competitively 
suppressed during the acute phase, but it persisted and 
went on to produce more parasites during the chronic 
phase than it would have done on its own. Thus, in CBA 
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Figure 2. Log AS (solid lines) and AJ (dashed lines) parasite 
densities over time in mixed AS+AJ infections for the three 
CBA mice that survived the acute phase. As the limit of 
detection was 100 parasites i.tl blood, y-axes start at 2. 
mice, competitive suppression gave way to facilitation. 
This may have resulted in enhanced transmission: the 
density of the avirulent clone peaked at around day 20 P1 
and coincided with a large gametocyte peak (figures id 
and 5b). Whether the presence of the more virulent clone 
actually enhanced the overall fitness of the avirulent clone 
would depend on the host mortality rate induced by the 
virulent clone and on how many of the gametocytes pro-
duced around this time were of the virulent clone. 
Our experiment, with just two parasite clones and two 
mouse strains, generated the whole spectrum of outcomes 
currently captured in a range of different mixed-strain 
models of virulence evolution. In extreme coinfection 
models, clone dynamics are unaffected by the presence of 
other clones (e.g. May & Nowak 1995; Leung & Forbes 
1998); in our experiments, this was so for clone AJ in both 
mouse strains. Coexistence with competitive suppression 
of at least one clone, as envisaged in other models (e.g. 
Sasaki & Iwasa 1991; Frank 1992, 1996; Herre 1995; Van 
Baalen & Sabelis 1995), occurred within CBA mice. 
Finally, the competitive exclusion of AS from C57 mice 
before much transmission-stage production occurred 
bears substantial resemblance to superinfection models  
(which are perhaps better called superseding infection 
models; Van Baalen & Sabelis 1995). These models allow 
no coexistence and postulate that competitive suppression 
instantly reduces transmission to zero (e.g. Levin & 
Pimentel 1981; Bremermann & Pickering 1983; Bremer-
mann & Thieme 1989; Knolle 1989; Nowak & May 1994; 
Leung & Forbes 1998; Gandon etal. 2002). Thus, it may 
prove difficult to capture the real-world complexities of a 
disease such as malaria (and others; Hood 2003) in 
models that assume that the outcome of competition is 
independent of environmental conditions, such as host 
genotype. 
A general conclusion of the above models is that mixed-
clone infections will generate selection for increased 
virulence. However, the precise details of competition will 
affect the transient evolutionary dynamics and the magni-
tude of standing virulence in a population, which is what 
is relevant to animal and human health. Competitive 
exclusion of avirulent clones, for instance, will affect 
potential evolutionary trajectories, rates of evolution and 
average levels of virulence in a population. 
Several recent studies have shown that parasite viru-
lence depends on host genotype (e.g. Ebert & Hamilton 
1996; Ebert et al. 1998; Imhoof & Schmid-Hempel 1998; 
Canus et al. 2001; Mackinnon et al. 2002), and theory has 
shown that such host-genotype dependence of virulence 
can explain why polymorphisms in growth rate and viru-
lence are maintained (Regoes et al. 2000). If the outcome 
of competition is as dependent on host genotype as is the 
expression of virulence itself, this could also contribute to 
the maintenance of growth-rate and virulence polymor-
phisms in the parasite population. Wille et al. (2002) also 
suggested this when they found that some strains of the 
endophyte E. bromicola competitively excluded other 
strains on one genotype of its host B. erectus, but not on 
another. 
Clone AS was competitively suppressed by AJ, except 
during the chronic phases of infections in CBA mice, 
where AS did better than it did on its own. This could be 
the result of a combination of strain-specific immunity and 
antigenic variation. In two of the surviving CBA mice we 
saw AS overgrow AJ after it had been suppressed (figure 
2b,c). This might suggest that the immune system had 
been focusing on the clone that had produced the highest 
number of parasites up until then (AJ), giving AS some 
advantage. Strain-specific immunity is certainly well 
known in P. chabaudi (e.g. Jarra & Brown 1985; Buck-
ling & Read 2001; R. Carter, unpublished results), and 
facilitation of one pathogen as a result of the immune 
response focusing on another has also been suggested for 
fungal species infecting leaf-cutter ants (Hughes & 
Boomsma 2004). Plasmodium chabaudi is also known to 
produce antigenic variants at high rates (McLean et al. 
1982, 1990; Brannan et al. 1994; Phillips et al. 1997). 
Novel antigenic variants escape variant-specific host 
responses, and when there are more clones in an infection, 
each generating variants, it seems likely that the immune 
response may be less efficient at controlling the infection. 
A combination of strain-specific immunity and antigenic 
variation has also been suggested to play a role in mixed-
species and mixed-strain infections of plasmodia in 
humans (Bruce et al. 2000). 
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AS 	AJ 	AS+AJ 	 AS 	AJ 	AS+AJ 
Figure 3. Numbers of parasites produced during (a,c,e) the acute phase and (b,d,f) the chronic phase of the infection for C57 
(solid lines) and CBA (dashed lines) mice (mean ± 1 s.e.). Plotted points are: (a) and (b) AS parasite densities in single AS 
and mixed AS+AJ infections; (c) and (d) AJ parasite densities in single AJ and mixed AS+AJ infections; and (e) and (f) 
overall parasite numbers in single AS, single AJ and mixed AS+AJ infections. All data points are based on five replicate mice, 
except for single AJ infections in C57 mice (four mice), mixed AS+AJ infections in C57 mice (four mice) and mixed AS+AJ 
infections in CBA mice (three mice). The asterisk denotes a parasite density below detection, as AS disappeared from mixed 








day6 	day 13 	 day6 	day 13 
Figure 4. Proportions of AS (open bars) and AJ (filled bars) 
(mean± 1 s.c.) in mixed AS+AJ infections in (a) C57 and 
(b) CBA mice on days 6 and 13 P1. Data are based on five 
replicate mice in a follow-up experiment. The asterisk 
denotes a proportion of 0, as AS disappeared below 
detection levels from these mixed AS+AJ infections in C57 
mice. 
Why did infections in C57 and CBA mice show such 
different dynamics and outcomes of competition? One 
important possibility is the strain difference in the efficacy 
of immune control. Mouse strains differ considerably in  
their resistance to P. chabaudi infections (Stevenson et al. 
1982). Resistance is associated with reduced parasite den-
sities, and appears to be a complex genetic trait, involving 
many genes affecting immunity and the production and 
characteristics of red blood cells (Stevenson et al. 1982; 
Yap et al. 1994; Fortin et al. 2002). Parasite densities were 
higher in CBA mice (figure 3e), and such higher densities 
could reduce the chance of stochastic loss and increase 
the chance of producing antigenic escape variants. 
If differences in overall immune control do explain the 
strain differences in the outcome of competition, we 
would expect to find coexistence of the two parasite clones 
in C57 mice that were made more susceptible, for 
example by administration of anti-interleukin 12 mono-
clonal antibodies (Yap et aL 1994). Conversely, we would 
expect clone AS to disappear in CBA mice that were made 
more resistant, for example by artificially increasing their 
interleukin-12 levels (Yap et at. 1994). 
If overall resistance does affect the outcome of within-
host competition, then we would expect to find differences 
not only between host genotypes, but also between indi-
viduals that differ in their sex, nutritional or health status, 
vaccination status, or any other factor that influences 
resistance. Semi-immune mice are much more resistant to 
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Figure 5. Log gametocyte densities over time (mean ± 1 s.e,) 
for (a) C57 and (b) CBA mice infected with single AS (thick 
solid lines), single AJ (dashed lines) or mixed AS±AJ (thin 
solid lines) infections. Shown are overall (AS+AJ) numbers 
of gametocytes only, as our real-time quantitative PCR 
cannot be used to distinguish between AS and AJ 
gametocytes. All data points are based on five replicate mice, 
except for single AJ infections in C57 mice (four mice after 
day 12), mixed AS+AJ infections in C57 mice (four mice 
after day 7) and mixed AS+AJ infections in CBA mice (four 
mice on day 11 and three mice from day 12 onwards). As 
the limit of detection was 100 gametocytes l.i1' blood, y-axes 
start at 2. 
P. chabaudi infection than are naive mice (Buckling & 
Read 2001; Mackinnon & Read 2003). Extrapolating 
from our results, we would expect that only the virulent 
clone would survive in such vaccinated hosts. It is 
important to test this, because this implies that vaccination 
could increase the frequency of virulent clones in a popu-
lation, thus leading to unforeseen consequences of vacci-
nation (Gandon et al. 2001, 2003; Read et al. 2004). 
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Abstract 
Background: Malaria infections are often genetically diverse, potentially leading to competition 
between co-infecting strains. Such competition is of key importance in the spread of drug 
resistance. 
Methods: The effects of drug treatment on within-host competition were studied using the rodent 
malaria P!asmodium chobaudi. Mice were infected simultaneously with a drug-resistant and a drug-
sensitive clone and were then either drug-treated or left untreated. Transmission was assessed by 
feeding mice to Anopheles stephensi mosquitoes. 
Results: In the absence of drugs, the sensitive clone competitively suppressed the resistant clone; 
this resulted in lower asexual parasite densities and also reduced transmission to the mosquito 
vector. Drug treatment, however, allowed the resistant clone to fill the ecological space emptied 
by the removal of the sensitive clone, allowing it to transmit as well as it would have done in the 
absence of competition. 
Conclusion: These results show that under drug pressure, resistant strains can have two 
advantages: (I) they survive better than sensitive strains and (2) they can exploit the opportunities 
presented by the removal of their competitors. When mixed infections are common, such effects 
could increase the spread of drug resistance. 
Background 
Malaria infections often consist of more than one parasite 
genotype 11-31. Humans represent ecological niches for 
co-infecting malaria parasites, with shared predators 
(immune responses) and limited resources, so that com-
petition between coinfecting malaria strains is likely to be 
intense 141. Such competition could strongly affect the rel-
ative transmission of newly arisen drug-resistant strains, 
and thus the spread of drug resistance [5]. 
Resistant and sensitive strains will co-occur in the same 
host both when de nova mutations arise, and when hosts 
acquire resistant and sensitive strains from one mosquito 
bite simultaneously or from different mosquito bites. In 
the absence of drug treatment, the transmission success of 
the resistant strain will depend on its intrinsic fitness and 
competitive ability. However, if drug treatment does 
occur, the resistant strain has two potential fitness advan-
tages. First, it will better survive the drug than the sensitive 
strain. Second, treatment can remove drug-sensitive 
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competitors, thus freeing up ecological space for the resist-
ant strains to occupy; this would increase the relative 
transmission of the drug-resistant strain. This second 
effect, well recognized in theory, has the potential to 
greatly enhance the rate of spread of drug resistance in a 
population 151. However, there is no direct experimental 
evidence that removal of competitors by drug treatment 
does enhance the transmission of drug-resistant parasites. 
This paper reports the first direct experimental demonstra-
tion that competitive release of drug-resistant strains can 
occur following drug treatment. 
Competition between drug-sensitive and -resistant 
malaria clones was studied using the rodent malaria Plas-
modium chabaudi. This parasite is commonly used as a 
model for human malaria [6], and has been extensively 
used to study drug resistance 1 7 1. In the absence of drugs, 
the drug-resistant clone is competitively suppressed by a 
drug-sensitive clone 181. Here, competition between the 
two strains in drug-treated and untreated mice is 
compared. - 
Methods 
Two genetically distinct Plasmodium chabaudi chabaudi 
clones were used: an AS clone resistant to the antifolate 
drug pyrimethamine [9], and AJ, a sensitive clone. These 
clones will be referred to as R (for resistant) and S (for sen-
sitive) from hereon. Hosts were eight weeks old CBA/Ca 
inbred female mice (Ann Walker, University of Edin-
burgh; Harlan, England). Two experiments were per-
formed. In the first, two groups of five mice were infected 
with 106  R parasites, and two groups with 106 R + 106 S 
parasites, as described elsewhere 181. One group from 
each of these two infection types was drug-treated within 
three hours of inoculation and again on days 1, 2 and 3 P1 
(post-infection), using an oral administration of 8 mg 
pyrimethamine per kg mouse body weight. 
Asexual parasite densities and gametocyte densities - the 
latter being the transmission stages to the mosquito - 
were monitored using microscopic examination of thin 
blood smears and determination of red blood cell densi-
ties using flow cytometty (Beckman Coulter), as described 
elsewhere 181. Real-time quantitative PCR was used to dis-
tinguish and quantify R and S parasites in mixed infec-
tions 18,101. This protocol cannot distinguish between 
asexual parasites and gametocytes, but real-time PCR data 
were used as estimates of asexual densities, because game-
tocyte densities were 2-3 orders of magnitude lower than 
asexual densities and thus a negligible component of 
overall parasite numbers. For each infection, two phases 
were distinguished: the acute phase, involving the first 
wave of parasites, and the chronic phase, beginning when 
parasite numbers began to recover after the collapse of 
that first wave around day 12. All parasites had disap-
peared below detectable levels after 50 days. 
In the second experiment, two groups of nine mice were 
infected as above with either R parasites or R+S parasites. 
The subsequent transmission success of clone R was 
assayed by allowing batches of 30 starved Anopheles 
stephensi mosquitoes to feed on 3 mice from each group 
on each of days 7, 14, and 21 P1, as described elsewhere 
[e.g. [111]. Eight days after the feeds, mosquitoes were dis-
sected, and DNA extracted from midguts carrying oocysts. 
Real-time quantitative PCR was subsequently used to 
determine the prevalence of clone R in these mosquitoes. 
All procedures were regulated and carried out under the 
British Home Office Animals (Scientific Procedures) Act 
1986. 
Results 
Two untreated mice infected with R+S parasites died on 
days 10 and 11 P1 respectively, and were excluded from 
the analysis. 
In untreated mice, there were far fewer R parasites during 
the acute phase in mixed infections with clone S than in 
R-only infections (Figures la,lc). However, in drug-
treated mice, where S parasites were entirely removed by 
pyrimethamine (none of the PCR reactions performed 
were positive for clone S), there were as many R parasites 
in mixed infections as there were in R-only infections (Fig-
ures ib, 1 c; Drug treatment x Alone/Mixed interaction: 
F 1 , 14 = 14.4, p = 0.002). Thus, R parasites were competi-
tively suppressed in mixed infections in untreated mice, 
but this suppression was negated when mice were treated 
with pyrimethamine, which effectively removed S 
parasites. 
During the chronic phase, clone R was more numerous in 
untreated mice in mixed infections than in single-clone 
infections (due to the parasite peak around day 21; Fig-
ures la,ld). Thus, in untreated mice in the chronic phase, 
clone R did not suffer from competition, and actually ben-
efited from the presence of clone S (facilitation). In drug-
treated mice, however, R parasites were similarly numer-
ous in mixed- and single- clone infections (Figures lb,ld; 
Drug treatment x Alone/Mixed interaction: F 1 , 14 = 13.8, p 
= 0.002). 
The large peak of R parasites in the chronic phase in the 
untreated mixed infections around day 21 (Figure la) 
coincided with a large peak of gametocytes, the transmis-
sible stages of the parasite (Figure 2a). This was in contrast 
with single-done infections of R in untreated mice, and 
infections in drug-treated mice, where gametocytes were 
mainly produced around day 14 (Figures 2a,2b). Overall, 
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Figure I 
Log asexual parasite densities of the resistant clone R over time in untreated (a) and drug-treated (b) mice infected with R 
alone or a mixture of R+S clones, and total numbers of R parasites produced over the acute (c) and chronic phases (d). All data 
points (mean ± I s.e.m.) are based on 5 replicate mice, except for mixed infections in untreated mice in (a) (4 mice on day II 
and 3 mice from day 12 onwards) and (c) and (d) (3 mice). As the limit of detection was 100 parasites per .tl blood, y-axes in 
(a) and (b) start at 2. 
gametocyte numbers were the same for all four infection 
types (p > 0.05 for both Drug treatment and Alone! 
Mixed). Whether clone R really suffered from competitive 
suppression by clone S in untreated mice thus depends on 
how many of the gametocytes around day 21 were of the 
R genotype, and on how transmissible they were. 
The second experiment assessed transmission to mosqui-
toes on days 7, 14- and 21 P1. It was found that the resist-
ant clone R infected far fewer mosquitoes from mixed 
infections than from single infections (figure 3; Alone/ 
Mixed: p = 0.002), indicating that transmissibility of 
gametocytes produced around day 21 was low, probably 
as a result of transmission-blocking immunity [121. Thus, 
the competitive suppression of the resistant clone in 
untreated infections translated into reduced transmission 
success. 
Discussion 
These results show that drug treatment of malaria infec-
tions can severely affect ecological interactions between 
co-infecting strains. The drug-resistant clone was compet-
itively suppressed by the drug-sensitive clone in untreated 
mice, in terms of both within-host growth and transmis-
sion to the mosquito vector. However, drug treatment 
removed that competitive suppression, and allowed the 
resistant clone to fill the ecological space emptied, giving 
it a substantial and additional fitness benefit in addition 
Page 3 of 6 












Malaria Journal 2004, 3:33 	 http://www.malariajournal.com/content/3/1/33  








0 	10 	20 	30 	40 	50 	0 	10 	20 	30 	40 	50 
Day post-infection 
Figure 2 
Log gametocyte densities over time (mean ± I s.e.m.) for untreated (a) and drug-treated (b) mice. In (a) gametocyte densities 
for mixed Ri-S infections reflect overall R+S gametocytes, as the PCR assay could not distinguish between these (see text); in 
(b) all gametocytes are produced by clone R, as clone S was cleared from mixed infections. All data points are based on 5 rep-
licate mice, except for mixed infections in untreated mice in (a): 4 mice on day II and 3 mice from day 12 onwards. As the limit 
of detection was 100 gametocytes per i.xl blood, y-axes start at 2. 
alone 	mixed 
Figure 3 
Proportions of mosquitoes infected with the resistant clone 
R (mean and 95% confidence interval): mosquitoes fed either 
on mice infected with clone R alone or mice infected with a 
mixture of clones R and S. Means are based on 9 mice (3 on 
day 7, 3 on day 14 and 3 on day 21 P1) from which totals of 
205 (R alone) and 216 (mixed R+S) mosquitoes took a blood 
meal. Infection with clone R was assessed by real-time PCR. 
to the simple survival advantage conferred by resistance. 
Thus, under drug pressure, resistant strains can have two 
advantages: they survive better than sensitive strains and 
they can exploit the opportunities presented by the 
removal of their competitors, thereby increasing their rel-
ative transmission. Competition was studied between two 
unrelated clones, and thus did not reflect the situation in 
which a resistant clone arose de novo 1131, but it seems 
likely that the competitive release following drug therapy 
would also apply there. 
Competitive release following drug treatment will greatly 
enhance the spread of drug resistance 1 5 1. Also, with only 
the resistant strain left in the host, the probability of 
outbreeding is reduced, thus reducing the chances of mei-
otic recombination destroying multi-locus resistance 1141. 
In combination, these two processes could enhance the 
spread of drug resistance, especially in areas with high 
numbers of strains per infection 1 5 1. 
Of course, this is an argument for judicious use of drugs, 
not their non-use. Clearance of drug-sensitive strains from 
mixed infections might enhance the spread of drug resist-
ance, but this has to be offset against the short-term public 
health benefits, such as reducing overall malaria preva-
lence. In these experiments, the drug-sensitive done was 
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also the more virulent clone 181, and when it was cleared 
from mixed infections by drug treatment, mice were less 
sick, in that they lost less weight and became less anaemic 
(results not shown). 
In this experiment, mice were drug-treated before symp-
toms occurred, resulting in competitive release. This situ-
ation perhaps best mimics the case of prophylactic drug 
use, or what might occur to new co-infections in high 
transmission areas where drug use is common. A batteiy 
of more complex experiments will be necessary to deter-
mine if competitive release occurs when treatment follows 
symptoms, and when drugs are used to treat semi-
immune individuals. The facilitation observed in chronic 
infections (Figures la,ld) suggests the situation might be 
very complex. 
Within-host competition in P. chabaudi is now firmly 
established [8,15,16]. Evidence for competition between 
co-infecting genotypes in human malaria infections is 
necessarily indirect, but consistent with this 141. In older 
children and adults, for example, parasite densities do not 
increase with increasing numbers of clones, thus indicat-
ing that parasite clones are not regulated independently 
1171. Given this, and the high frequency of mixed infec-
tions in human malaria 11-3,181 often consisting of both 
resistant and sensitive genotypes [191, and the fact that 
genetic diversity can be altered by antimalaria prophylaxis 
1201, it is highly likely that competitive release of drug 
resistance also occurs in human malaria. Indeed, a recent 
study has already implicated release of within-host 
competition as a key-factor in the spread of drug resist-
ance in Uganda 1211. 
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Evolution and ecology, after the malaria genomes 
Jacobus C. de Roode and Andrew F. Read 
Institute of Cell, Animal and Population Biology, University of Edinburgh, King's Buildings, West Mains Road, Edinburgh EH9 3JT, UK 
The first of the three genomes responsible for malaria 
was published last year; with the recent and much 
hyped publication of parasite and vector genomes in 
Nature and Science respectively, the life-cycle triad is 
now complete. The genomes and associated papers 
demonstrate that evolutionary biologists and ecolo-
gists have much to contribute to malaria control - and 
to the unravelling of some very interesting biology. 
The recently announced sequencing of the genomes of the 
most virulent human malaria parasite Plasmodium 
falciparum [11, its most important vector Anopheles 
gambiae [2], and that of the rodent malaria Plasmodium 
yoelii yoelii [3], has rightly engendered much enthusiasm 
among malaria researchers. It is now possible, for 
instance, to search the full genomes for new drug and 
vaccine targets, and hundreds of candidates are likely to be 
found. Quite when this will impact on malaria control 
is, however, an open question. Novel drugs are certainly 
required. But testing the candidate vaccines that we 
already have is currently rate-limiting and, even if the 
candidates now under trial were actually to work, regu-
latory bureaucracy means it would be 10-15 years before 
they could be deployed (by which time another ten million 
people will have died). The substantial human [41 and 
economic [5] costs of malaria will be with us for some time. 
Malaria research has been dominated by biomedical 
science, but the failure of that science to control malaria is 
largely because of evolution and ecology. Both parasite and 
vector have evolved around drugs; vaccines are not in use 
because the parasite possesses adaptations to promote 
somatic evolution; and the robust ecology of the vector and 
parasite challenge standard public health approaches. The 
time is ripe for ecologists and evolutionists to join bio-
medical researchers in the post-genomic malaria world. 
Not only will this solve many emerging evolutionary 
puzzles, but it will also be an absolute necessity to solve the 
ecological questions that, for example, genetically modified 
(GM) mosquitoes will pose. Here, we summarize some of 
the opportunities that emerge from the Nature and Science 
issues that contained the genomes. 
Evolution of antigen ic -variation 
One puzzle is species divergence in antigenic variation 
genes. Comparison of the P falciparum and P y. yoelii 
genomes reveals that the two species use nonhomologous 
gene families to change their antigenic properties and thus 
escape immune recognition [6]. The P falciparum genome 
Corresponding author: Jacobus C. do Roode (J.de.roodeO'od.ac.uk).  
contains 59 var, 149 rif and 28 stevor genes [1]. Rif and 
stevor genes are probably involved in antigenic variation, 
but var genes definitely are. They encode proteins on the 
red blood cell membrane, where they are involved in 
adhesion to host endothelial receptors [1], thus making 
them a direct target for the immune system. An individual 
parasite only transports one var protein to its cell surface, 
but individuals in a clonal lineage can express different 
proteins and hence evade the immune system. 
The rodent malaria P y. yoelii does not possess homologues 
of var, rif or stevor genes [3], in spite of great overall gene 
synteny between the two species: of - 5300 P falciparum 
genes, >3300 P y. yoelii orthologues were found. A probable 
candidate for P y. yoelii antigenic variation genes is the yir 
gene family, containing no less than 838 genes. They are 
homologous with the vir gene family in the human malaria 
parasite P vivax, encoding proteins that are immunovariant 
in natural infections and that are likely to be involved in 
antigenic variation and immune evasion [3]. 
Differences in the gene families involved could mirror 
differences in the strategies adopted. Even so, why would 
these species differ in the genetic basis of antigenic 
variation? Presumably they share a common ancestor that 
also had to deal with acquired immunity. The differences 
cannot be caused simply by adaptations to different hosts, 
because P y. yoelii and P vivax have homologous immune 
evasion genes. Searches for homologous gene families in 
other rodent and primate malarias, as well as those in birds 
and lizards, will be very interesting, especially given that 
more rigorous Plasnzodium phylogenies are beginning to 
emerge [7]. The nature of selection on diversity-generating 
mechanisms has long been the subject of conventional 
evolutionary biology. With the genomes in our hands, it is 
now time to apply this expertise to infectious disease [6]. 
Evolution of multigene families 
Antigenic variation genes are not the only genes to occur in 
gene families. In fact, both the Plasmodium and Anopheles 
genome show many expansions of genes and gene families, 
possibly providing parasite and vector with a great adap-
tive ability. 
The Anopheles genome contains many gene families, 
and these are often highly divergent from those in 
Drosophila melanogaster. For instance, the 242 Anópnetes 
genes from 18 families implicated in innate immunity 
show marked diversification from Drosophila and a deficit 
of orthologues [8]. Of the 79 Anopheles G protein-coupled 
receptors identified as candidate odorant receptors, 27 do 
not have close Drosophila relatives [9]. It is tempting to 
attribute these genome-wide differences to selection 
http://tree.trends.com  
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pressures from different food sources. But why should 
detecting rotting fruit or humans require radically different 
genetic control? And why should the fruit- and blood-borne 
pathogens require such different immune control? Has gene 
proliferation been a cause or a consequence of the adaptive 
plasticity that has the malaria parasite and its vector 
resilient in the face of 100 years of medical onslaught? 
Vector behaviour and physiology 
Malaria parasites decrease vector fecundity [101 and 
increase biting rate and blood-meal size [11]. These altera-
tions could be adaptive for the parasite (e.g. reallocation from 
reproduction to parasite nutrition) or host (reallocation from 
reproduction to immune function), or adaptive for neither. 
Differentiating between these alternatives can be done by 
measuring the fitness consequences of the altered pheno-
types for the players involved, but it is not always easy to 
manipulate these experimentally. A different approach is to 
determine which genes are running the show. 
Holt et al. [2] present a study of blood-meal-fed and 
nonblood-meal-fed mosquitoes, and show that genes 
involved in egg melanisation and yolk and oocyte pro-
duction were upregulated in blood-fed mosquitoes. A next 
step is to compare gene expression patterns of mosquitoes 
fed infected or uninfected blood. Alternatively, are there 
Anopheles-like genes in the malaria genome? These might 
be good candidates as host-manipulation genes. 
One candidate gene involved in the decreased fecundity 
is one of 35 putative regulatory genes [121. This gene is 
closely related to an Aedes aegypti homologue that is 
expressed in ovaries only during reproductive arrest and 
the first 24 hr of a reproductive cycle when ecdysteroids 
are being synthesized. This receptor is possibly involved in 
hormonal regulation and physiological pathways that, in 
D. melanogaster and Caenorhabditis elegans, are involved 
in the link between longevity and fecundity. If this is the 
key regulatory switch between arrest/longevity and repro-
duction in An. gambiae, it could be the target mechanism 
of any adaptive manipulation of the reproductive physi-
ology of the mosquito by the parasite. 
Ecological challenges of GM mosquitoes 
In the past, malaria control has been achieved mainly by 
mosquito control [13]; With the increasing problems of 
insecticide resistance, many malaria researchers now 
focus their hopes on changing the genetic makeup of the 
mosquito to block transmission or to decrease mosquito 
fitness. The genomes will provide many candidate genes to 
accomplish this. Rapidly advancing technology has 
already made it possible to create transgenic mosquitoes 
that do not transmit malaria [14]. Indeed, we are now at a 
stage at which the technological challenges of manipulat-
ing genes in vivo are trivial compared to the ecological 
challenges of using this technology to control malaria [15]. 
There is room for a lot more thinking about which genes 
should be used and then how they should be driven into wild 
populations [151. This is an area that has already seen 
significant contributions from evolutionary biologists [161. 
But much more is needed, particularly to fill out our 
incomplete understanding of parasite transmission ecology 
[171. For example, we need to know more about gene flow  
within .and between mosquito populations. What are the 
fitness consequences of genetic modification of mosquitoes? 
And what counter evolution by the parasite will GM 
mosquitoes prompt? Scott et al. [17] argue that continued 
evaluation of GM technology will require release of GM 
mosquitoes on isolated oceanic or ecological islands that have 
been thoroughly characterized with respect to the genetic 
and ecological makeup of local mosquito vector populations 
and site-specific patterns of pathogen transmission and 
disease. That is a lot of untrendy 'muddy boots' ecology. 
Outlook 
Clearly, the molecular biologists who make GM mosquitoes 
will need ecologists to tackle these complicated ecological 
problems. In a time of increasingly big science, even the early 
findings from the post-genomic era show that readers of 
TREE will be as needed in malaria research as are readers of 
Trends in Genetics, Parasitology or Microbiology. Indeed, in 
an academic world where we know an enormous amount 
about banana-dwelling flies, one could argue that a focus by 
evolutionary biologists and ecologists on an organism that is 
at least as interesting as a fruit fly is long overdue. Research 
funding opportunities are arguably the only benefit of the 
catastrophic death toll from malaria. 
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alaria in the 
frame 
The publication last year of the genome sequence of 
the malaria parasite P falciparum offers new hope for 
the discovery of a vaccine, says Jaap de Roode 
26 
Genome sequence of malaria parasite, 
P fakiparum, reveals 23 million base 
pairs and a predicted 5279 proteins 
Search for a single protein vaccine 
yields 50-100 new candidates 
'Priming' and 'boosting' methods raise 
the immune response 
Trials of RTS,S vaccine demonstrate 
34-47 per cent protection among 
African males 
Estimated seven to 23 years before first 
African child vaccinated 
SEPTEMBER 2003 	'U 	F' ' BLT.,IN 
G I FFAATTATAACICTTTT ... ONE Jick of the mouse on any computer ounected to the World Wide 'X'ch. 
,ind ilioti,ands ofA.s, Cs, Gs and Ts glide over 
tile Lm npucer screen. We are at http:/' 
PlasmoDB.org , the websie that hosts the data-
base containing the full genome and prediere' 
protein makeup of the malaria parasite I/u 
modiurn fi'aiciparurn. Gone live in 2000, aiw 
completed last October, the website now c 
ceives thousands of hits every day from ru 
searchers all over the world who are looking t 
things with fancy names such as TRAI' 
GUJRP and SALSA. 
Behind these seemingly trivial four lettcr ,  
the alphabet lies a human tragedy: the As, ( 
Gs and Ts stand for the four building bloc!, 
that make up the genetic backbone of a par.-
site that kills almost one person every 30 5Cc 
onds. Mounting to over a million deaths 
year, most of these are children in sub-Saharaii 
Africa. Another 500 million people suffer frori: 
anaemia and immune suppression that lease 
them vulnerable to other fatal diseases, exa.uF 
bated by their poverty and limited access 
cure and treatment. More people suffer h 
malaria today than ever before in human hit-
ry; and with the malaria parasite becoming it- - 
creasingly resistant to available drugs, it seuti 
clear that the world is desperately in need 01 - 
vaccine. 
More than six years ago, a consortium 1 
labs from around the world decided to rake iii 
the huge task of sequencing the full genonse Ii 
the malaria parasite and so gain more insight 
in its genetic and protein make-up. The publi-
cation of this genome sequence in Narure last 
October revealed 23 million base pairs, pre-
dicted 5279 proteins, and was unsurprisingly 
heralded as the great breakthrough in malaria. 
Now that we can start to unveil the biology, of 
PfaIciparurn, we can look for its Achilles' heels 
that we could use to fight it, and this will un-
doubtedly lead to the discovery of many new 
drug targets. Indeed, it will also lead to the dis-
covery of genes, proteins or portions of the 
malaria parasite that could be used as a vac-
cine. But most researchers now realise that it 
will still he many years, and many millions of 
malaria victims, before all the problems are 
solved to make a vaccine candidate into an ef-
fective and life-saving entity. 
St 1 1 K ~ J)I 	I LltII, SI 	tIC' 	0115151 of de1il ui 
inactivated forms of the bacterium or virus 
that causes it. Indeed such an approach works 
well enough with malaria: 90 per cent of vol-
unteers infected with irradiated malaria sporo-
zoites are well protected against malaria. But 
producing them in large enough numbers has 
proven impossible: malaria parasites are not so 
easily produced in flasks or Petri dishes as bac-
teria or virus particles. 
That is why there still is no malaria vaccine, 
and why scientists have been searching for sin-
gle malaria proteins that on their own trigger a 
strong enough immune response to give pro-
tection against the disease. Given the parasite's 
lifecycle, there seems ample choice: any pro-
tein that triggers an immune response that pre-
vents liver ccli invasion (preventing infection), 
red blood cell invasion (preventing disease), or 
F 	hF -iF iF, 	Ft c 1lF1III 
sIiifj tl 	is .1 siiiic. l3u1 it is a eIi.I!Ieilging 
task: even though several such proteins have 
been found and do trigger some kind of ml- - 
mune response, no one has yet found a protein 
that on its own can mimic infection with the 
full parasite, consistiisg of thousands of pro-
teins. With the genome in our hands, however, 
some researchers now hope that we can identi-
fy which of the predicted 5279 proteins could 
he used in such a way. 
Henk Stunnenberg at the University of Ni)-
megen in The Netherlands, has for some time 
now worked on a potential vaccine that he 
hopes will disrupt parasite fertilisation in the 
mosquito, and block parasite transmission to 
new patients. With the genome available, he is 
optimistic that such a vaccine will be within 
reach. He recently set out to determine which 
proteins are produced during different stages 
Mosquito bite 
Malarial disease starts with the bite of a nios-
quito that injects tiny parasites called sporo-
zoites into the human bloodstream. These 
sporozoites migrate to the liver, where they iii-
vade liver cells, replicate, and burst out of rite 
cells. One sporozoite can give rise to no less 
than 30000 new parasites that travel to the 
blood where they start causing disease. The 
parasites invade red blood cells, replicate with-
in them and rupture the cells, before invading 
more red blood cells. This process repeats itself 
every 48 hours, and results in the fevers so 
characteristic of malaria. Some parasites make 
the red blood cells stick to blood vessels (there-
by in some cases killing the patient), while oth-
ers escape this ongoing cycle by turning into 
gametocytes — precursors of sex cells - of 
which male and female forms exist. Gamero-
cvtes, when taken up by a new blood-feeding 
mosquito, mature and fertilise each other to 
give rise to a new generation of malaria para-
sites, ready to infect a new patient. 
fivary 
gland 
E::otes 	 , 
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The malaria genome will not only come in handy for developing vaccines; many malaria 
researchers believe it will also be a great tool with which to design new drugs against the 
parasite. 
For decades doctors in developing countries have depended an relatively cheap drugs 
such as chloroquine and Fansidar. But the malaria parasite has quickly grown resistant to 
these drugs; it took less than 15 years for resistance to spread through the whole of 
Africa. Today these drugs are useless in many areas. And because many of the drugs that 
are used these days are chemically related, resistance against one drug can facilitate resis-
tance against another. The world is thus desperately in need of new classes of drugs, un-
related to the ones now in use. 
There is good hope that the Plasmodiurn falciparum genome will help in identifying 
these new drugs. Perhaps the most interesting target for drug development is the apico-
plast, an organelle located inside the malaria parasite. Related to chloroplasts in plants, it 
is the only place in the parasite where lipid biosynthesis occurs, and is therefore vital for 
the parasite's survival. Because this organelle has no human counterpart, it is an ideal 
drug target: drugs will target the parasite, but leave the malaria patient unharmed. The 
sequencing project revealed that about 10 per cent of all the genes in the malaria 
genome code for proteins that head for the apicoplast. Therefore it should offer no less 
than 500 new drug targets. 
Even before completion of the malaria genome, researchers already identified genes in-
volved in the apicoplast's lipid biosynthesis. They could do this, because during the years 
that it took to sequence the genome, the database containing the sequence was regularly 
updated. A group of German researchers identified enzymes in the isoprenoid pathway, 
and used two existing drugs to target these. Doing this, they could inhibit growth of P 
falciparum parasites in culture, even though these parasites were resistant to other drugs. 
Interestingly, one of these drugs, fosmidomycin, had been developed for treating urinary 
infections. It is now in clinical trials as an antimalarial drug. 
Other researchers - from both the US and Great Britain - identified the so-called shiki-
mate pathway in P falciparum. This is a pathway that in plants is located in chloroplasts, 
and is involved in the production of, among other compounds, folate and aromatic 
nnn.iiirk .-'t HiH q pesticide commonly used to kill weeds, inhib-
ited growth of P falciparum parasites. 
The apicoplast is not the only opportu-
nity to create new drug treatments, how-
aver. Researchers at St George's Hospital 
Miedical School in London, for example, 
have recently found a way to stop the 
malaria parasite's sugar transport from 
working. By blocking the transporter that 
absorbs the glucose into the parasite, they 
were able to kill malaria parasites, because 
sugar is vital for the parasite's growth in 
red blood cells. 
The next few years will see malariolo-
gists unravelling the molecular biology 
and biochemistry of the parasite. We can 
therefore expect many more and new anti-
malaria drugs. D 
1 t he malart,i It fccvcle. lo do this, his team 
,iiid colleagues at the University of Southern 
I)enrnark extracted proteins from blood-stage 
parasites, gametocytes and gametes. They 
broke these proteins into smaller pieces (pep-
tides) by using rrypsin, an enzyme that cleaves 
proteins at every lysine or arginine residue it 
a)unters. Stunnenberg then ran these pep- 
as through a mass spectrometer to deter-
mine  the mass of each of the 
ptides. Because each of the peptides has its 
own specific mass (based on which and how 
many amino acids it consists of), this results in 
peptide fl ngerprints'. And because computer 
.tlgorithms are able (0 predict amino acid se-
uences and therefore peptide fingerprints on 
the basis of DNA sequences, Srunnenberg was 
,ible to compare his fingerprints with those in 
rue malaria database. Doing this he found 
about 1300 proteins: 23 per cent of all the pre-
dicted malaria proteins. 
Most of these are not interesting as vaccine 
,sndidares, Stunnenberg points out, because  
they don't occur on the outside of the parasites 
are not seen by the immune system, and will 
therefore not trigger a useful Immune re-
sponse. The most interesting proteins are those 
that occur on the outside of parasites, and the 
researchers set out to determine which of the 
1300 proteins were likely to be found here. 
They did this by searching for signal pcptides - 
regions of proteins that indicate they occur on 
the outside of cell membranes - and trans-
membrane domains - regions that suggest the 
proteins are attached to a membrane. Doing 
this they found roughly 150-200 potentIal 
ransmembrarte proteins. 'Half of those occur 
on gametocytes and gametes', says Stunnen-
berg. 'so we have some 50-100 new candidates 
[for transmissioit blocking vaccines] that we 
teed to investigate.' 
Stunncnberg now hopes to obtain blood 
serum from malaria patients, and see if this 
contains antibodies that bind to these proteins. 
If so, then they are apparently visible to the 
immune system, and nsight be good vaccine 
candidates. It is also possible to find homolo-
OUS genes in the rodent malaria parasite P/us-
uodzum berghei. In the laboratory, this parasite 
infects mice, and it is easily manipulated. By 
disrupting the particular genes that code for 
these proteins, you could find out if indeed the 
parasite's reproduction is disrupted. 
In a similar way, Stunnenberg, along with 
colleagues from the University of Leiden, has 
already identified the so-called Pfs48/45 pro-
tein, present on the surface of gametocytes. 
When disrupting the gene in 1? berg/sri, male 
gametocyres turn out to be infertile, something 
that also happened with antibodies that 
blocked the protein. It would therefore be a 
great vaccine: the human body would produce 
antibodies against it, blocking fertilisation in 
the mosquito and preventing malaria transmis-
sion. 'It would be an excellent transmission 
blocking vaccine', Stunnenberg says, 'if it was 
tior so difficult to fold it cotrectly.' For only in 
its correct conformation does the protein trig-
ger antibodies in the human body. Mimicking 
that conformation in the lab has so far proven 
ttnpossible, and large-scale production of it for 
use as a vaccine seems therefore out of reach. 
But within the 50-100 new candidates, Stun-
nenberg hopes there will be proteins that have 
similar effects, but which can more easily be 
produced in the lab. 
Priming and boosting 
While Stunnenberg focuses his hope on an 
anti-transmission vaccine, many other re-
searchers have stepped into the 'post_genomic 
malarial era' to identify vaccines that will pre-
vent parasite invasion of liver cells or red blood 
cells, and so prevent infection or alleviate dis-
ease. Ultimately, they hope, this will result in 
many proteins that trigger immunity against 
different stages of the parasite. Combined 
within one vaccine, these might form the ulti-
mate preventative: a parasite escaping an 'anti-
liver' vaccine would still be killed by a vaccine 
that blocks red blood cell invasion. 
With the genome in our hands, it seems 
likely that tens, maybe even hundreds of such 
proteins will be found over the coming few 
years. But Adrian Hill of the University of ox-
ford cautions against too much optimism. 'It is 
important to have the genome', he says, 'but it 
is not suddenly going to make a successfi.il vac-
cine.' He says that the reason we still don't have 
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a malaria vaccine, is not so much the lack of 
vaccine candidates - there must he 60 or more 
now' - but how effective they are at stimulat-
ing the immune system: even though irradiat-
ed parasites triggel a protective immune 
response, most malaria proteins on their own 
don't, 
The TRAP protein, for example, a protein 
involved in the invasion of liver cells, is a great 
vaccine candidate, but does not elicit a strong 
immune response on its own. Over the past 
Few years. however, Hill and his colleagues 
save developed a method to increase the im-
rnune response by so-called 'pruning' and 
boosting'. They incorporated the TRAP gene 
vith some other bits of malaria DNA into a 
alasniid, a circular piece of DNA. When in-
ected into muscle tissue, muscle cells translate 
:his DNA into malaria proteins against which 
:he body produces an important class of im-
nune cells called T-cells. If the researchers 
hen also injected a weakened virus that was 
nodified to contain the same protein and 
nalaria DNA bits, the body generated a much 
tronger immune response. Hill thinks this is 
ecause the virus triggers a stronger response 
han the plasmid, and giving the priming 
)NA vaccine causes the induced T-cells to be-
:ome malaria specific. 
Hill points out that these vaccines have al-
'eady been tested in safety trials and clinical 
rials in both the UK and the Gambia in 
frica. After challenge with sporozoites, he 
ound significant levels of protection in vacci-
sated people. 'And that can mean they don't 
et malaria at all. or t he' have a significant  rc- 
cluction of infection', he says. 
He also mentions results from trials with the 
RTS,S vaccine, developed by GlaxoSmithKline 
Biologicai. This vaccine contains a portion of 
the circumsporozoite protein, which occurs on 
the surface of sporozoites, and is combined 
with a hepatitis B surface antigen to trigger a 
stronger immune response. In 306 male adult 
volunteers in the Gambia, it resulted in 34 per 
cent protection when given in three doses, and 
four doses resulted in 47 per cent protection. 
Even though protection did not last, but 
waned over time, Hill says: 'there is real 
progress. Five years ago, there was no vaccine 
that caused protection in humans. Now, at 
least two vaccines give clear protection'. 
Hill says that a loi more has to he done to 
increase levels of protection by changing the 
way that vaccines are administered, because 
current levels of protection are still far from 
satisfactory. Now where does the genome come 
in? 'Maybe once we learn more about how to 
get these strong responses', Hill says, 'then you 
would try a variety of vaccine candidates.' 
Within reach 
With progress both in learning how to in-
crease protection with existing vaccines, and 
the discovery of more - and maybe better - 
vaccine candidates emerging from the malaria 
genome, many researchers in the field now be-
lieve a vaccine is within reach. But they warn 
it will as least be another seven to 23 difficult 
years before we will see the first African child 
vaccinated. 
The fact is that besides the rechnial hurdles 
there are many other obstacles to overcome: 
once a good enough vaccine is found, it will 
have to be produced in large quantities, and a 
whole infrastructure to deliver it to the people 
who need it most must also be put in place. Of 
the many problems, however, the most impor-
tant one might be economic. It is now clear 
that for a disease that almost exclusively hits 
the poor, we need guaranteed markets to en-
courage pharmaceutical uIrms to license and 
manufacture vaccines. At the moment, the 
public support for a malaria vaccine is roughly 
tenfold less than the support for a vaccine for 
HIV, a disease of comparable global impact. 
For the time being, even the initial follow-
up of the genomic research seems a huge task. 
Keeping a mass spectrometer in the air for only 
half a year, would cost Henk Stunnenberg 
£50000. With limited funding for research in 
general, and for developing world diseases in 
particular, he says it won't be easy to obtain 
that amount of nsoney. But with another 
malaria victim every 30 seconds, and more 
than 50 potential vaccine candidates, he is de-
termined not to give up. 
Jaap dv Rooa'e is PhD student at the Institute of 
Cell, Animal and Population Bzoloe,; L'nu'vrnv 
ofEdinburgli. 
Further reading 
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